# TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms ,,,,,,,,,,,
"# Nicholas L Calistri1, Tiera A. Liby1, Zhi Hu1, Hongmei Zhang1, Mark Dane1, Sean M. Gross1, Laura M. Heiser1,2,# (1 Biomedical Engineering Department, Oregon Health & Science University, Portland Oregon
2 Knight Cancer Institute, Oregon Health & Science University, Portland Oregon
# Corresponding author: heiserl@ohsu.edu)",,,,,,,,,,,
# Supplementary Information 3,,,,,,,,,,,
ONTOLOGY,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count,geneset,enrichmentDB
NA,R-HSA-909733,Interferon alpha/beta signaling,May-37,77/11009,5.371196825277659e-6,0.001552276,0.001300395,2537/684/9636/10410/3106,5,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-6798695,Neutrophil degranulation,Aug-37,480/11009,1.5547046019144043e-4,0.022465481497663142,0.018820108,684/567/3106/1915/3958/6590/1938/2919,8,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-913531,Interferon Signaling,Jun-37,269/11009,2.474596313926579e-4,0.023302159,0.019521021660329076,2537/684/9636/10410/567/3106,6,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72766,Translation,Jun-37,292/11009,3.845101639649685e-4,0.023302159,0.019521021660329076,8667/3646/1937/1915/51386/1938,6,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-375276,Peptide ligand-binding receptors,May-37,201/11009,5.231376422404276e-4,0.023302159,0.019521021660329076,56477/351/301/3576/2919,5,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1236977,Endosomal/Vacuolar pathway,Feb-37,11/11009,5.930927247048488e-4,0.023302159,0.019521021660329076,567/3106,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",Mar-37,52/11009,6.895676500893351e-4,0.023302159,0.019521021660329076,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-879415,Advanced glycosylation endproduct receptor signaling,Feb-37,13/11009,8.375577114070017e-4,0.023302159,0.019521021660329076,351/3958,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-6809371,Formation of the cornified envelope,Apr-37,129/11009,8.808434124010708e-4,0.023302159,0.019521021660329076,25984/3866/3880/3887,4,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-380108,Chemokine receptors bind chemokines,Mar-37,59/11009,9.980856799470202e-4,0.023302159,0.019521021660329076,56477/3576/2919,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72649,Translation initiation complex formation,Mar-37,59/11009,9.980856799470202e-4,0.023302159,0.019521021660329076,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72702,Ribosomal scanning and start codon recognition,Mar-37,59/11009,9.980856799470202e-4,0.023302159,0.019521021660329076,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",Mar-37,60/11009,0.001048194,0.023302159,0.019521021660329076,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-844456,The NLRP3 inflammasome,Feb-37,16/11009,0.001280392,0.026430958901384357,0.022142125,10628/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8876725,Protein methylation,Feb-37,19/11009,0.001813015,0.034930753,0.029262696020454993,1915/1938,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-622312,Inflammasomes,Feb-37,21/11009,0.002217113,0.040046595,0.033548413,10628/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9679506,SARS-CoV Infections,Jun-37,414/11009,0.002355773,0.040048144470455065,0.033549711,684/9636/567/5349/3106/1915,6,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1236974,ER-Phagosome pathway,Mar-37,90/11009,0.003358083,0.049060373,0.041099566,5720/567/3106,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9660826,Purinergic signaling in leishmaniasis infection,Feb-37,26/11009,0.003395182,0.049060373,0.041099566,10628/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9664424,Cell recruitment (pro-inflammatory response),Feb-37,26/11009,0.003395182,0.049060373,0.041099566,10628/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-156842,Eukaryotic Translation Elongation,Mar-37,94/11009,0.003796441,0.052234875150114844,0.043758955689405986,1937/1915/1938,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-418594,G alpha (i) signalling events,May-37,318/11009,0.003976357,0.052234875150114844,0.043758955689405986,56477/351/301/3576/2919,5,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",Feb-37,29/11009,0.004214583,0.052957154,0.044364033,567/3106,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72689,Formation of a pool of free 40S subunits,Mar-37,102/11009,0.004774277,0.057321781,0.048020432,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),May-37,335/11009,0.004958632,0.057321781,0.048020432,56477/351/301/3576/2919,5,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1236975,Antigen processing-Cross presentation,Mar-37,105/11009,0.00517667,0.057540683,0.048203814,5720/567/3106,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-6805567,Keratinization,Apr-37,214/11009,0.005548062,0.059384814,0.049748706,25984/3866/3880/3887,4,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,Mar-37,112/11009,0.006193533,0.063259599,0.052994747,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,Mar-37,113/11009,0.006347849,0.063259599,0.052994747,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72613,Eukaryotic Translation Initiation,Mar-37,120/11009,0.007492675,0.069851064,0.058516644298156284,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-72737,Cap-dependent Translation Initiation,Mar-37,120/11009,0.007492675,0.069851064,0.058516644298156284,8667/3646/51386,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,Mar-37,126/11009,0.008565436,0.07735659,0.064804282,9636/567/3106,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-162909,Host Interactions of HIV factors,Mar-37,130/11009,0.009328373,0.081693936,0.068437826,5720/293/567,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2172127,DAP12 interactions,Feb-37,45/11009,0.009936194,0.082044571,0.068731566,567/3106,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-445355,Smooth Muscle Contraction,Feb-37,45/11009,0.009936194,0.082044571,0.068731566,103910/301,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-6783783,Interleukin-10 signaling,Feb-37,47/11009,0.010803972720989345,0.086731892,0.072658296,3576/2919,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",Feb-37,57/11009,0.015619485962077594,0.12200084981190336,0.10220431781729293,10628/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-351202,Metabolism of polyamines,Feb-37,59/11009,0.016674828,0.1268164560516683,0.10623851718041781,5720/6303,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-500792,GPCR ligand binding,May-37,468/11009,0.019279155377150234,0.14286348471785687,0.11968166630889482,56477/351/301/3576/2919,5,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-449147,Signaling by Interleukins,May-37,473/11009,0.020091226088772902,0.14515910849138422,0.1216047894846781,5720/351/301/3576/2919,5,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9824439,Bacterial Infection Pathways,Feb-37,73/11009,0.024871434797733502,0.17531328430597518,0.14686598211755342,567/1938,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9705683,SARS-CoV-2-host interactions,Mar-37,203/11009,0.030316581202739227,0.20364311007730831,0.17059885382546316,9636/567/3106,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,Feb-37,82/11009,0.030844454360801347,0.20364311007730831,0.17059885382546316,9636/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-397014,Muscle contraction,Mar-37,205/11009,0.031084257562044987,0.20364311007730831,0.17059885382546316,103910/5349/301,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-164940,Nef mediated downregulation of MHC class I complex cell surface expression,Jan-37,10/11009,0.033118429666551874,0.20364311007730831,0.17059885382546316,567,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-70635,Urea cycle,Jan-37,10/11009,0.033118429666551874,0.20364311007730831,0.17059885382546316,445,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,Jan-37,10/11009,0.033118429666551874,0.20364311007730831,0.17059885382546316,10628,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-73614,Pyrimidine salvage,Jan-37,11/11009,0.036370963,0.21144241244828282,0.1771325982994174,1890,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-71291,Metabolism of amino acids and derivatives,Apr-37,376/11009,0.03642307,0.21144241244828282,0.1771325982994174,5720/100131187/445/6303,4,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-156902,Peptide chain elongation,Feb-37,90/11009,0.036581732,0.21144241244828282,0.1771325982994174,1915/1938,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-3371511,HSF1 activation,Jan-37,12/11009,0.03961285,0.21521579177357672,0.18029368824593933,1915,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-73621,Pyrimidine catabolism,Jan-37,12/11009,0.03961285,0.21521579177357672,0.18029368824593933,1890,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Jan-37,12/11009,0.03961285,0.21521579177357672,0.18029368824593933,293,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-877300,Interferon gamma signaling,Feb-37,96/11009,0.041133912366302476,0.21521579177357672,0.18029368824593933,567/3106,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9692914,SARS-CoV-1-host interactions,Feb-37,96/11009,0.041133912366302476,0.21521579177357672,0.18029368824593933,684/1915,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-162906,HIV Infection,Mar-37,231/11009,0.041993662,0.21521579177357672,0.18029368824593933,5720/293/567,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-201681,TCF dependent signaling in response to WNT,Mar-37,232/11009,0.042447405297902675,0.21521579177357672,0.18029368824593933,5720/6422/6659,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1614558,Degradation of cysteine and homocysteine,Jan-37,15/11009,0.049274971,0.24085132357719807,0.20176945701240415,100131187,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,Jan-37,15/11009,0.049274971,0.24085132357719807,0.20176945701240415,6422,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,Feb-37,108/11009,0.050837131,0.24085132357719807,0.20176945701240415,301/3576,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8957275,Post-translational protein phosphorylation,Feb-37,108/11009,0.050837131,0.24085132357719807,0.20176945701240415,351/3490,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),Feb-37,110/11009,0.052527919,0.24096140657692902,0.20186167733634555,3490/3576,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-977225,Amyloid fiber formation,Feb-37,110/11009,0.052527919,0.24096140657692902,0.20186167733634555,567/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9020702,Interleukin-1 signaling,Feb-37,115/11009,0.056842217630371276,0.2566781389871453,0.21502812590436504,5720/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8878166,Transcriptional regulation by RUNX2,Feb-37,121/11009,0.062178230981499105,0.2764539808254345,0.23159503037643392,5720/3958,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5625900,RHO GTPases activate CIT,Jan-37,20/11009,0.065168714,0.2790551272410195,0.23377410040223814,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5627117,RHO GTPases Activate ROCKs,Jan-37,20/11009,0.065168714,0.2790551272410195,0.23377410040223814,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Feb-37,125/11009,0.065827866,0.2790551272410195,0.23377410040223814,351/3490,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,Jan-37,21/11009,0.068316294,0.2790551272410195,0.23377410040223814,567,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,Jan-37,21/11009,0.068316294,0.2790551272410195,0.23377410040223814,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Jan-37,22/11009,0.071453562,0.2790551272410195,0.23377410040223814,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8863678,Neurodegenerative Diseases,Jan-37,22/11009,0.071453562,0.2790551272410195,0.23377410040223814,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Jan-37,22/11009,0.071453562,0.2790551272410195,0.23377410040223814,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9613829,Chaperone Mediated Autophagy,Jan-37,22/11009,0.071453562,0.2790551272410195,0.23377410040223814,1915,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Feb-37,133/11009,0.073337497,0.282593823,0.2367385877689517,567/3106,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8956321,Nucleotide salvage,Jan-37,23/11009,0.07458055,0.2836023549402849,0.23758346980974512,1890,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5627123,RHO GTPases activate PAKs,Jan-37,24/11009,0.077697291,0.28830004366063816,0.24151888560170015,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9694516,SARS-CoV-2 Infection,Mar-37,299/11009,0.078330412,0.28830004366063816,0.24151888560170015,9636/567/3106,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-400685,Sema4D in semaphorin signaling,Jan-37,25/11009,0.080803818,0.28830004366063816,0.24151888560170015,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-933542,TRAF6 mediated NF-kB activation,Jan-37,25/11009,0.080803818,0.28830004366063816,0.24151888560170015,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,Jan-37,25/11009,0.080803818,0.28830004366063816,0.24151888560170015,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9678108,SARS-CoV-1 Infection,Feb-37,142/11009,0.08210108,0.2893562451450283,0.24240370199729194,684/1915,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,Jan-37,27/11009,0.08698636,0.299274501,0.250712567,3576,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9635486,Infection with Mycobacterium tuberculosis,Jan-37,27/11009,0.08698636,0.299274501,0.250712567,567,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,Jan-37,28/11009,0.09006244,0.30621229499140784,0.2565245960590924,567,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1614635,Sulfur amino acid metabolism,Jan-37,29/11009,0.093128435,0.3073681674952085,0.25749291030376237,100131187,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-446652,Interleukin-1 family signaling,Feb-37,153/11009,0.093228589,0.3073681674952085,0.25749291030376237,5720/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2424491,DAP12 signaling,Jan-37,30/11009,0.096184377,0.3073681674952085,0.25749291030376237,567,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-3928663,EPHA-mediated growth cone collapse,Jan-37,30/11009,0.096184377,0.3073681674952085,0.25749291030376237,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168255,Influenza Infection,Feb-37,157/11009,0.097380276,0.3073681674952085,0.25749291030376237,9636/293,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-195721,Signaling by WNT,Mar-37,331/11009,0.098996402,0.3073681674952085,0.25749291030376237,5720/6422/6659,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5339562,Uptake and actions of bacterial toxins,Jan-37,31/11009,0.099230299,0.3073681674952085,0.25749291030376237,1938,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-381042,PERK regulates gene expression,Jan-37,32/11009,0.10226623263883383,0.3073681674952085,0.25749291030376237,3576,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5656169,Termination of translesion DNA synthesis,Jan-37,32/11009,0.10226623263883383,0.3073681674952085,0.25749291030376237,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9609507,Protein localization,Feb-37,164/11009,0.10477155737999874,0.3073681674952085,0.25749291030376237,293/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9658195,Leishmania infection,Feb-37,164/11009,0.10477155737999874,0.3073681674952085,0.25749291030376237,10628/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9824443,Parasitic Infection Pathways,Feb-37,164/11009,0.10477155737999874,0.3073681674952085,0.25749291030376237,10628/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1592389,Activation of Matrix Metalloproteinases,Jan-37,33/11009,0.1052922096263863,0.3073681674952085,0.25749291030376237,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5357956,TNFR1-induced NF-kappa-B signaling pathway,Jan-37,33/11009,0.1052922096263863,0.3073681674952085,0.25749291030376237,10399,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-432720,Lysosome Vesicle Biogenesis,Jan-37,35/11009,0.11131442069759201,0.3185135404119217,0.26682977342830805,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,Jan-37,35/11009,0.11131442069759201,0.3185135404119217,0.26682977342830805,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-176033,Interactions of Vpr with host cellular proteins,Jan-37,36/11009,0.1143107179851981,0.32073589803613833,0.26869151902499294,293,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8956319,Nucleotide catabolism,Jan-37,36/11009,0.1143107179851981,0.32073589803613833,0.26869151902499294,1890,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9735869,SARS-CoV-1 modulates host translation machinery,Jan-37,37/11009,0.11729718508029907,0.32595083161736954,0.27306024866871237,1915,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,Jan-37,39/11009,0.12324075402662726,0.339205504,0.2841641446227997,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168276,NS1 Mediated Effects on Host Pathways,Jan-37,40/11009,0.12619791830201654,0.3408523213951662,0.28554374037839453,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,Jan-37,40/11009,0.12619791830201654,0.3408523213951662,0.28554374037839453,684,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,Jan-37,42/11009,0.13208316179273838,0.3498941237870144,0.29311836995451945,6659,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-425397,"Transport of vitamins, nucleosides, and related molecules",Jan-37,42/11009,0.13208316179273838,0.3498941237870144,0.29311836995451945,293,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-983169,Class I MHC mediated antigen processing & presentation,Mar-37,381/11009,0.1351868123865493,0.3498941237870144,0.29311836995451945,5720/567/3106,3,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2559583,Cellular Senescence,Feb-37,195/11009,0.13917506000980728,0.3498941237870144,0.29311836995451945,3490/3576,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation,Jan-37,45/11009,0.14083877750121143,0.3498941237870144,0.29311836995451945,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5357905,Regulation of TNFR1 signaling,Jan-37,48/11009,0.14950842961576138,0.3498941237870144,0.29311836995451945,10399,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-73893,DNA Damage Bypass,Jan-37,48/11009,0.14950842961576138,0.3498941237870144,0.29311836995451945,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),Jan-37,49/11009,0.15237935271622793,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,Jan-37,50/11009,0.15524084577731379,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),Jan-37,51/11009,0.15809293891594312,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-180534,Vpu mediated degradation of CD4,Jan-37,52/11009,0.1609356621555954,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,Jan-37,52/11009,0.1609356621555954,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,Jan-37,52/11009,0.1609356621555954,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69610,p53-Independent DNA Damage Response,Jan-37,52/11009,0.1609356621555954,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,Jan-37,52/11009,0.1609356621555954,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,Jan-37,52/11009,0.1609356621555954,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,Jan-37,52/11009,0.1609356621555954,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9711123,Cellular response to chemical stress,Feb-37,215/11009,0.16253736078091552,0.3498941237870144,0.29311836995451945,5720/10628,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-169911,Regulation of Apoptosis,Jan-37,53/11009,0.16376904542658588,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-416476,G alpha (q) signalling events,Feb-37,217/11009,0.16491373440190948,0.3498941237870144,0.29311836995451945,351/301,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-180585,Vif-mediated degradation of APOBEC3G,Jan-37,54/11009,0.1665931185663464,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9604323,Negative regulation of NOTCH4 signaling,Jan-37,54/11009,0.1665931185663464,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,Jan-37,55/11009,0.16940791131970512,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-4641257,Degradation of AXIN,Jan-37,55/11009,0.16940791131970512,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,Jan-37,55/11009,0.16940791131970512,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8941858,Regulation of RUNX3 expression and activity,Jan-37,55/11009,0.16940791131970512,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9700206,Signaling by ALK in cancer,Jan-37,55/11009,0.16940791131970512,0.3498941237870144,0.29311836995451945,1937,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,Jan-37,55/11009,0.16940791131970512,0.3498941237870144,0.29311836995451945,1937,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9824272,Somitogenesis,Jan-37,55/11009,0.16940791131970512,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,Jan-37,56/11009,0.1722134533391657,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5362768,Hh mutants are degraded by ERAD,Jan-37,56/11009,0.1722134533391657,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5578775,Ion homeostasis,Jan-37,56/11009,0.1722134533391657,0.3498941237870144,0.29311836995451945,5349,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-4641258,Degradation of DVL,Jan-37,57/11009,0.17500977418518515,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69541,Stabilization of p53,Jan-37,57/11009,0.17500977418518515,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-75893,TNF signaling,Jan-37,57/11009,0.17500977418518515,0.3498941237870144,0.29311836995451945,10399,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-936837,Ion transport by P-type ATPases,Jan-37,57/11009,0.17500977418518515,0.3498941237870144,0.29311836995451945,5349,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5387390,Hh mutants abrogate ligand secretion,Jan-37,59/11009,0.18057487014015994,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,Jan-37,59/11009,0.18057487014015994,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,Jan-37,60/11009,0.18334370391228916,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,Jan-37,60/11009,0.18334370391228916,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5610780,Degradation of GLI1 by the proteasome,Jan-37,60/11009,0.18334370391228916,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5610783,Degradation of GLI2 by the proteasome,Jan-37,60/11009,0.18334370391228916,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,Jan-37,60/11009,0.18334370391228916,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",Jan-37,61/11009,0.1861034338378753,0.3498941237870144,0.29311836995451945,1938,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,Jan-37,61/11009,0.1861034338378753,0.3498941237870144,0.29311836995451945,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5678895,Defective CFTR causes cystic fibrosis,Jan-37,61/11009,0.1861034338378753,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8878171,Transcriptional regulation by RUNX1,Feb-37,236/11009,0.18778873381420516,0.3498941237870144,0.29311836995451945,5720/3958,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,Jan-37,63/11009,0.19159569847650026,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1442490,Collagen degradation,Jan-37,64/11009,0.19432829112736572,0.3498941237870144,0.29311836995451945,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-4608870,Asymmetric localization of PCP proteins,Jan-37,64/11009,0.19432829112736572,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9707564,Cytoprotection by HMOX1,Jan-37,64/11009,0.19432829112736572,0.3498941237870144,0.29311836995451945,10628,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1268020,Mitochondrial protein import,Jan-37,65/11009,0.19705189580788518,0.3498941237870144,0.29311836995451945,293,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-373755,Semaphorin interactions,Jan-37,65/11009,0.19705189580788518,0.3498941237870144,0.29311836995451945,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5358346,Hedgehog ligand biogenesis,Jan-37,65/11009,0.19705189580788518,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9614085,FOXO-mediated transcription,Jan-37,65/11009,0.19705189580788518,0.3498941237870144,0.29311836995451945,10628,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Jan-37,66/11009,0.19976654126248228,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69563,p53-Dependent G1 DNA Damage Response,Jan-37,66/11009,0.19976654126248228,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,Jan-37,66/11009,0.19976654126248228,0.3498941237870144,0.29311836995451945,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1169091,Activation of NF-kappaB in B cells,Jan-37,67/11009,0.20247225614626985,0.35038611991779633,0.2935305320746427,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,Jan-37,67/11009,0.20247225614626985,0.35038611991779633,0.2935305320746427,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5658442,Regulation of RAS by GAPs,Jan-37,68/11009,0.20516906902532195,0.35085124821489966,0.2939201860842357,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69615,G1/S DNA Damage Checkpoints,Jan-37,68/11009,0.20516906902532195,0.35085124821489966,0.2939201860842357,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8948751,Regulation of PTEN stability and activity,Jan-37,69/11009,0.20785700837694066,0.3512904995376366,0.2942881620603038,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9793380,Formation of paraxial mesoderm,Jan-37,69/11009,0.20785700837694066,0.3512904995376366,0.2942881620603038,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-68949,Orc1 removal from chromatin,Jan-37,71/11009,0.2132063799648386,0.3528069973315059,0.2955585845428751,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,Jan-37,72/11009,0.21586786871427166,0.3528069973315059,0.2955585845428751,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-199992,trans-Golgi Network Vesicle Budding,Jan-37,72/11009,0.21586786871427166,0.3528069973315059,0.2955585845428751,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,Jan-37,72/11009,0.21586786871427166,0.3528069973315059,0.2955585845428751,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1169408,ISG15 antiviral mechanism,Jan-37,73/11009,0.21852059696311266,0.3528069973315059,0.2955585845428751,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,Jan-37,73/11009,0.21852059696311266,0.3528069973315059,0.2955585845428751,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,Jan-37,73/11009,0.21852059696311266,0.3528069973315059,0.2955585845428751,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8939902,Regulation of RUNX2 expression and activity,Jan-37,73/11009,0.21852059696311266,0.3528069973315059,0.2955585845428751,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1234174,Cellular response to hypoxia,Jan-37,75/11009,0.22379988402162865,0.35537454111126743,0.29770950448221273,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,Jan-37,75/11009,0.22379988402162865,0.35537454111126743,0.29770950448221273,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9833482,PKR-mediated signaling,Jan-37,75/11009,0.22379988402162865,0.35537454111126743,0.29770950448221273,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,Jan-37,76/11009,0.22642649864493203,0.35563727232818126,0.2979296034801737,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-3000178,ECM proteoglycans,Jan-37,76/11009,0.22642649864493203,0.35563727232818126,0.2979296034801737,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,Jan-37,77/11009,0.22904446439542492,0.3558809151090204,0.2981337114371688,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9009391,Extra-nuclear estrogen signaling,Jan-37,77/11009,0.22904446439542492,0.3558809151090204,0.2981337114371688,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5619084,ABC transporter disorders,Jan-37,78/11009,0.23165380896342447,0.35801043203438326,0.29991768117977835,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,Jan-37,80/11009,0.2368467448828293,0.3640888791017961,0.30500980584014975,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2871837,FCERI mediated NF-kB activation,Jan-37,82/11009,0.2420055262077908,0.3662246591422876,0.30679902241022083,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9013694,Signaling by NOTCH4,Jan-37,82/11009,0.2420055262077908,0.3662246591422876,0.30679902241022083,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),Jan-37,83/11009,0.24457217721266955,0.3662246591422876,0.30679902241022083,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-195253,Degradation of beta-catenin by the destruction complex,Jan-37,83/11009,0.24457217721266955,0.3662246591422876,0.30679902241022083,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69202,Cyclin E associated events during G1/S transition,Jan-37,83/11009,0.24457217721266955,0.3662246591422876,0.30679902241022083,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5632684,Hedgehog 'on' state,Jan-37,85/11009,0.24968013579463788,0.3700387653571813,0.3099942306762036,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,Jan-37,85/11009,0.24968013579463788,0.3700387653571813,0.3099942306762036,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,Jan-37,87/11009,0.25475448333720097,0.37372612,0.3130832549695764,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-453276,Regulation of mitotic cell cycle,Jan-37,87/11009,0.25475448333720097,0.37372612,0.3130832549695764,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,Jan-37,88/11009,0.25727912022756216,0.37540440343233755,0.31448921066996044,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-3371556,Cellular response to heat stress,Jan-37,89/11009,0.25979543490127166,0.37540440343233755,0.31448921066996044,1915,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5687128,MAPK6/MAPK4 signaling,Jan-37,89/11009,0.25979543490127166,0.37540440343233755,0.31448921066996044,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1474290,Collagen formation,Jan-37,90/11009,0.26230345403210076,0.3768203500105005,0.31567539793267213,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69052,Switching of origins to a post-replicative state,Jan-37,91/11009,0.26480320421076264,0.3768203500105005,0.31567539793267213,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1474244,Extracellular matrix organization,Feb-37,300/11009,0.267288794,0.3768203500105005,0.31567539793267213,4316/351,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2682334,EPH-Ephrin signaling,Jan-37,92/11009,0.26729471194516474,0.3768203500105005,0.31567539793267213,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-4086400,PCP/CE pathway,Jan-37,92/11009,0.26729471194516474,0.3768203500105005,0.31567539793267213,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5625740,RHO GTPases activate PKNs,Jan-37,94/11009,0.27225310570028305,0.38119309383909844,0.3193385961864601,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-381119,Unfolded Protein Response (UPR),Jan-37,95/11009,0.2747200443250276,0.38119309383909844,0.3193385961864601,3576,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8878159,Transcriptional regulation by RUNX3,Jan-37,96/11009,0.2771788457140668,0.38119309383909844,0.3193385961864601,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,Jan-37,97/11009,0.2796295359650134,0.38119309383909844,0.3193385961864601,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,Jan-37,97/11009,0.2796295359650134,0.38119309383909844,0.3193385961864601,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-975871,MyD88 cascade initiated on plasma membrane,Jan-37,97/11009,0.2796295359650134,0.38119309383909844,0.3193385961864601,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9759194,Nuclear events mediated by NFE2L2,Jan-37,97/11009,0.2796295359650134,0.38119309383909844,0.3193385961864601,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-202424,Downstream TCR signaling,Jan-37,98/11009,0.28207214109416434,0.38242991885404565,0.3203747271405227,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-15869,Metabolism of nucleotides,Jan-37,99/11009,0.28450668703674675,0.38242991885404565,0.3203747271405227,1890,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9679191,Potential therapeutics for SARS,Jan-37,99/11009,0.28450668703674675,0.38242991885404565,0.3203747271405227,5349,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5607764,CLEC7A (Dectin-1) signaling,Jan-37,101/11009,0.2893517046992352,0.38569393221527976,0.3231091036587665,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,Jan-37,102/11009,0.2917622278864488,0.38569393221527976,0.3231091036587665,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5689603,UCH proteinases,Jan-37,102/11009,0.2917622278864488,0.38569393221527976,0.3231091036587665,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-382556,ABC-family proteins mediated transport,Jan-37,103/11009,0.2941647948221966,0.38569393221527976,0.3231091036587665,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Jan-37,103/11009,0.2941647948221966,0.38569393221527976,0.3231091036587665,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9645723,Diseases of programmed cell death,Jan-37,104/11009,0.2965594310400197,0.38569393221527976,0.3231091036587665,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-975155,MyD88 dependent cascade initiated on endosome,Jan-37,104/11009,0.2965594310400197,0.38569393221527976,0.3231091036587665,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,Jan-37,105/11009,0.29894616199385005,0.38569393221527976,0.3231091036587665,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,Jan-37,105/11009,0.29894616199385005,0.38569393221527976,0.3231091036587665,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,Jan-37,108/11009,0.30605917662161664,0.39311600908287647,0.32932683332384477,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-166166,MyD88-independent TLR4 cascade,Jan-37,110/11009,0.31076212314836626,0.3956398836558495,0.3314411700631775,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling,Jan-37,110/11009,0.31076212314836626,0.3956398836558495,0.3314411700631775,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-983705,Signaling by the B Cell Receptor (BCR),Jan-37,112/11009,0.31543405280215475,0.39754195506435286,0.33303460085522185,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Jan-37,113/11009,0.31775844851164536,0.39754195506435286,0.33303460085522185,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,Jan-37,113/11009,0.31775844851164536,0.39754195506435286,0.33303460085522185,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5610787,Hedgehog 'off' state,Jan-37,113/11009,0.31775844851164536,0.39754195506435286,0.33303460085522185,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9758941,Gastrulation,Jan-37,114/11009,0.32007516449962925,0.3987143212947967,0.3340167324633154,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,Jan-37,116/11009,0.32468565591796983,0.40100066051407385,0.335932078,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,Jan-37,116/11009,0.32468565591796983,0.40100066051407385,0.335932078,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-202403,TCR signaling,Jan-37,120/11009,0.33381556247358246,0.40878261675790395,0.34245129067316665,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69239,Synthesis of DNA,Jan-37,120/11009,0.33381556247358246,0.40878261675790395,0.34245129067316665,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9755511,KEAP1-NFE2L2 pathway,Jan-37,126/11009,0.34728564170234066,0.423483335,0.35476658934727223,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-114608,Platelet degranulation,Jan-37,129/11009,0.35392093218071197,0.4279629682017814,0.35851933231254673,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,Jan-37,129/11009,0.35392093218071197,0.4279629682017814,0.35851933231254673,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69206,G1/S Transition,Jan-37,131/11009,0.3583079493285064,0.43146248898307643,0.3614510015155985,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5576891,Cardiac conduction,Jan-37,132/11009,0.36049057535119844,0.4322895281182421,0.3621438407109659,5349,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,Jan-37,134/11009,0.36483417889514547,0.4338974390975187,0.3634908431703854,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,Jan-37,134/11009,0.36483417889514547,0.4338974390975187,0.3634908431703854,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1474228,Degradation of the extracellular matrix,Jan-37,140/11009,0.37769346618725874,0.4455241295025215,0.3732309225480967,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-6807070,PTEN Regulation,Jan-37,140/11009,0.37769346618725874,0.4455241295025215,0.3732309225480967,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-68867,Assembly of the pre-replicative complex,Jan-37,141/11009,0.37981190778732044,0.4462017941078683,0.3737986255502084,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5621481,C-type lectin receptors (CLRs),Jan-37,143/11009,0.38402776172124153,0.4493280288965134,0.3764175802083339,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,Jan-37,146/11009,0.3902993074121879,0.4529979913338245,0.37949203426253736,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-3858494,Beta-catenin independent WNT signaling,Jan-37,146/11009,0.3902993074121879,0.4529979913338245,0.37949203426253736,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,Jan-37,149/11009,0.3965087077821189,0.4547262561469538,0.38093986127772494,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-453279,Mitotic G1 phase and G1/S transition,Jan-37,149/11009,0.3965087077821189,0.4547262561469538,0.38093986127772494,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5358351,Signaling by Hedgehog,Jan-37,149/11009,0.3965087077821189,0.4547262561469538,0.38093986127772494,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9612973,Autophagy,Jan-37,151/11009,0.4006140788165342,0.4576184536678988,0.3833627548483581,1915,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-73887,Death Receptor Signaling,Jan-37,154/11009,0.40672123168679575,0.46276549589560617,0.38767460956470373,10399,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69002,DNA Replication Pre-Initiation,Jan-37,158/11009,0.41476999760869415,0.47007266395652003,0.3937960761609893,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69242,S Phase,Jan-37,162/11009,0.4227124814597918,0.4772027622729681,0.3997692053279281,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,Feb-37,433/11009,0.43042906562503425,0.4840233461697856,0.40548304359515813,5720/1937,2,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69481,G2/M Checkpoints,Jan-37,167/11009,0.4324932048979828,0.48445944269580243,0.40584837668925355,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-168898,Toll-like Receptor Cascades,Jan-37,168/11009,0.4344299095114096,0.4847499762501829,0.4060917666637846,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,Jan-37,172/11009,0.44211262262074946,0.4914251843746023,0.411683819,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5619115,Disorders of transmembrane transporters,Jan-37,176/11009,0.4496937568963101,0.49793676529897934,0.4171387944591705,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-109581,Apoptosis,Jan-37,180/11009,0.457174619,0.5042880334501549,0.42245947074680607,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69306,DNA Replication,Jan-37,186/11009,0.4682107171497437,0.5125488532434694,0.4293798442760807,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-983712,Ion channel transport,Jan-37,186/11009,0.4682107171497437,0.5125488532434694,0.4293798442760807,5349,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2467813,Separation of Sister Chromatids,Jan-37,190/11009,0.4754465053740887,0.518505812,0.4343701935890383,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69275,G2/M Transition,Jan-37,197/11009,0.48787929153924003,0.5300643430633097,0.444053174,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-453274,Mitotic G2-G2/M phases,Jan-37,199/11009,0.4913785363725559,0.5318666554744145,0.4455630331783475,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5357801,Programmed Cell Death,Jan-37,213/11009,0.5152301080167546,0.555602616,0.4654474660009959,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-376176,Signaling by ROBO receptors,Jan-37,219/11009,0.525115764,0.5620683552262419,0.47086403825181433,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5689880,Ub-specific processing proteases,Jan-37,219/11009,0.525115764,0.5620683552262419,0.47086403825181433,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8939211,ESR-mediated signaling,Jan-37,222/11009,0.5299847592131542,0.5651866989394893,0.4734763822840376,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-157118,Signaling by NOTCH,Jan-37,235/11009,0.5505283177417558,0.5822948041495017,0.4878084318134599,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-68882,Mitotic Anaphase,Jan-37,235/11009,0.5505283177417558,0.5822948041495017,0.4878084318134599,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-2555396,Mitotic Metaphase and Anaphase,Jan-37,236/11009,0.55207189,0.5822948041495017,0.4878084318134599,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8951664,Neddylation,Jan-37,246/11009,0.5672266677997704,0.5955016872144764,0.4988722930589312,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-425407,SLC-mediated transmembrane transport,Jan-37,247/11009,0.5687144140871816,0.5955016872144764,0.4988722930589312,293,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-76002,"Platelet activation, signaling and aggregation",Jan-37,263/11009,0.5918524143524864,0.6174922301367096,0.5172945289799424,351,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-1257604,PIP3 activates AKT signaling,Jan-37,268/11009,0.5988320337738311,0.6225268264771122,0.5215121838999665,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5673001,RAF/MAP kinase cascade,Jan-37,280/11009,0.6151126638735338,0.6371597127578897,0.5337706572001991,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5684996,MAPK1/MAPK3 signaling,Jan-37,286/11009,0.6230100708351762,0.6430353945405927,0.5386929183913178,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-69620,Cell Cycle Checkpoints,Jan-37,292/11009,0.630749725,0.6487070123782975,0.543444228,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5688426,Deubiquitination,Jan-37,297/11009,0.6370811440090618,0.65186828890876225,0.5460925385139876,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9006931,Signaling by Nuclear Receptors,Jan-37,298/11009,0.6383346912151547,0.65186828890876225,0.5460925385139876,4316,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,Jan-37,309/11009,0.6518486461519093,0.6622181836111646,0.554763002,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-9006925,Intracellular signaling by second messengers,Jan-37,310/11009,0.653052534,0.6622181836111646,0.554763002,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-5683057,MAPK family signaling cascades,Jan-37,325/11009,0.6706320963296553,0.6764540808231629,0.566688904,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-195258,RHO GTPase Effectors,Jan-37,326/11009,0.6717727377032795,0.6764540808231629,0.566688904,103910,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-73894,DNA Repair,Jan-37,335/11009,0.6818670429452175,0.6842346368443329,0.5732069439963451,9636,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-68886,M Phase,Jan-37,416/11009,0.7601185781317241,0.7601185781317241,0.6367775376809198,5720,1,PTX_24.vs.DMSO_24,reactome
NA,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,16/201,77/11009,4.3068963342462476e-13,1.9617912802491657e-10,1.1900634607785683e-10,5721/7314/7316/10383/7277/5714/7846/5694/5704/5687/5685/10381/5689/10376/1026/3320,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-909733,Interferon alpha/beta signaling,16/201,77/11009,4.3068963342462476e-13,1.9617912802491657e-10,1.1900634607785683e-10,2537/9636/3107/3106/8519/7314/7316/10410/3434/3133/3429/3105/5610/6772/684/3669,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1236974,ER-Phagosome pathway,16/201,90/11009,5.493358941120278e-12,1.6681499984535245e-9,1.0119345417853143e-9,3107/567/3106/6890/5721/7314/7316/3133/3105/5714/5694/5704/5687/5685/23480/5689,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9711123,Cellular response to chemical stress,22/201,215/11009,5.006101317025902e-11,1.1401395749526492e-8,6.916324187996312e-9,81631/5721/7314/7316/8878/5052/5714/5694/5704/1337/5687/645/6648/25824/54205/5685/1349/6500/7295/5689/1026/1728,22,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1236975,Antigen processing-Cross presentation,16/201,105/11009,6.30260118314068e-11,1.1483339355682318e-8,6.966032886629171e-9,3107/567/3106/6890/5721/7314/7316/3133/3105/5714/5694/5704/5687/5685/23480/5689,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-913531,Interferon Signaling,24/201,269/11009,1.1372421630198958e-10,1.7267126841852086e-8,1.0474598869920092e-8,2537/9636/3107/567/3106/8519/7314/7316/10410/3434/3133/3429/10383/3105/7277/7846/6672/5610/8894/6772/684/3669/10381/10376,24,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,10/201,32/11009,1.4967524185066244e-10,1.9479163617993353e-8,1.1816466461894401e-8,5202/10383/7277/7846/22948/10575/60/10381/10376/10576,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,12/201,60/11009,6.41597731638671e-10,7.306194169035366e-8,4.432089593556608e-8,5721/7314/7316/5714/5694/5704/5687/5685/595/6500/5689/1026,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,9/201,28/11009,9.644404294685262e-10,9.354249352679234e-8,5.674482535278291e-8,5202/10383/7277/7846/22948/10575/60/10381/10576,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9755511,KEAP1-NFE2L2 pathway,16/201,126/11009,1.02681112543131e-9,9.354249352679234e-8,5.674482535278291e-8,81631/5721/7314/7316/8878/5052/5714/5694/5704/5687/5685/6500/7295/5689/1026/1728,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5610787,Hedgehog 'off' state,15/201,113/11009,1.8618102606437487e-9,1.5419174067695044e-7,9.353592218545146e-8,5721/7314/7316/10383/7277/5714/7846/5694/5704/5687/5685/10381/6500/5689/10376,15,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9759194,Nuclear events mediated by NFE2L2,14/201,97/11009,2.149403615068619e-9,1.6317555777729266e-7,9.898569279921269e-8,5721/7314/7316/8878/5052/5714/5694/5704/5687/5685/6500/7295/5689/1728,14,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-449147,Signaling by Interleukins,29/201,473/11009,8.561538213669432e-9,5.79350787976437e-7,3.514462576551267e-7,3576/5721/7314/7316/8767/8878/2919/5714/301/5694/5704/5687/6648/375/6772/1072/302/5685/3934/595/6500/5292/7076/5689/1026/3320/6288/4792/6364,29,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,8/201,25/11009,8.903305193929877e-9,5.79350787976437e-7,3.514462576551267e-7,10383/7277/7846/22948/10575/10381/10376/10576,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9020702,Interleukin-1 signaling,14/201,115/11009,2.050882898017511e-8,1.2455695467293018e-6,7.555884361117145e-7,5721/7314/7316/8767/8878/5714/5694/5704/5687/5685/6500/5689/6288/4792,14,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-180534,Vpu mediated degradation of CD4,10/201,52/11009,2.6714490030533818e-8,1.334061104414292e-6,8.092692585562462e-7,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,10/201,52/11009,2.6714490030533818e-8,1.334061104414292e-6,8.092692585562462e-7,5721/7314/7316/5714/5694/5704/5687/5685/595/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,10/201,52/11009,2.6714490030533818e-8,1.334061104414292e-6,8.092692585562462e-7,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1169091,Activation of NF-kappaB in B cells,11/201,67/11009,3.007465960776372e-8,1.334061104414292e-6,8.092692585562462e-7,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689/4792,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),12/201,83/11009,3.075223182513736e-8,1.334061104414292e-6,8.092692585562462e-7,5721/7314/7316/5714/5694/5704/5687/5685/801/6500/5689/4792,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69202,Cyclin E associated events during G1/S transition,12/201,83/11009,3.075223182513736e-8,1.334061104414292e-6,8.092692585562462e-7,5721/7314/7316/5714/5694/5704/5687/5685/595/6500/5689/1026,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9604323,Negative regulation of NOTCH4 signaling,10/201,54/11009,3.914788088147182e-8,1.5358769639540373e-6,9.316949634015478e-7,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8878166,Transcriptional regulation by RUNX2,14/201,121/11009,3.9619966976594454e-8,1.5358769639540373e-6,9.316949634015478e-7,5721/7314/7316/5714/5694/5704/5687/6772/3958/5685/595/6500/5689/1026,14,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,12/201,85/11009,4.046218126772436e-8,1.5358769639540373e-6,9.316949634015478e-7,5721/7314/7316/5714/5694/5704/5687/5685/595/6500/5689/1026,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6798695,Neutrophil degranulation,28/201,480/11009,4.633131299492497e-8,1.5889863783843692e-6,9.639122406283364e-7,3107/567/3106/5329/1604/6386/2919/10383/961/84418/967/10487/9218/6282/527/2171/3958/302/3934/684/966/23406/5689/3320/4257/5315/6286/10576,28,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,10/201,55/11009,4.70939980421273e-8,1.5889863783843692e-6,9.639122406283364e-7,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,10/201,55/11009,4.70939980421273e-8,1.5889863783843692e-6,9.639122406283364e-7,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,10/201,56/11009,5.642912923305116e-8,1.8359620261182002e-6,1.1137328138102202e-6,5721/7314/7316/5714/5694/5704/5687/3315/5685/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8939902,Regulation of RUNX2 expression and activity,11/201,73/11009,7.568991416992565e-8,2.3777073037518023e-6,1.4423667854523036e-6,5721/7314/7316/5714/5694/5704/5687/6772/5685/6500/5689,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5358351,Signaling by Hedgehog,15/201,149/11009,8.44668023841733e-8,2.564975232399396e-6,1.5559674123400343e-6,5721/7314/7316/10383/7277/5714/7846/5694/5704/5687/5685/10381/6500/5689/10376,15,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,10/201,59/11009,9.49398680837859e-8,2.790007091107386e-6,1.6924764259418537e-6,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69275,G2/M Transition,17/201,197/11009,1.1088002126420484e-7,2.8376264481735934e-6,1.7213633199966911e-6,5721/7314/7316/10383/7277/5714/7846/5694/5704/5687/5685/10381/6500/5689/10376/1026/3320,17,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,10/201,60/11009,1.1213452484549874e-7,2.8376264481735934e-6,1.7213633199966911e-6,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5610780,Degradation of GLI1 by the proteasome,10/201,60/11009,1.1213452484549874e-7,2.8376264481735934e-6,1.7213633199966911e-6,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5610783,Degradation of GLI2 by the proteasome,10/201,60/11009,1.1213452484549874e-7,2.8376264481735934e-6,1.7213633199966911e-6,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,10/201,60/11009,1.1213452484549874e-7,2.8376264481735934e-6,1.7213633199966911e-6,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-453274,Mitotic G2-G2/M phases,17/201,199/11009,1.2844317746849952e-7,3.162479315508191e-6,1.918425837011728e-6,5721/7314/7316/10383/7277/5714/7846/5694/5704/5687/5685/10381/6500/5689/10376/1026/3320,17,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-202424,Downstream TCR signaling,12/201,98/11009,2.0300025768438188e-7,4.866664072380839e-6,2.9522198139695424e-6,5721/7314/7316/8767/5714/5694/5704/5687/5685/6500/5689/4792,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,9/201,50/11009,2.4715885761586726e-7,5.7733774176424374e-6,3.5022510188483208e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2871837,FCERI mediated NF-kB activation,11/201,82/11009,2.5807382619447833e-7,5.877631391579244e-6,3.565493651371082e-6,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689/4792,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5607764,CLEC7A (Dectin-1) signaling,12/201,101/11009,2.839658128194456e-7,6.0445189992287365e-6,3.66673115095625e-6,5721/7314/7316/5714/5694/5704/5687/5685/801/6500/5689/4792,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69563,p53-Dependent G1 DNA Damage Response,10/201,66/11009,2.85306604793453e-7,6.0445189992287365e-6,3.66673115095625e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689/1026,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,10/201,66/11009,2.85306604793453e-7,6.0445189992287365e-6,3.66673115095625e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689/1026,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,12/201,102/11009,3.167323818985573e-7,6.557799997945129e-6,3.978098098008195e-6,5721/7314/7316/5714/5694/5704/51330/5687/5685/6500/5689/4050,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,9/201,52/11009,3.51665312242315e-7,6.674314571932271e-6,4.048778265947706e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,9/201,52/11009,3.51665312242315e-7,6.674314571932271e-6,4.048778265947706e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69610,p53-Independent DNA Damage Response,9/201,52/11009,3.51665312242315e-7,6.674314571932271e-6,4.048778265947706e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,9/201,52/11009,3.51665312242315e-7,6.674314571932271e-6,4.048778265947706e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69615,G1/S DNA Damage Checkpoints,10/201,68/11009,3.8090700306158763e-7,7.081760812022578e-6,4.29594364355174e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689/1026,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-169911,Regulation of Apoptosis,9/201,53/11009,4.1696781792566395e-7,7.5971536426055964e-06,4.6085916718099695e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,13/201,126/11009,4.75289216866359e-7,8.489970128730453e-6,5.150192752421846e-6,9636/3107/567/3106/64135/7555/7314/7316/8767/3133/3105/6772/3320,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-180585,Vif-mediated degradation of APOBEC3G,9/201,54/11009,4.925318053345032e-7,8.628778358841008e-6,5.234396716611622e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-68949,Orc1 removal from chromatin,10/201,71/11009,5.768122850323262e-7,9.60165312898733e-6,5.824562820172567e-6,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4641257,Degradation of AXIN,9/201,55/11009,5.796826806743174e-7,9.60165312898733e-6,5.824562820172567e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8941858,Regulation of RUNX3 expression and activity,9/201,55/11009,5.796826806743174e-7,9.60165312898733e-6,5.824562820172567e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",7/201,29/11009,6.76306532042396e-7,1.072946155861018e-5,6.508714909319247e-6,3107/567/3106/6890/3133/3105/3309,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5362768,Hh mutants are degraded by ERAD,9/201,56/11009,6.798801692481762e-7,1.072946155861018e-5,6.508714909319247e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-162909,Host Interactions of HIV factors,13/201,130/11009,6.831051266733154e-7,1.072946155861018e-5,6.508714909319247e-6,567/5721/7314/7316/3105/5714/5694/5704/5687/375/5685/6500/5689,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-446652,Interleukin-1 family signaling,14/201,153/11009,7.505399254738228e-7,1.1588845289943264e-5,7.03003498436676e-6,5721/7314/7316/8767/8878/5714/5694/5704/5687/5685/6500/5689/6288/4792,14,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4641258,Degradation of DVL,9/201,57/11009,7.947280986100369e-7,1.1868808161208912e-5,7.199866294568928e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69541,Stabilization of p53,9/201,57/11009,7.947280986100369e-7,1.1868808161208912e-5,7.199866294568928e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1236977,Endosomal/Vacuolar pathway,5/201,11/11009,8.157836197424122e-7,1.1986756090086089e-5,7.271415965445947e-6,3107/567/3106/3133/3105,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983705,Signaling by the B Cell Receptor (BCR),12/201,112/11009,8.827931350838565e-7,1.276546898510148e-5,7.743799430560143e-6,5721/7314/7316/5714/5694/5704/5687/5685/801/6500/5689/4792,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9646399,Aggrephagy,8/201,43/11009,9.003504725609951e-7,1.2815926257860415e-5,7.77440786339675e-6,7314/7316/10383/7277/7846/10381/10376/3320,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5387390,Hh mutants abrogate ligand secretion,9/201,59/11009,1.0755726365252527e-6,1.5074564182684696e-5,9.14454468300822e-6,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1632852,Macroautophagy,13/201,136/11009,1.1477576856101358e-6,1.5842534115012633e-5,9.61041124314707e-6,25978/81631/7314/7316/8878/10383/7277/7846/6009/10381/11345/10376/3320,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8878159,Transcriptional regulation by RUNX3,11/201,96/11009,1.3007552602521886e-6,1.7686388687906625e-5,1.0728931840257644e-5,5721/7314/7316/5714/5694/5704/5687/5685/595/5689/1026,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-68882,Mitotic Anaphase,17/201,235/11009,1.3609174387353556e-6,1.8232290980704542e-5,1.1060087543901882e-5,25978/5721/7314/7316/10383/7277/5714/7846/5694/5704/10726/5687/5685/10381/5689/10376/4000,17,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5626467,RHO GTPases activate IQGAPs,7/201,32/11009,1.3922637231678891e-6,1.838191669283981e-5,1.1150853618049454e-5,10383/7277/7846/60/801/10381/10376,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5678895,Defective CFTR causes cystic fibrosis,9/201,61/11009,1.438326209771157e-6,1.8518284203323437e-5,1.1233576990865796e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2555396,Mitotic Metaphase and Anaphase,17/201,236/11009,1.4432471772074247e-6,1.8518284203323437e-5,1.1233576990865796e-5,25978/5721/7314/7316/10383/7277/5714/7846/5694/5704/10726/5687/5685/10381/5689/10376/4000,17,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5357801,Programmed Cell Death,16/201,213/11009,1.7192108936322714e-6,2.1752793390263878e-5,1.319569764849331e-5,25978/5721/7314/7316/6386/5714/2810/5694/5704/5687/5366/54205/5685/5689/3320/4000,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,10/201,80/11009,1.7834288876464905e-6,2.2256215296519902e-5,1.350108386466341e-5,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-202403,TCR signaling,12/201,120/11009,1.8547209388157043e-6,2.283311858460955e-5,1.3851045417898217e-5,5721/7314/7316/8767/5714/5694/5704/5687/5685/6500/5689/4792,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,9/201,63/11009,1.9020982435108255e-6,2.310415333117816e-5,1.4015460741658712e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2467813,Separation of Sister Chromatids,15/201,190/11009,1.973050082820318e-6,2.365063980854355e-5,1.4346970823831952e-5,5721/7314/7316/10383/7277/5714/7846/5694/5704/10726/5687/5685/10381/5689/10376,15,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9663891,Selective autophagy,10/201,81/11009,2.002638612199569e-6,2.3693555528750746e-5,1.4373004393776808e-5,81631/7314/7316/8878/10383/7277/7846/10381/10376/3320,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6807878,COPI-mediated anterograde transport,11/201,101/11009,2.1651117892139793e-6,2.5124594734042395e-5,1.5241102588679019e-5,1604/54732/378/10383/7277/7846/11316/375/966/10381/10376,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4608870,Asymmetric localization of PCP proteins,9/201,64/11009,2.1787519033911627e-6,2.5124594734042395e-5,1.5241102588679019e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013694,Signaling by NOTCH4,10/201,82/11009,2.2449392769225003e-6,2.556424601595497e-5,1.550780421558306e-5,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5689603,UCH proteinases,11/201,102/11009,2.388542267021343e-6,2.686372845995609e-5,1.629609733835224e-5,11047/5721/7314/7316/5714/5694/5704/5687/60/5685/5689,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5358346,Hedgehog ligand biogenesis,9/201,65/11009,2.4893810809353304e-6,2.7575367805143966e-5,1.672779259079159e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-195253,Degradation of beta-catenin by the destruction complex,10/201,83/11009,2.5123551348265084e-6,2.7575367805143966e-5,1.672779259079159e-5,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,9/201,66/11009,2.837392840326154e-6,3.077220092306102e-5,1.8667058160040483e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,9/201,67/11009,3.226457983629711e-6,3.4580037918666665e-5,2.097697141059564e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),8/201,51/11009,3.4886581789211126e-6,3.6955437220896906e-5,2.241793811424215e-5,5721/5714/5694/5704/5687/5685/5689/1728,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5658442,Regulation of RAS by GAPs,9/201,68/11009,3.6605250823604456e-6,3.8330325862418e-5,2.3251974207371252e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9612973,Autophagy,13/201,151/11009,3.7387780619411286e-6,3.8704850163958724e-5,2.3479168451185316e-5,25978/81631/7314/7316/8878/10383/7277/7846/6009/10381/11345/10376/3320,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,10/201,87/11009,3.8787332745042625e-6,3.926140014525981e-5,2.3816783264499853e-5,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-453276,Regulation of mitotic cell cycle,10/201,87/11009,3.8787332745042625e-6,3.926140014525981e-5,2.3816783264499853e-5,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8948751,Regulation of PTEN stability and activity,9/201,69/11009,4.143834853876551e-6,4.1483885185511406e-5,2.5164988991153144e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,10/201,88/11009,4.307268425513392e-6,4.265132103959457e-5,2.587317990153925e-5,5721/7314/7316/5714/5694/5704/5687/3315/5685/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9705683,SARS-CoV-2-host interactions,15/201,203/11009,4.48773654759416e-6,4.3960516073744935e-05,2.6667364883836257e-5,9636/3107/567/3106/64135/81631/7555/7314/7316/8767/3133/3105/2810/6772/3320,15,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69206,G1/S Transition,12/201,131/11009,4.683391563443644e-6,4.538903951379957e-5,2.7533936963134516e-5,5721/7314/7316/5714/5694/5704/5687/5685/595/6500/5689/1026,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5687128,MAPK6/MAPK4 signaling,10/201,89/11009,4.7762754494781676e-6,4.580196773131169e-5,2.778442782244917e-5,5721/7314/7316/5714/5694/5704/5687/3315/5685/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-162906,HIV Infection,16/201,231/11009,4.940760534669118e-6,4.6885758823787154e-5,2.8441878077864987e-5,567/25978/5721/7314/7316/3105/5440/5714/5694/5704/51510/5687/375/5685/6500/5689,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-390466,Chaperonin-mediated protein folding,10/201,90/11009,5.288919561257644e-6,4.9672223920677466e-5,3.0132205856324068e-5,5202/10383/7277/7846/22948/10575/60/10381/10376/10576,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69052,Switching of origins to a post-replicative state,10/201,91/11009,5.8485603536755315e-6,5.354443763110488e-5,3.2481171363256175e-5,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,12/201,134/11009,5.929194041899226e-6,5.354443763110488e-5,3.2481171363256175e-5,5721/7314/7316/5714/5694/5704/5687/5685/801/6500/5689/4792,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,9/201,72/11009,5.936320747246534e-6,5.354443763110488e-5,3.2481171363256175e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,9/201,72/11009,5.936320747246534e-6,5.354443763110488e-5,3.2481171363256175e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983169,Class I MHC mediated antigen processing & presentation,21/201,381/11009,6.176389395812705e-6,5.5163634701817396e-5,3.3463410039232916e-5,3107/567/3106/6890/55905/5721/7314/7316/3133/3105/5714/5694/3309/5704/5687/10616/5685/23480/6500/5689/114907,21,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4086400,PCP/CE pathway,10/201,92/11009,6.4587601993145305e-6,5.712553923859745e-5,3.4653542203782606e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689/1212,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,9/201,73/11009,6.665372890326515e-6,5.7830044791309097e-5,3.5080909949086915e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,9/201,73/11009,6.665372890326515e-6,5.7830044791309097e-5,3.5080909949086915e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-193639,p75NTR signals via NF-kB,5/201,16/11009,7.158737083731817e-6,6.152461776678948e-5,3.7322114885394275e-5,7314/7316/8767/8878/4792,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1234174,Cellular response to hypoxia,9/201,75/11009,8.35585378016456e-6,6.983653939201756e-5,4.2364299706290624e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,9/201,75/11009,8.35585378016456e-6,6.983653939201756e-5,4.2364299706290624e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9833482,PKR-mediated signaling,9/201,75/11009,8.35585378016456e-6,6.983653939201756e-5,4.2364299706290624e-5,9636/10383/7277/7846/5610/8894/6772/10381/10376,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,9/201,76/11009,9.330310835191229e-6,7.714201670353293e-5,4.679595443914124e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-917937,Iron uptake and transport,8/201,58/11009,9.413750023549001e-6,7.714201670353293e-5,4.679595443914124e-5,529/7314/7316/533/8992/527/3934/6500,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-391251,Protein folding,10/201,96/11009,9.483980099665959e-6,7.714201670353293e-5,4.679595443914124e-5,5202/10383/7277/7846/22948/10575/60/10381/10376/10576,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-351202,Metabolism of polyamines,8/201,59/11009,1.0721699417591939e-5,8.643777141085182e-5,5.243495290391958e-5,5721/5714/5694/5704/5687/5685/5689/1728,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9619483,Activation of AMPK downstream of NMDARs,6/201,29/11009,1.150285010835603e-5,9.09494025831044e-5,5.517180236423802e-5,10383/7277/7846/801/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5619084,ABC transporter disorders,9/201,78/11009,1.1573340481452009e-5,9.09494025831044e-5,5.517180236423802e-5,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5621481,C-type lectin receptors (CLRs),12/201,143/11009,1.1580824039121965e-5,9.09494025831044e-5,5.517180236423802e-5,5721/7314/7316/5714/5694/5704/5687/5685/801/6500/5689/4792,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,5/201,18/11009,1.3630077296053792e-5,1.0612820868978637e-4,6.437958237002466e-5,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9668328,Sealing of the nuclear envelope (NE) by ESCRT-III,6/201,31/11009,1.7295034850184082e-5,0.000133441,8.094820242500766e-5,25978/10383/7277/7846/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,12/201,149/11009,1.757732395514452e-5,0.000133441,8.094820242500766e-5,9636/7314/7316/3434/10383/7277/7846/5610/8894/6772/10381/10376,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-453279,Mitotic G1 phase and G1/S transition,12/201,149/11009,1.757732395514452e-5,0.000133441,8.094820242500766e-5,5721/7314/7316/5714/5694/5704/5687/5685/595/6500/5689/1026,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-382556,ABC-family proteins mediated transport,10/201,103/11009,1.7756278507646037e-5,1.336857001691367e-4,8.109653080917068e-5,5721/7314/7316/5714/5694/5704/5687/8894/5685/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-190872,Transport of connexons to the plasma membrane,5/201,19/11009,1.8224686027584387e-5,1.3608761451745392e-4,8.255358209216395e-5,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-190828,Gap junction trafficking,7/201,47/11009,2.063066896889057e-5,1.5267559022438465e-4,9.261619373482227e-5,10383/7277/7846/60/10381/1212/10376,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-390450,Folding of actin by CCT/TriC,4/201,10/11009,2.078130975611822e-5,1.5267559022438465e-4,9.261619373482227e-5,22948/10575/60/10576,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381042,PERK regulates gene expression,6/201,32/11009,2.096490511026475e-5,1.527922284436095e-4,9.26869489085389e-5,467/3576/1649/3309/8894/9709,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9614085,FOXO-mediated transcription,8/201,65/11009,2.222327069115899e-5,1.606777746003638e-4,9.747048548753941e-5,1647/2810/1649/6648/7295/1026/694/114907,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-114608,Platelet degranulation,11/201,129/11009,2.3225297462329876e-5,1.6658629117879912e-4,1.0105471473669135e-4,7277/967/3309/10487/8407/7873/1072/928/801/7076/10447,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5632684,Hedgehog 'on' state,9/201,85/11009,2.340619678472699e-5,1.6658629117879912e-4,1.0105471473669135e-4,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5627117,RHO GTPases Activate ROCKs,5/201,20/11009,2.3940730469893718e-5,1.6906980975250525e-4,1.0256126884287393e-4,10627/103910/389/1072/4637,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-199977,ER to Golgi Anterograde Transport,12/201,154/11009,2.448857396384141e-5,1.7160839139276557e-4,1.0410122535236226e-4,1604/54732/378/10383/7277/7846/10342/11316/375/966/10381/10376,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-109581,Apoptosis,13/201,180/11009,2.5207579293383256e-5,1.7529850943719195e-4,1.0633972783468227e-4,5721/7314/7316/5714/2810/5694/5704/5687/5366/54205/5685/5689/4000,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,10/201,108/11009,2.6930226343278187e-5,1.8574898907376005e-4,1.1267920649803457e-4,3576/301/6772/3934/595/5292/7076/1026/3320/6288,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),7/201,49/11009,2.732202473752343e-5,1.8574898907376005e-4,1.1267920649803457e-4,5721/5714/5694/5704/5687/5685/5689,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-157858,Gap junction trafficking and regulation,7/201,49/11009,2.732202473752343e-5,1.8574898907376005e-4,1.1267920649803457e-4,10383/7277/7846/60/10381/1212/10376,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5628897,TP53 Regulates Metabolic Genes,9/201,87/11009,2.8256133895970824e-5,1.9067657762392165e-4,1.1566838436947119e-4,5052/2810/1337/25824/54205/6009/1349/7295/54541,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664873,Pexophagy,4/201,11/11009,3.219018183404723e-5,2.156268797854193e-4,1.308037574525913e-4,81631/7314/7316/8878,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,11/201,134/11009,3.314837714053845e-5,2.1998975644840375e-4,1.3345036932857124e-4,7277/967/3309/10487/8407/7873/1072/928/801/7076/10447,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9694516,SARS-CoV-2 Infection,17/201,299/11009,3.332446365519179e-5,2.1998975644840375e-4,1.3345036932857124e-4,9636/3107/567/3106/25978/64135/81631/7555/7314/7316/8767/3133/1603/3105/2810/6772/3320,17,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-389977,Post-chaperonin tubulin folding pathway,5/201,22/11009,3.947253541417594e-5,2.5870129325405956e-4,1.569335940359134e-4,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69242,S Phase,12/201,162/11009,4.048021399000895e-5,2.634105353207011e-4,1.5979031838161424e-4,5721/7314/7316/5714/5694/5704/5687/5685/595/6500/5689/1026,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,21/201,433/11009,4.222415542788901e-5,2.7280996875749566e-4,1.6549221052364113e-4,5721/7314/7316/8878/5440/5714/5694/5704/5687/10342/11221/6772/60/5685/801/6500/5292/5689/1026/3320/4000,21,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,8/201,72/11009,4.725053467919443e-5,3.0313547248412767e-4,1.8388829285824368e-4,10383/7277/7846/2810/60/801/10381/10376,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381119,Unfolded Protein Response (UPR),9/201,95/11009,5.708626782112558e-5,3.6367545444087695e-4,2.2061310714825856e-4,467/3576/1649/3309/8894/7494/9709/27230/4000,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,7/201,55/11009,5.884064733408842e-5,3.696815842852038e-4,2.242565506380865e-4,10383/7277/7846/3301/10381/10376/3320,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9824272,Somitogenesis,7/201,55/11009,5.884064733408842e-5,3.696815842852038e-4,2.242565506380865e-4,5721/5714/5694/5704/5687/5685/5689,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69239,Synthesis of DNA,10/201,120/11009,6.678278306216803e-5,4.143522123613986e-4,2.51354684256438e-4,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-209543,p75NTR recruits signalling complexes,4/201,13/11009,6.777001058380724e-5,4.143522123613986e-4,2.51354684256438e-4,7314/7316/8767/8878,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-209560,NF-kB is activated and signals survival,4/201,13/11009,6.777001058380724e-5,4.143522123613986e-4,2.51354684256438e-4,7314/7316/8878/4792,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-75205,Dissolution of Fibrin Clot,4/201,13/11009,6.777001058380724e-5,4.143522123613986e-4,2.51354684256438e-4,5329/302/5270/6281,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9679506,SARS-CoV Infections,20/201,414/11009,6.84684718043291e-5,4.1583185209162536e-4,2.5225226454226506e-4,9636/3107/567/3106/25978/64135/81631/7555/7314/7316/8767/3133/1603/3105/10284/2810/6772/684/3320/4792,20,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3858494,Beta-catenin independent WNT signaling,11/201,146/11009,7.293777017979758e-5,4.400417790317589e-4,2.669385105918001e-4,5721/7314/7316/5714/5694/5704/5687/5685/801/5689/1212,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,9/201,99/11009,7.898360269983287e-5,4.7338198723386675e-4,2.871633754668438e-4,54732/378/10383/7277/7846/11316/375/10381/10376,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1852241,Organelle biogenesis and maintenance,16/201,296/11009,1.0375498882497121e-4,6.177829726767894e-4,3.747600215556236e-4,83658/378/10383/7277/7846/22948/10575/6648/54205/506/801/10381/509/10376/3320/10576,16,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3700989,Transcriptional Regulation by TP53,18/201,362/11009,1.1144882968780513e-4,6.592849600363019e-4,3.9993599170264993e-4,1647/7314/7316/5052/5440/2810/1337/5366/25824/54205/6009/6446/1349/7295/1026/64065/3486/54541,18,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6809371,Formation of the cornified envelope,10/201,129/11009,1.227570606351053e-4,7.21494724119877e-4,4.376737306175231e-4,3872/3856/3861/3868/64065/3875/3854/3853/3887/3855,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,4/201,15/11009,1.2571873016857939e-4,7.341651486126655e-4,4.4535987407897553e-4,467/23645/1649/8894,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-948021,Transport to the Golgi and subsequent modification,12/201,185/11009,1.4563029922858855e-4,8.450267681353132e-4,5.126108420718e-4,1604/54732/378/10383/7277/7846/10342/11316/375/966/10381/10376,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-445355,Smooth Muscle Contraction,6/201,45/11009,1.54691509674734e-4,8.919238310992573e-4,5.410595774765845e-4,10627/103910/301/302/801/4637,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5689880,Ub-specific processing proteases,13/201,219/11009,1.877675854547645e-4,0.001075826,6.526182215408895e-4,64135/11047/5721/7314/7316/5714/5694/5704/7417/5687/5685/5689/4792,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-437239,Recycling pathway of L1,6/201,47/11009,1.9784347198405772e-4,0.001126471,6.833409394186203e-4,10383/7277/7846/60/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6807070,PTEN Regulation,10/201,140/11009,2.407781343820861e-4,0.001362415,8.264695688172291e-4,5721/7314/7316/5714/5694/5704/5687/6009/5685/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9793380,Formation of paraxial mesoderm,7/201,69/11009,2.522088744656938e-4,0.001418286,8.60361657534043e-4,5721/5714/5694/5704/5687/5685/5689,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2682334,EPH-Ephrin signaling,8/201,92/11009,2.6921211579505406e-4,0.001504615,9.127307768317944e-4,10627/103910/6386/1072/60/1212/4637/1942,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5688426,Deubiquitination,15/201,297/11009,3.5620088604804243e-4,0.001977659,0.001199689,64135/11047/5721/7314/7316/8767/5714/5694/5704/7417/5687/60/5685/5689/4792,15,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9824439,Bacterial Infection Pathways,7/201,73/11009,3.581929719722002e-4,0.001977659,0.001199689,567/7314/7316/928/801/3320/2023,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-157118,Signaling by NOTCH,13/201,235/11009,3.7323187064353255e-4,0.002048279,0.001242528,5721/7314/7316/5714/5694/5704/5687/6772/5685/595/6500/5689/4192,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5619115,Disorders of transmembrane transporters,11/201,176/11009,3.789239818760082e-4,0.002067064,0.001253924,6520/5721/7314/7316/5714/5694/5704/682/5687/5685/5689,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5625900,RHO GTPases activate CIT,4/201,20/11009,4.153954745425111e-4,0.002252531,0.001366432,10627/103910/389/4637,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2995410,Nuclear Envelope (NE) Reassembly,7/201,75/11009,4.231523846260073e-4,0.002281017,0.001383712,25978/10383/7277/7846/10381/10376/4000,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5620924,Intraflagellar transport,6/201,54/11009,4.280603985543318e-4,0.0022939,0.001391528,83658/10383/7277/7846/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-446203,Asparagine N-linked glycosylation,15/201,304/11009,4.555217500848064e-4,0.002426785,0.001472139,7314/7316/1604/54732/1603/378/10383/7277/7846/10342/11316/375/966/10381/10376,15,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-190861,Gap junction assembly,5/201,36/11009,4.5917972010095986e-4,0.002432051,0.001475333,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,4/201,21/11009,5.058512693326315e-4,0.00266376,0.001615892,10627/103910/389/4637,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3299685,Detoxification of Reactive Oxygen Species,5/201,37/11009,5.231376422404278e-4,0.002738956,0.001661508,5052/6648/25824/54205/7295,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-447115,Interleukin-12 family signaling,6/201,57/11009,5.747976136288572e-4,0.002984662,0.001810558,5721/6648/375/6772/1072/302,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8951664,Neddylation,13/201,246/11009,5.766197366426201e-4,0.002984662,0.001810558,5721/7314/7316/8878/5714/5694/5704/5687/5685/6500/5689/1026/114907,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,9/201,129/11009,5.845170504588021e-4,0.003008447,0.001824986,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,5/201,38/11009,5.935670301370889e-4,0.003037863,0.001842831,5721/6648/375/1072/302,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-68886,M Phase,18/201,416/11009,6.060512576633136e-4,0.003084428,0.001871079,25978/5721/7314/7316/10383/7277/5714/7846/5694/5704/10726/5687/5685/10381/5689/10376/3320/4000,18,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5205685,PINK1-PRKN Mediated Mitophagy,4/201,22/11009,6.094909879811781e-4,0.003084702,0.001871244,81631/7314/7316/8878,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,3/201,10/11009,6.545499157416816e-4,0.003294447,0.00199848,1649/3309/7494,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,7/201,82/11009,7.280362675236543e-4,0.003629889,0.002201967,9636/64135/7314/7316/3320/6288/4792,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8856688,Golgi-to-ER retrograde transport,9/201,133/11009,7.291654993674599e-4,0.003629889,0.002201967,54732/378/10383/7277/7846/11316/375/10381/10376,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,5/201,40/11009,7.554810632141467e-4,0.003732144,0.002263997,64135/7314/7316/684/4792,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5218859,Regulated Necrosis,6/201,60/11009,7.578998156566664e-4,0.003732144,0.002263997,25978/7314/7316/6386/54205/3320,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,5/201,41/11009,8.478069903512125e-4,0.004152431,0.002518951,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5627123,RHO GTPases activate PAKs,4/201,24/11009,8.60442865509008e-4,0.004191783,0.002542823,10627/103910/801/4637,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9708530,Regulation of BACH1 activity,3/201,11/11009,8.879348159570435e-4,0.004302705,0.002610111,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,5/201,42/11009,9.482858536092852e-4,0.004570838,0.002772766,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69481,G2/M Checkpoints,10/201,167/11009,9.695954786754765e-4,0.004648955,0.002820153,5721/7314/7316/5714/2810/5694/5704/5687/5685/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-400685,Sema4D in semaphorin signaling,4/201,25/11009,0.001009829,0.004816514,0.002921797,10627/103910/389/4637,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-68867,Assembly of the pre-replicative complex,9/201,141/11009,0.001106273,0.005234848,0.003175568,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,7/201,88/11009,0.001109029,0.005234848,0.003175568,7314/7316/10383/7277/7846/6500/3320,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5617833,Cilium Assembly,11/201,201/11009,0.001145715,0.005380135,0.003263702,83658/378/10383/7277/7846/22948/10575/10381/10376/3320/10576,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-373755,Semaphorin interactions,6/201,65/11009,0.001159666,0.005417724,0.003286504,10627/103910/389/1072/3320/4637,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,3/201,12/11009,0.001168048,0.005429038,0.003293367,1649/3309/7494,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,10/201,172/11009,0.001213805,0.00561308,0.003405011,5721/7314/7316/5714/5694/5704/9939/5687/5685/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1257604,PIP3 activates AKT signaling,13/201,268/11009,0.001271264,0.005849101,0.003548186,5721/7314/7316/5714/5694/5704/5687/6009/5685/6446/5689/1026/8870,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation,5/201,45/11009,0.001303062,0.005965271,0.003618658,7314/7316/8767/6288/4792,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,4/201,27/11009,0.001361618,0.006171313,0.003743647,467/3576/1649/9709,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9635486,Infection with Mycobacterium tuberculosis,4/201,27/11009,0.001361618,0.006171313,0.003743647,567/7314/7316/2023,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-373760,L1CAM interactions,8/201,119/11009,0.001492913,0.006732889,0.004084311,6386/10383/7277/7846/60/10381/10376/100133941,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9682385,FLT3 signaling in disease,4/201,28/11009,0.001566095,0.007025095,0.004261569,7314/7316/5292/1026,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69231,Cyclin D associated events in G1,5/201,47/11009,0.001588551,0.007025095,0.004261569,7314/7316/595/6500/1026,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69236,G1 Phase,5/201,47/11009,0.001588551,0.007025095,0.004261569,7314/7316/595/6500/1026,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9020591,Interleukin-12 signaling,5/201,47/11009,0.001588551,0.007025095,0.004261569,5721/6648/375/1072/302,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9006925,Intracellular signaling by second messengers,14/201,310/11009,0.001646153,0.007244664,0.004394764,5721/7314/7316/5714/5694/5704/5687/6009/5685/6446/801/5689/1026/8870,14,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-162588,Budding and maturation of HIV virion,4/201,29/11009,0.001791,0.007806702,0.004735708,25978/7314/7316/51510,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5205647,Mitophagy,4/201,29/11009,0.001791,0.007806702,0.004735708,81631/7314/7316/8878,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-877300,Interferon gamma signaling,7/201,96/11009,0.001842637,0.007993534,0.004849044,3107/567/3106/3133/3105/6672/6772,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,4/201,30/11009,0.002037355,0.008713757,0.005285947,7314/7316/7050/6772,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3928663,EPHA-mediated growth cone collapse,4/201,30/11009,0.002037355,0.008713757,0.005285947,10627/103910/4637/1942,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-77387,Insulin receptor recycling,4/201,30/11009,0.002037355,0.008713757,0.005285947,529/533/8992/527,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1169408,ISG15 antiviral mechanism,6/201,73/11009,0.002119035,0.009020753,0.005472177,9636/7314/7316/3434/5610/6772,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69306,DNA Replication,10/201,186/11009,0.002175245,0.009216967,0.005591204,5721/7314/7316/5714/5694/5704/5687/5685/6500/5689,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-376176,Signaling by ROBO receptors,11/201,219/11009,0.002268153,0.009566146,0.005803023,5721/7314/7316/5714/5694/5704/10487/9939/5687/5685/5689,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,5/201,51/11009,0.002293755,0.009629543,0.005841482,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-917977,Transferrin endocytosis and recycling,4/201,31/11009,0.002306171,0.009637256,0.00584616,529/533/8992/527,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69002,DNA Replication Pre-Initiation,9/201,158/11009,0.002433286,0.010122025179752704,0.006140231,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5213460,RIPK1-mediated regulated necrosis,4/201,32/11009,0.002598448,0.010663001906182927,0.006468399,7314/7316/6386/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5675482,Regulation of necroptotic cell death,4/201,32/11009,0.002598448,0.010663001906182927,0.006468399,7314/7316/6386/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-917729,Endosomal Sorting Complex Required For Transport (ESCRT),4/201,32/11009,0.002598448,0.010663001906182927,0.006468399,25978/7314/7316/51510,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-195258,RHO GTPase Effectors,14/201,326/11009,0.002619911,0.010702865396162628,0.006492581,10627/103910/10383/7277/7846/2810/10726/389/1072/60/801/10381/10376/4637,14,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-205043,NRIF signals cell death from the nucleus,3/201,16/11009,0.002817347,0.011407124381422482,0.006919799,7314/7316/8878,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,3/201,16/11009,0.002817347,0.011407124381422482,0.006919799,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9639288,Amino acids regulate mTORC1,5/201,55/11009,0.003203183,0.012911944778805567,0.007832655,529/533/8992/527/6009,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-438064,Post NMDA receptor activation events,6/201,80/11009,0.003367686,0.013486874195049603,0.008181419,10383/7277/7846/801/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,3/201,17/11009,0.00337542,0.013486874195049603,0.008181419,1647/1026/694,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,4/201,35/11009,0.003625836,0.014424178739895531,0.008750007,9636/64135/7314/7316,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1222556,ROS and RNS production in phagocytes,4/201,36/11009,0.004021668,0.015873143,0.009628979,529/533/8992/527,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8878171,Transcriptional regulation by RUNX1,11/201,236/11009,0.004024913,0.015873143,0.009628979,5721/7314/7316/5714/5694/5704/5687/3958/5685/595/5689,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5663220,RHO GTPases Activate Formins,8/201,140/11009,0.004111581,0.016145044827509693,0.009793921,10383/7277/7846/10726/389/60/10381/10376,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983189,Kinesins,5/201,59/11009,0.00434741,0.016997811968411696,0.010311226857029452,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,13/201,309/11009,0.004392162,0.017099400486840187,0.010372852568711188,55905/5721/7314/7316/5714/5694/5704/5687/10616/5685/6500/5689/114907,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9678108,SARS-CoV-1 Infection,8/201,142/11009,0.004479187,0.017363998084486864,0.010533362983829916,25978/64135/81631/7314/7316/2810/684/4792,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,3/201,19/11009,0.004682648,0.017923916,0.010873020728559847,7314/7316/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,3/201,19/11009,0.004682648,0.017923916,0.010873020728559847,7314/7316/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9818027,NFE2L2 regulating anti-oxidant/detoxification enzymes,3/201,19/11009,0.004682648,0.017923916,0.010873020728559847,5052/7295/1728,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9758941,Gastrulation,7/201,114/11009,0.004835847,0.018432872,0.011181764035420013,5721/5714/5694/5704/5687/5685/5689,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5673001,RAF/MAP kinase cascade,12/201,280/11009,0.005296469,0.020104514176007043,0.012195817138371595,5721/7314/7316/5714/5694/5704/5687/11221/60/5685/801/5689,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5689896,Ovarian tumor domain proteases,4/201,39/11009,0.005382135,0.020344916177746673,0.012341650000944022,64135/7314/7316/8767,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6805567,Keratinization,10/201,214/11009,0.005895954,0.022195098296956123,0.013464009,3872/3856/3861/3868/64065/3875/3854/3853/3887/3855,10,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5684996,MAPK1/MAPK3 signaling,12/201,286/11009,0.006245952,0.023362416613522386,0.014172129,5721/7314/7316/5714/5694/5704/5687/11221/60/5685/801/5689,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,3/201,21/11009,0.006257332,0.023362416613522386,0.014172129,567/3105/375,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5683057,MAPK family signaling cascades,13/201,325/11009,0.00665632,0.024750642526360625,0.015014255388918282,5721/7314/7316/5714/5694/5704/5687/11221/3315/60/5685/801/5689,13,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,6/201,93/11009,0.007033255,0.025947518,0.015740305,10383/7277/7846/801/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,3/201,22/11009,0.007149097,0.025947518,0.015740305,7314/7316/4192,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,3/201,22/11009,0.007149097,0.025947518,0.015740305,5052/6648/4000,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8863678,Neurodegenerative Diseases,3/201,22/11009,0.007149097,0.025947518,0.015740305,5052/6648/4000,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,3/201,22/11009,0.007149097,0.025947518,0.015740305,9218/27230/23480,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9613829,Chaperone Mediated Autophagy,3/201,22/11009,0.007149097,0.025947518,0.015740305,7314/7316/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69620,Cell Cycle Checkpoints,12/201,292/11009,0.007325729,0.026483090255794095,0.016065194273836618,5721/7314/7316/5714/2810/5694/5704/10726/5687/5685/5689/1026,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,6/201,94/11009,0.007401559,0.026651462271852076,0.016167332,10383/7277/7846/10381/10376/3320,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9711097,Cellular response to starvation,8/201,157/11009,0.008101017,0.028756263178422076,0.017444148,467/529/533/8992/1649/527/8894/6009,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,3/201,23/11009,0.00811236,0.028756263178422076,0.017444148,7314/7316/8767,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5620922,BBSome-mediated cargo-targeting to cilium,3/201,23/11009,0.00811236,0.028756263178422076,0.017444148,22948/10575/10576,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9637690,Response of Mtb to phagocytosis,3/201,23/11009,0.00811236,0.028756263178422076,0.017444148,7314/7316/2023,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9692914,SARS-CoV-1-host interactions,6/201,96/11009,0.008179668,0.028882471397300095,0.017520708860803685,64135/7314/7316/2810/684/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,6/201,97/11009,0.008590028,0.029868381031224387,0.018118782184288872,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,6/201,97/11009,0.008590028,0.029868381031224387,0.018118782184288872,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-193704,p75 NTR receptor-mediated signalling,6/201,97/11009,0.008590028,0.029868381031224387,0.018118782184288872,7314/7316/8767/8878/57142/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975871,MyD88 cascade initiated on plasma membrane,6/201,97/11009,0.008590028,0.029868381031224387,0.018118782184288872,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-76002,"Platelet activation, signaling and aggregation",11/201,263/11009,0.008890241,0.030794713051493856,0.018680714486145094,7277/967/3309/10487/8407/7873/1072/928/801/7076/10447,11,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2172127,DAP12 interactions,4/201,45/11009,0.008957914,0.030911588188146693,0.018751613,3107/567/3106/3133,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-450302,activated TAK1 mediates p38 MAPK activation,3/201,24/11009,0.009148348,0.031449603,0.019077984398243153,7314/7316/8767,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1643713,Signaling by EGFR in Cancer,3/201,25/11009,0.010258145787811536,0.034740412,0.021074258,7314/7316/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-933542,TRAF6 mediated NF-kB activation,3/201,25/11009,0.010258145787811536,0.034740412,0.021074258,64135/6288/4792,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,3/201,25/11009,0.010258145787811536,0.034740412,0.021074258,7314/7316/6772,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,3/201,25/11009,0.010258145787811536,0.034740412,0.021074258,5052/6648/4000,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6783783,Interleukin-10 signaling,4/201,47/11009,0.010425968602489018,0.03517799,0.021339701817959977,3576/2919/7076/6364,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,6/201,103/11009,0.011367639,0.038213725,0.023181241567710606,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,3/201,26/11009,0.011442702926631047,0.038324641,0.023248526,7314/7316/23645,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,9/201,202/11009,0.011819063933707744,0.039440173,0.023925231,54732/378/10383/7277/7846/11316/375/10381/10376,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975155,MyD88 dependent cascade initiated on endosome,6/201,104/11009,0.011885642834243981,0.039517593510935284,0.023972195,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,6/201,105/11009,0.012420078,0.040995256,0.024868576,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,6/201,105/11009,0.012420078,0.040995256,0.024868576,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8982491,Glycogen metabolism,3/201,27/11009,0.012702839,0.041626927742265125,0.025251761586098785,7314/7316/801,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9648002,RAS processing,3/201,27/11009,0.012702839,0.041626927742265125,0.025251761586098785,7314/7316/801,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9009391,Extra-nuclear estrogen signaling,5/201,77/11009,0.013197472128014733,0.043092821,0.026141003083221034,3315/595/801/3320/4316,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-164940,Nef mediated downregulation of MHC class I complex cell surface expression,2/201,10/11009,0.013554050003524453,0.04378631,0.026561688,567/3105,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-937042,IRAK2 mediated activation of TAK1 complex,2/201,10/11009,0.013554050003524453,0.04378631,0.026561688,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,2/201,10/11009,0.013554050003524453,0.04378631,0.026561688,5292/1026,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,4/201,51/11009,0.013809038,0.044295893,0.026870811,7314/7316/7050/6772,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5620920,Cargo trafficking to the periciliary membrane,4/201,51/11009,0.013809038,0.044295893,0.026870811,378/22948/10575/10576,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,3/201,28/11009,0.014039247819802592,0.044876333,0.027222918210143526,567/3105/375,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,6/201,108/11009,0.014124505057938497,0.044990993383853047,0.027292473888177068,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381070,IRE1alpha activates chaperones,4/201,52/11009,0.014751393238615195,0.046824109,0.02840448,3309/7494/27230/4000,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-166166,MyD88-independent TLR4 cascade,6/201,110/11009,0.015347539109980636,0.048212442,0.029246672,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling,6/201,110/11009,0.015347539109980636,0.048212442,0.029246672,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-977225,Amyloid fiber formation,6/201,110/11009,0.015347539109980636,0.048212442,0.029246672,567/7314/7316/9445/6288/793,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8863795,Downregulation of ERBB2 signaling,3/201,29/11009,0.015452507206983558,0.048375374795745774,0.029345510159762583,7314/7316/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-196025,Formation of annular gap junctions,2/201,11/11009,0.016368742,0.050720831,0.030768313,60/1212,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9014325,"TICAM1,TRAF6-dependent induction of TAK1 complex",2/201,11/11009,0.016368742,0.050720831,0.030768313,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9645460,Alpha-protein kinase 1 signaling pathway,2/201,11/11009,0.016368742,0.050720831,0.030768313,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9674555,Signaling by CSF3 (G-CSF),3/201,30/11009,0.016943079691180307,0.052322527,0.031739935,7314/7316/6772,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,6/201,113/11009,0.017317014935845174,0.053117174,0.032221984197479056,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,6/201,113/11009,0.017317014935845174,0.053117174,0.032221984197479056,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-195721,Signaling by WNT,12/201,331/11009,0.018357634,0.056120149981456556,0.034043652135033436,5721/7314/7316/5714/5694/5704/5687/5685/801/6500/5689/1212,12,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5339562,Uptake and actions of bacterial toxins,3/201,31/11009,0.01851132,0.056212708,0.0340998,928/801/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,3/201,31/11009,0.01851132,0.056212708,0.0340998,7314/7316/6772,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,4/201,56/11009,0.018922736,0.057271137,0.034741864966783255,6648/54205/506/801,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1474151,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",2/201,12/11009,0.019408881195750554,0.057354409,0.034792379,801/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-190873,Gap junction degradation,2/201,12/11009,0.019408881195750554,0.057354409,0.034792379,60/1212,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-203615,eNOS activation,2/201,12/11009,0.019408881195750554,0.057354409,0.034792379,801/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4755510,SUMOylation of immune response proteins,2/201,12/11009,0.019408881195750554,0.057354409,0.034792379,5610/4792,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5689877,Josephin domain DUBs,2/201,12/11009,0.019408881195750554,0.057354409,0.034792379,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,2/201,12/11009,0.019408881195750554,0.057354409,0.034792379,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,6/201,116/11009,0.019453910268903647,0.057354409,0.034792379,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,6/201,116/11009,0.019453910268903647,0.057354409,0.034792379,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",4/201,57/11009,0.020068298057018843,0.058974901709497304,0.035775404,7314/7316/8767/7295,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5656169,Termination of translesion DNA synthesis,3/201,32/11009,0.020157479026720423,0.058994378521037616,0.035787219,9636/7314/7316,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,6/201,117/11009,0.020204441,0.058994378521037616,0.035787219,10383/7277/7846/10726/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983712,Ion channel transport,8/201,186/11009,0.020774158674975937,0.060464085,0.036678773513914124,529/7314/7316/533/8992/527/6446/801,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1980145,Signaling by NOTCH2,3/201,33/11009,0.02188171,0.063283294,0.038388964,7314/7316/4192,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5357956,TNFR1-induced NF-kappa-B signaling pathway,3/201,33/11009,0.02188171,0.063283294,0.038388964,7314/7316/10616,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,4/201,59/11009,0.02248545,0.064727782,0.039265221,7314/7316/51255/3105,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,2/201,13/11009,0.022665381,0.064727782,0.039265221,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-879415,Advanced glycosylation endproduct receptor signaling,2/201,13/11009,0.022665381,0.064727782,0.039265221,3958/6288,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9637687,Suppression of phagosomal maturation,2/201,13/11009,0.022665381,0.064727782,0.039265221,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73887,Death Receptor Signaling,7/201,154/11009,0.022795502,0.064895944,0.039367232,7314/7316/8767/8878/57142/10616/4792,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2132295,MHC class II antigen presentation,6/201,123/11009,0.025123490619323393,0.071300623,0.043252443269863196,10383/7277/7846/375/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9615710,Late endosomal microautophagy,3/201,35/11009,0.025564529585573644,0.072326977,0.043875051,25978/7314/7316,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9006936,Signaling by TGFB family members,6/201,124/11009,0.026014444748358817,0.072572845,0.0440242,7314/7316/23645/7050/6772/3624,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174490,Membrane binding and targetting of GAG proteins,2/201,14/11009,0.026129411,0.072572845,0.0440242,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174495,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",2/201,14/11009,0.026129411,0.072572845,0.0440242,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3322077,Glycogen synthesis,2/201,14/11009,0.026129411,0.072572845,0.0440242,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9679504,Translation of Replicase and Assembly of the Replication Transcription Complex,2/201,14/11009,0.026129411,0.072572845,0.0440242,25978/81631,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,2/201,14/11009,0.026129411,0.072572845,0.0440242,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-201681,TCF dependent signaling in response to WNT,9/201,232/11009,0.026524661638686234,0.073446707,0.044554302864534545,5721/7314/7316/5714/5694/5704/5687/5685/5689,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,3/201,36/11009,0.027522971507060377,0.075750535,0.045951853,7314/7316/7050,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6804757,Regulation of TP53 Degradation,3/201,36/11009,0.027522971507060377,0.075750535,0.045951853,7314/7316/6446,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,6/201,126/11009,0.027858934,0.076444243,0.04637267,10383/7277/7846/10726/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-170834,Signaling by TGF-beta Receptor Complex,5/201,94/11009,0.028677174,0.078110207,0.047383278934077004,7314/7316/23645/7050/6772,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5625740,RHO GTPases activate PKNs,5/201,94/11009,0.028677174,0.078110207,0.047383278934077004,10627/103910/2810/389/4637,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA,4/201,64/11009,0.029277997463733347,0.078110207,0.047383278934077004,7314/7316/5440/4792,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-450294,MAP kinase activation,4/201,64/11009,0.029277997463733347,0.078110207,0.047383278934077004,7314/7316/8767/6500,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9707564,Cytoprotection by HMOX1,4/201,64/11009,0.029277997463733347,0.078110207,0.047383278934077004,1337/645/54205/1349,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168638,NOD1/2 Signaling Pathway,3/201,37/11009,0.029559198452731087,0.078110207,0.047383278934077004,7314/7316/8767,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6806003,Regulation of TP53 Expression and Degradation,3/201,37/11009,0.029559198452731087,0.078110207,0.047383278934077004,7314/7316/6446,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-937039,IRAK1 recruits IKK complex,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9694676,Translation of Replicase and Assembly of the Replication Transcription Complex,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,25978/81631,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9706369,Negative regulation of FLT3,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,2/201,15/11009,0.029792385,0.078110207,0.047383278934077004,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1592230,Mitochondrial biogenesis,5/201,95/11009,0.029837927648773063,0.078110207,0.047383278934077004,6648/54205/506/801/509,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,3/201,38/11009,0.031672936,0.082205255,0.049867420374284585,22948/10575/10576,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5696394,DNA Damage Recognition in GG-NER,3/201,38/11009,0.031672936,0.082205255,0.049867420374284585,7314/7316/60,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,3/201,38/11009,0.031672936,0.082205255,0.049867420374284585,22948/10575/10576,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-110312,Translesion synthesis by REV1,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1295596,Spry regulation of FGF signaling,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-175474,Assembly Of The HIV Virion,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,801/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3229121,Glycogen storage diseases,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-399954,Sema3A PAK dependent Axon repulsion,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,1072/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8866427,VLDLR internalisation and degradation,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,5292/1026,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,2/201,16/11009,0.033645962,0.084907123,0.051506429620770684,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,3/201,39/11009,0.033863836,0.085220869,0.051696754,9636/7314/7316,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,6/201,133/11009,0.034988553,0.087808737,0.053266609,3107/567/3106/8519/3133/3105,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5655862,Translesion synthesis by POLK,2/201,17/11009,0.037682034,0.093283514,0.056587723,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5656121,Translesion synthesis by POLI,2/201,17/11009,0.037682034,0.093283514,0.056587723,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,2/201,17/11009,0.037682034,0.093283514,0.056587723,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,2/201,17/11009,0.037682034,0.093283514,0.056587723,595/1026,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",2/201,17/11009,0.037682034,0.093283514,0.056587723,595/1026,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380259,Loss of Nlp from mitotic centrosomes,4/201,70/11009,0.038873770511005545,0.095455539,0.057905319,10383/7277/7846/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,4/201,70/11009,0.038873770511005545,0.095455539,0.057905319,10383/7277/7846/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-400253,Circadian Clock,4/201,70/11009,0.038873770511005545,0.095455539,0.057905319,7314/7316/6500/8553,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-163210,Formation of ATP by chemiosmotic coupling,2/201,18/11009,0.041892724920085694,0.10150072447393103,0.061572454,506/509,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,2/201,18/11009,0.041892724920085694,0.10150072447393103,0.061572454,51330/4050,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,2/201,18/11009,0.041892724920085694,0.10150072447393103,0.061572454,1647/2810,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-936964,"Activation of IRF3, IRF7 mediated by TBK1, IKBKE",2/201,18/11009,0.041892724920085694,0.10150072447393103,0.061572454,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9758274,Regulation of NF-kappa B signaling,2/201,18/11009,0.041892724920085694,0.10150072447393103,0.061572454,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-448424,Interleukin-17 signaling,4/201,72/11009,0.04242676,0.10252195736365224,0.062191955186223835,7314/7316/8767/6500,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5675221,Negative regulation of MAPK pathway,3/201,43/11009,0.043389752,0.10457159871644993,0.06343531,7314/7316/11221,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8854518,AURKA Activation by TPX2,4/201,73/11009,0.044269853752409376,0.10641117880856184,0.064551238,10383/7277/7846/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,7/201,178/11009,0.044716225,0.1072012662601327,0.065030521,682/1337/2739/54205/506/1349/509,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,3/201,44/11009,0.045958943,0.1092028941977935,0.066244751,5366/64065/3486,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-110320,Translesion Synthesis by POLH,2/201,19/11009,0.046270381,0.1092028941977935,0.066244751,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3928664,Ephrin signaling,2/201,19/11009,0.046270381,0.1092028941977935,0.066244751,10627/6386,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5423646,Aflatoxin activation and detoxification,2/201,19/11009,0.046270381,0.1092028941977935,0.066244751,4259/4257,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6804760,Regulation of TP53 Activity through Methylation,2/201,19/11009,0.046270381,0.1092028941977935,0.066244751,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9703465,Signaling by FLT3 fusion proteins,2/201,19/11009,0.046270381,0.1092028941977935,0.066244751,5292/1026,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",2/201,20/11009,0.050807569,0.11906177137796267,0.072225351,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8876384,Listeria monocytogenes entry into host cells,2/201,20/11009,0.050807569,0.11906177137796267,0.072225351,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),5/201,110/11009,0.050839768458866605,0.11906177137796267,0.072225351,3576/7314/7316/1026/3490,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,6/201,146/11009,0.051132949,0.11944132447995683,0.072455596,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,3/201,47/11009,0.05410586,0.12606250329011573,0.076472141,7314/7316/23645,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4641263,Regulation of FZD by ubiquitination,2/201,21/11009,0.055497067,0.1279945021040916,0.077644131,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6807004,Negative regulation of MET activity,2/201,21/11009,0.055497067,0.1279945021040916,0.077644131,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8978934,Metabolism of cofactors,2/201,21/11009,0.055497067,0.1279945021040916,0.077644131,801/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-901032,ER Quality Control Compartment (ERQC),2/201,21/11009,0.055497067,0.1279945021040916,0.077644131,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8852135,Protein ubiquitination,4/201,79/11009,0.056257435,0.12942051370812685,0.07850918,7314/7316/51255/3105,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,3/201,48/11009,0.056965255571242705,0.12973836956350526,0.078701998,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5357905,Regulation of TNFR1 signaling,3/201,48/11009,0.056965255571242705,0.12973836956350526,0.078701998,7314/7316/10616,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,3/201,48/11009,0.056965255571242705,0.12973836956350526,0.078701998,1647/2810/1026,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73893,DNA Damage Bypass,3/201,48/11009,0.056965255571242705,0.12973836956350526,0.078701998,9636/7314/7316,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9012852,Signaling by NOTCH3,3/201,49/11009,0.059895074,0.13607085462922228,0.082543415,7314/7316/6772,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-912631,Regulation of signaling by CBL,2/201,22/11009,0.060331864,0.13672221010332616,0.082938541,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,4/201,82/11009,0.062843117,0.14077834018900456,0.085399074,10383/7277/7846/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380287,Centrosome maturation,4/201,82/11009,0.062843117,0.14077834018900456,0.085399074,10383/7277/7846/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-74752,Signaling by Insulin receptor,4/201,82/11009,0.062843117,0.14077834018900456,0.085399074,529/533/8992/527,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1227986,Signaling by ERBB2,3/201,50/11009,0.062894385,0.14077834018900456,0.085399074,7314/7316/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381038,XBP1(S) activates chaperone genes,3/201,50/11009,0.062894385,0.14077834018900456,0.085399074,7494/27230/4000,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,2/201,23/11009,0.065305151,0.14510485892469743,0.08802363,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73980,RNA Polymerase III Transcription Termination,2/201,23/11009,0.065305151,0.14510485892469743,0.08802363,5440/6741,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013418,RHOBTB2 GTPase cycle,2/201,23/11009,0.065305151,0.14510485892469743,0.08802363,3320/10576,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3928665,EPH-ephrin mediated repulsion of cells,3/201,51/11009,0.065962219,0.14620822722680724,0.088692957,60/1212/1942,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6802957,Oncogenic MAPK signaling,4/201,84/11009,0.0674495,0.14914197607461854,0.09047263,11221/60/801/4000,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3371571,HSF1-dependent transactivation,2/201,24/11009,0.070410314,0.15531185584485455,0.094215407,3320/1410,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9609646,HCMV Infection,6/201,160/11009,0.072905438,0.16042718409233475,0.097318472,25978/10383/7277/7846/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,3/201,54/11009,0.075566698,0.16329121883090164,0.099055855,7314/7316/5440,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8848021,Signaling by PTK6,3/201,54/11009,0.075566698,0.16329121883090164,0.099055855,7314/7316/595,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,3/201,54/11009,0.075566698,0.16329121883090164,0.099055855,7314/7316/595,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,2/201,25/11009,0.075640938,0.16329121883090164,0.099055855,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-210991,Basigin interactions,2/201,25/11009,0.075640938,0.16329121883090164,0.099055855,6520/682,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,2/201,25/11009,0.075640938,0.16329121883090164,0.099055855,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,2/201,25/11009,0.075640938,0.16329121883090164,0.099055855,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-937041,IKK complex recruitment mediated by RIP1,2/201,25/11009,0.075640938,0.16329121883090164,0.099055855,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),5/201,125/11009,0.078721354,0.16872385881535282,0.10235140779716936,7076/3490/3491/3489/3486,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-109606,Intrinsic Pathway for Apoptosis,3/201,55/11009,0.078898314,0.16872385881535282,0.10235140779716936,2810/5366/54205,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9700206,Signaling by ALK in cancer,3/201,55/11009,0.078898314,0.16872385881535282,0.10235140779716936,8878/10342/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,3/201,55/11009,0.078898314,0.16872385881535282,0.10235140779716936,8878/10342/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3371556,Cellular response to heat stress,4/201,89/11009,0.07970637,0.17005270057274446,0.10315751089108653,3309/10049/3320/1410,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9609507,Protein localization,6/201,164/11009,0.079969733,0.170215949,0.10325654102260597,7314/7316/9218/27230/23480/506,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-68877,Mitotic Prometaphase,7/201,204/11009,0.080212249,0.17033417049554572,0.10332825641014674,10383/7277/7846/10726/10381/10376/3320,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-901042,Calnexin/calreticulin cycle,2/201,26/11009,0.080990791,0.17158746591863672,0.10408853152381334,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-163200,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",5/201,127/11009,0.082954677,0.17534039634121015,0.10636513730329346,1337/54205/506/1349/509,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72163,mRNA Splicing - Major Pathway,7/201,207/11009,0.085128944,0.17951960208443524,0.10890033057291408,5440/10284/51639/9939/6629/4809/8896,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-75893,TNF signaling,3/201,57/11009,0.085750094,0.17999616604806035,0.10918942420155028,7314/7316/10616,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9694635,Translation of Structural Proteins,3/201,57/11009,0.085750094,0.17999616604806035,0.10918942420155028,7314/7316/1603,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168898,Toll-like Receptor Cascades,6/201,168/11009,0.087405669,0.1826297344994833,0.11078700168955889,7314/7316/8767/6500/6288/4792,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,6/201,168/11009,0.087405669,0.1826297344994833,0.11078700168955889,10383/7277/7846/60/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,3/201,58/11009,0.089267968,0.18440616456479564,0.11186462117570939,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2644603,Signaling by NOTCH1 in Cancer,3/201,58/11009,0.089267968,0.18440616456479564,0.11186462117570939,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,3/201,58/11009,0.089267968,0.18440616456479564,0.11186462117570939,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,3/201,58/11009,0.089267968,0.18440616456479564,0.11186462117570939,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,3/201,58/11009,0.089267968,0.18440616456479564,0.11186462117570939,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5620971,Pyroptosis,2/201,28/11009,0.092024179,0.1896697447669574,0.11505761858299456,25978/54205,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380108,Chemokine receptors bind chemokines,3/201,59/11009,0.092845603,0.19093079901466903,0.11582260036131636,3576/2919/6364,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-420029,Tight junction interactions,2/201,29/11009,0.097696155,0.19822092883706469,0.1202449449875313,1366/1364,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5218920,VEGFR2 mediated vascular permeability,2/201,29/11009,0.097696155,0.19822092883706469,0.1202449449875313,801/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,2/201,29/11009,0.097696155,0.19822092883706469,0.1202449449875313,5440/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654732,Negative regulation of FGFR3 signaling,2/201,29/11009,0.097696155,0.19822092883706469,0.1202449449875313,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",2/201,29/11009,0.097696155,0.19822092883706469,0.1202449449875313,6648/114907,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9683701,Translation of Structural Proteins,2/201,29/11009,0.097696155,0.19822092883706469,0.1202449449875313,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72172,mRNA Splicing,7/201,215/11009,0.099065522,0.20055264473450207,0.12165941242777005,5440/10284/51639/9939/6629/4809/8896,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,3/201,61/11009,0.10017537411496644,0.20234981334530916,0.12274961234766571,1072/60/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9609690,HCMV Early Events,5/201,135/11009,0.10106226745138465,0.20368965851374207,0.1235623903399556,10383/7277/7846/10381/10376,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-162599,Late Phase of HIV Life Cycle,5/201,136/11009,0.1034549661118932,0.2062492669770189,0.12511510215833946,25978/7314/7316/5440/51510,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,2/201,30/11009,0.10346423162293922,0.2062492669770189,0.12511510215833946,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-114452,Activation of BH3-only proteins,2/201,30/11009,0.10346423162293922,0.2062492669770189,0.12511510215833946,2810/5366,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2424491,DAP12 signaling,2/201,30/11009,0.10346423162293922,0.2062492669770189,0.12511510215833946,567/3133,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,2/201,30/11009,0.10346423162293922,0.2062492669770189,0.12511510215833946,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5620912,Anchoring of the basal body to the plasma membrane,4/201,98/11009,0.10432460814150153,0.20751030134696047,0.12588007187839187,10383/7277/7846/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4420097,VEGFA-VEGFR2 Pathway,4/201,99/11009,0.10725300157602734,0.21287033646135273,0.12913158084489013,3315/60/801/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-182971,EGFR downregulation,2/201,31/11009,0.10932305312118724,0.21464073576164136,0.13020554194333778,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,2/201,31/11009,0.10932305312118724,0.21464073576164136,0.13020554194333778,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654733,Negative regulation of FGFR4 signaling,2/201,31/11009,0.10932305312118724,0.21464073576164136,0.13020554194333778,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-70268,Pyruvate metabolism,2/201,31/11009,0.10932305312118724,0.21464073576164136,0.13020554194333778,682/2739,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8949613,Cristae formation,2/201,31/11009,0.10932305312118724,0.21464073576164136,0.13020554194333778,506/509,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,3/201,65/11009,0.11549867,0.2262780402412802,0.13726497328172868,7314/7316/5440,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6782135,Dual incision in TC-NER,3/201,66/11009,0.11946051200537461,0.23353761037960574,0.14166877976693396,7314/7316/5440,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1592389,Activation of Matrix Metalloproteinases,2/201,33/11009,0.12129230957329362,0.23560190622872174,0.14292102463467432,7076/4316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2559585,Oncogene Induced Senescence,2/201,33/11009,0.12129230957329362,0.23560190622872174,0.14292102463467432,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654726,Negative regulation of FGFR1 signaling,2/201,33/11009,0.12129230957329362,0.23560190622872174,0.14292102463467432,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6802952,Signaling by BRAF and RAF1 fusions,3/201,67/11009,0.1234722364361877,0.23932597317737658,0.14518012122955998,60/801/4000,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654727,Negative regulation of FGFR2 signaling,2/201,34/11009,0.12739282453619058,0.24587894735692717,0.14915529188559334,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5663084,Diseases of carbohydrate metabolism,2/201,34/11009,0.12739282453619058,0.24587894735692717,0.14915529188559334,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-432720,Lysosome Vesicle Biogenesis,2/201,35/11009,0.1335642363513795,0.2556239901598881,0.15506683786924866,375/1212,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,2/201,35/11009,0.1335642363513795,0.2556239901598881,0.15506683786924866,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,2/201,35/11009,0.1335642363513795,0.2556239901598881,0.15506683786924866,595/1026,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9706574,RHOBTB GTPase Cycle,2/201,35/11009,0.1335642363513795,0.2556239901598881,0.15506683786924866,3320/10576,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-194138,Signaling by VEGF,4/201,108/11009,0.135213658,0.2576979974843147,0.15632497392023254,3315/60/801/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8957275,Post-translational protein phosphorylation,4/201,108/11009,0.135213658,0.2576979974843147,0.15632497392023254,7076/3490/3491/3486,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9772573,Late SARS-CoV-2 Infection Events,3/201,70/11009,0.13579396183567383,0.25826367271878675,0.1566681243022278,7314/7316/1603,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-162587,HIV Life Cycle,5/201,149/11009,0.13702878602866658,0.2600692168169068,0.1577634049672148,25978/7314/7316/5440/51510,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2672351,Stimuli-sensing channels,4/201,109/11009,0.13848936022654687,0.2622948173937301,0.1591135006432588,7314/7316/6446/801,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-156590,Glutathione conjugation,2/201,36/11009,0.1398019578128101,0.26423150117732364,0.1602883333734992,4259/4257,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5696398,Nucleotide Excision Repair,4/201,111/11009,0.14513569829887973,0.27374455724695534,0.16605915137171592,7314/7316/5440/60,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5689901,Metalloprotease DUBs,2/201,37/11009,0.14610154406195738,0.2738652400009119,0.16613236004446094,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8964043,Plasma lipoprotein clearance,2/201,37/11009,0.14610154406195738,0.2738652400009119,0.16613236004446094,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9675126,Diseases of mitotic cell cycle,2/201,37/11009,0.14610154406195738,0.2738652400009119,0.16613236004446094,595/1026,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2559583,Cellular Senescence,6/201,195/11009,0.14687158920591936,0.2747433629704159,0.1666650477317792,3576/7314/7316/7295/1026/3490,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1500931,Cell-Cell communication,5/201,153/11009,0.14822873770752154,0.2766881021569617,0.1678447670372695,961/1366/60/3861/1364,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654738,Signaling by FGFR2,3/201,73/11009,0.14851864100412104,0.2766881021569617,0.1678447670372695,7314/7316/5440,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013407,RHOH GTPase cycle,2/201,38/11009,0.15245868896235137,0.2822964748876059,0.17124692277542675,9528/10376,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9607240,FLT3 Signaling,2/201,38/11009,0.15245868896235137,0.2822964748876059,0.17124692277542675,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9772572,Early SARS-CoV-2 Infection Events,2/201,38/11009,0.15245868896235137,0.2822964748876059,0.17124692277542675,25978/81631,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1980143,Signaling by NOTCH1,3/201,74/11009,0.15284376751808548,0.28243544058615794,0.17133122226325367,7314/7316/6500,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-446728,Cell junction organization,4/201,115/11009,0.15879237003208704,0.2928337026300229,0.17763902464701833,1366/60/3861/1364,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",3/201,76/11009,0.16161170165158745,0.2974308286961539,0.18042773709108642,7314/7316/8878,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-375276,Peptide ligand-binding receptors,6/201,201/11009,0.16211122324774704,0.29774863786027733,0.1806205267509915,3576/2919/301/1906/6288/6364,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168276,NS1 Mediated Effects on Host Pathways,2/201,40/11009,0.165329103,0.3018332915453815,0.1830983627723442,9636/5610,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654741,Signaling by FGFR3,2/201,40/11009,0.165329103,0.3018332915453815,0.1830983627723442,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6783310,Fanconi Anemia Pathway,2/201,40/11009,0.165329103,0.3018332915453815,0.1830983627723442,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-193697,p75NTR regulates axonogenesis,1/201,10/11009,0.16834805105691786,0.3049007445583542,0.1849591436745461,57142,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,1/201,10/11009,0.16834805105691786,0.3049007445583542,0.1849591436745461,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9020958,Interleukin-21 signaling,1/201,10/11009,0.16834805105691786,0.3049007445583542,0.1849591436745461,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,1/201,10/11009,0.16834805105691786,0.3049007445583542,0.1849591436745461,7295,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654743,Signaling by FGFR4,2/201,41/11009,0.17183442123625894,0.30875968,0.18730005429053448,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5696400,Dual Incision in GG-NER,2/201,41/11009,0.17183442123625894,0.30875968,0.18730005429053448,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-74158,RNA Polymerase III Transcription,2/201,41/11009,0.17183442123625894,0.30875968,0.18730005429053448,5440/6741,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,2/201,41/11009,0.17183442123625894,0.30875968,0.18730005429053448,5440/6741,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,6/201,205/11009,0.17263611634457496,0.30898133986229426,0.18743451779733603,10383/7277/7846/801/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-397014,Muscle contraction,6/201,205/11009,0.17263611634457496,0.30898133986229426,0.18743451779733603,10627/103910/301/302/801/4637,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),3/201,79/11009,0.17503874936614439,0.3120553829208562,0.18929929635848344,7314/7316/5440,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6806834,Signaling by MET,3/201,79/11009,0.17503874936614439,0.3120553829208562,0.18929929635848344,7314/7316/10653,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,2/201,42/11009,0.1783813915728482,0.3155445586851742,0.19141590306744058,3320/6288,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,2/201,42/11009,0.1783813915728482,0.3155445586851742,0.19141590306744058,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3928662,EPHB-mediated forward signaling,2/201,42/11009,0.1783813915728482,0.3155445586851742,0.19141590306744058,1072/60,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9035034,RHOF GTPase cycle,2/201,42/11009,0.1783813915728482,0.3155445586851742,0.19141590306744058,60/10409,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9006931,Signaling by Nuclear Receptors,8/201,298/11009,0.17885986122538444,0.3157777782486923,0.19155737891335542,5440/3315/2171/595/801/3320/1382/4316,8,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1059683,Interleukin-6 signaling,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111458,Formation of apoptosome,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,54205,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2025928,Calcineurin activates NFAT,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-446107,Type I hemidesmosome assembly,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,3861,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73614,Pyrimidine salvage,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,7378,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8934903,Receptor Mediated Mitophagy,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,81631,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9020956,Interleukin-27 signaling,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,2810,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9627069,Regulation of the apoptosome activity,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,54205,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9634285,Constitutive Signaling by Overexpressed ERBB2,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9754560,SARS-CoV-2 modulates autophagy,1/201,11/11009,0.1835459819358667,0.31728726668609974,0.19247306604679917,81631,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5362517,Signaling by Retinoic Acid,2/201,43/11009,0.18496634958779026,0.31793272542354134,0.19286461476383293,2171/1382,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5696395,Formation of Incision Complex in GG-NER,2/201,43/11009,0.18496634958779026,0.31793272542354134,0.19286461476383293,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9656223,Signaling by RAF1 mutants,2/201,43/11009,0.18496634958779026,0.31793272542354134,0.19286461476383293,60/801,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),3/201,84/11009,0.19806722457768805,0.3329722390345838,0.20198789703987113,7314/7316/60,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1475029,Reversible hydration of carbon dioxide,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,760,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-209822,Glycoprotein hormones,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,3624,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3371511,HSF1 activation,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-451306,Ionotropic activity of kainate receptors,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-451308,Activation of Ca-permeable Kainate Receptor,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6803211,TP53 Regulates Transcription of Death Receptors and Ligands,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,3486,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73621,Pyrimidine catabolism,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,7378,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8984722,Interleukin-35 Signalling,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9673767,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9673770,Signaling by PDGFRA extracellular domain mutants,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,1/201,12/11009,0.19846753654860483,0.3329722390345838,0.20198789703987113,2810,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8854214,TBC/RABGAPs,2/201,46/11009,0.20491427098374057,0.3431560677687273,0.20816561971064976,81631/11345,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,3/201,86/11009,0.20747737290487847,0.3468108013143932,0.21038265721885308,1072/60/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,2/201,47/11009,0.21161686701153673,0.3473170651503476,0.21068976740878445,60/801,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6802949,Signaling by RAS mutants,2/201,47/11009,0.21161686701153673,0.3473170651503476,0.21068976740878445,60/801,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,2/201,47/11009,0.21161686701153673,0.3473170651503476,0.21068976740878445,60/801,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9649948,Signaling downstream of RAS mutants,2/201,47/11009,0.21161686701153673,0.3473170651503476,0.21068976740878445,60/801,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-977606,Regulation of Complement cascade,2/201,47/11009,0.21161686701153673,0.3473170651503476,0.21068976740878445,1604/966,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111461,Cytochrome c-mediated apoptotic response,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,54205,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1237044,Erythrocytes take up carbon dioxide and release oxygen,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,760,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1480926,O2/CO2 exchange in erythrocytes,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,760,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-425561,Sodium/Calcium exchangers,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5140745,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,1212,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5210891,Uptake and function of anthrax toxins,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,2810,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,1/201,13/11009,0.21311771615701902,0.3473170651503476,0.21068976740878445,64135,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-421270,Cell-cell junction organization,3/201,88/11009,0.2169866309280426,0.35299075138472646,0.2141315436789894,1366/60/1364,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",2/201,48/11009,0.21834085011763668,0.3545606318309572,0.2150838658631377,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8939211,ESR-mediated signaling,6/201,222/11009,0.22027423434316942,0.35706374997620527,0.21660230947773731,5440/3315/595/801/3320/4316,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-190236,Signaling by FGFR,3/201,89/11009,0.22177547723663085,0.3579513031475382,0.21714071772194526,7314/7316/5440,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-198323,AKT phosphorylates targets in the cytosol,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,1026,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-209952,Peptide hormone biosynthesis,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,3624,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2453864,Retinoid cycle disease events,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,5947,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2474795,Diseases associated with visual transduction,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,5947,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3371568,Attenuation phase,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-418359,Reduction of cytosolic Ca++ levels,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,64065,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,1026,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-71240,Tryptophan catabolism,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,6520,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-877312,Regulation of IFNG signaling,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9005895,Pervasive developmental disorders,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9675143,Diseases of the neuronal system,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,5947,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9675151,Disorders of Developmental Biology,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9697154,Disorders of Nervous System Development,1/201,14/11009,0.22750143196753525,0.3579513031475382,0.21714071772194526,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-177929,Signaling by EGFR,2/201,50/11009,0.2318410918416732,0.36352364,0.2205210131658274,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72165,mRNA Splicing - Minor Pathway,2/201,50/11009,0.2318410918416732,0.36352364,0.2205210131658274,5440/51639,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-202733,Cell surface interactions at the vascular wall,4/201,137/11009,0.24100956774937818,0.37245180142874507,0.22593702206954897,6520/4072/961/682,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111447,Activation of BAD and translocation to mitochondria,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,2810,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1170546,Prolactin receptor signaling,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,6500,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-189483,Heme degradation,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,645,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4419969,Depolymerization of the Nuclear Lamina,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5099900,WNT5A-dependent internalization of FZD4,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,1212,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5637810,Constitutive Signaling by EGFRvIII,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5637812,Signaling by EGFRvIII in Cancer,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-918233,TRAF3-dependent IRF activation pathway,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,64135,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,1/201,15/11009,0.24162350674466337,0.37245180142874507,0.22593702206954897,2810,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5654736,Signaling by FGFR1,2/201,52/11009,0.24539222138721198,0.37762215149282113,0.22907346413279922,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-71291,Metabolism of amino acids and derivatives,9/201,376/11009,0.24952330290530567,0.38333175201810027,0.23253702676007004,6520/5721/5714/5694/5704/5687/5685/5689/1728,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-391160,Signal regulatory protein family interactions,1/201,16/11009,0.25548867639577544,0.38921435484373146,0.2361055361869074,961,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-70221,Glycogen breakdown (glycogenolysis),1/201,16/11009,0.25548867639577544,0.38921435484373146,0.2361055361869074,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-844456,The NLRP3 inflammasome,1/201,16/11009,0.25548867639577544,0.38921435484373146,0.2361055361869074,7295,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/201,16/11009,0.25548867639577544,0.38921435484373146,0.2361055361869074,1649,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9665348,Signaling by ERBB2 ECD mutants,1/201,16/11009,0.25548867639577544,0.38921435484373146,0.2361055361869074,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,7/201,285/11009,0.26536060044286036,0.4028534032328791,0.24437926708332255,5440/10284/51639/9939/6629/4809/8896,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),2/201,55/11009,0.2657682715070915,0.4028534032328791,0.24437926708332255,3638/3422,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,2/201,55/11009,0.2657682715070915,0.4028534032328791,0.24437926708332255,682/2739,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1502540,Signaling by Activin,1/201,17/11009,0.2691015915276278,0.4058800494729618,0.24621529374695814,3624,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,1/201,17/11009,0.2691015915276278,0.4058800494729618,0.24621529374695814,4792,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8934593,Regulation of RUNX1 Expression and Activity,1/201,17/11009,0.2691015915276278,0.4058800494729618,0.24621529374695814,595,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8856828,Clathrin-mediated endocytosis,4/201,146/11009,0.2771343734191235,0.4173048168344157,0.25314579564165257,7314/7316/60/1212,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1660514,Synthesis of PIPs at the Golgi membrane,1/201,18/11009,0.2824668189751295,0.4225406766606617,0.25632197729140604,375,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,1/201,18/11009,0.2824668189751295,0.4225406766606617,0.25632197729140604,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-446353,Cell-extracellular matrix interactions,1/201,18/11009,0.2824668189751295,0.4225406766606617,0.25632197729140604,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73780,RNA Polymerase III Chain Elongation,1/201,18/11009,0.2824668189751295,0.4225406766606617,0.25632197729140604,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,3/201,102/11009,0.28556054610990594,0.42594572409900155,0.2583875500051716,467/1649/8894,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1236394,Signaling by ERBB4,2/201,58/11009,0.2861457553771558,0.42594572409900155,0.2583875500051716,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-166658,Complement cascade,2/201,58/11009,0.2861457553771558,0.42594572409900155,0.2583875500051716,1604/966,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-611105,Respiratory electron transport,3/201,103/11009,0.290547415,0.4317923244668819,0.2619342195910948,1337/54205/1349,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72702,Ribosomal scanning and start codon recognition,2/201,59/11009,0.29292821687830506,0.43462150745299005,0.2636504609310992,1983/8894,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9645723,Diseases of programmed cell death,3/201,104/11009,0.2955407032618098,0.43502655290613657,0.2638961699413273,5052/6648/4000,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,1/201,19/11009,0.2955888433028524,0.43502655290613657,0.2638961699413273,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8851708,Signaling by FGFR2 IIIa TM,1/201,19/11009,0.2955888433028524,0.43502655290613657,0.2638961699413273,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8876725,Protein methylation,1/201,19/11009,0.2955888433028524,0.43502655290613657,0.2638961699413273,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,1/201,19/11009,0.2955888433028524,0.43502655290613657,0.2638961699413273,6500,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,3/201,106/11009,0.3055427465606493,0.4489106297170194,0.2723185401830668,7314/7316/1212,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111471,Apoptotic factor-mediated response,1/201,20/11009,0.30847206827975204,0.4489106297170194,0.2723185401830668,54205,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-163615,PKA activation,1/201,20/11009,0.30847206827975204,0.4489106297170194,0.2723185401830668,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,1/201,20/11009,0.30847206827975204,0.4489106297170194,0.2723185401830668,5366,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9669938,Signaling by KIT in disease,1/201,20/11009,0.30847206827975204,0.4489106297170194,0.2723185401830668,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",1/201,20/11009,0.30847206827975204,0.4489106297170194,0.2723185401830668,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9671555,Signaling by PDGFR in disease,1/201,20/11009,0.30847206827975204,0.4489106297170194,0.2723185401830668,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8986944,Transcriptional Regulation by MECP2,2/201,62/11009,0.3132172123052278,0.45508912346102476,0.2760665432053128,6446/801,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1226099,Signaling by FGFR in disease,2/201,63/11009,0.3199545078384183,0.4614212389533767,0.279907736,5440/6772,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9033241,Peroxisomal protein import,2/201,63/11009,0.3199545078384183,0.4614212389533767,0.279907736,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,1/201,21/11009,0.321120818,0.4614212389533767,0.279907736,4792,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,1/201,21/11009,0.321120818,0.4614212389533767,0.279907736,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5218921,VEGFR2 mediated cell proliferation,1/201,21/11009,0.321120818,0.4614212389533767,0.279907736,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5620916,VxPx cargo-targeting to cilium,1/201,21/11009,0.321120818,0.4614212389533767,0.279907736,378,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-622312,Inflammasomes,1/201,21/11009,0.321120818,0.4614212389533767,0.279907736,7295,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168255,Influenza Infection,4/201,157/11009,0.3223496598281407,0.4624575434699782,0.28053638028972044,9636/5440/5610/3320,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111931,PKA-mediated phosphorylation of CREB,1/201,22/11009,0.3335393399435558,0.47477240420090516,0.28800683136573485,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-140875,Common Pathway of Fibrin Clot Formation,1/201,22/11009,0.3335393399435558,0.47477240420090516,0.28800683136573485,5270,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-438066,"Unblocking of NMDA receptors, glutamate binding and activation",1/201,22/11009,0.3335393399435558,0.47477240420090516,0.28800683136573485,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,1/201,22/11009,0.3335393399435558,0.47477240420090516,0.28800683136573485,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,1/201,22/11009,0.3335393399435558,0.47477240420090516,0.28800683136573485,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-112409,RAF-independent MAPK1/3 activation,1/201,23/11009,0.34573180309740525,0.4868032034339045,0.29530496481922675,11221,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,1/201,23/11009,0.34573180309740525,0.4868032034339045,0.29530496481922675,5270,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,1/201,23/11009,0.34573180309740525,0.4868032034339045,0.29530496481922675,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),1/201,23/11009,0.34573180309740525,0.4868032034339045,0.29530496481922675,5947,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8949215,Mitochondrial calcium ion transport,1/201,23/11009,0.34573180309740525,0.4868032034339045,0.29530496481922675,7417,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8956321,Nucleotide salvage,1/201,23/11009,0.34573180309740525,0.4868032034339045,0.29530496481922675,7378,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013422,RHOBTB1 GTPase cycle,1/201,23/11009,0.34573180309740525,0.4868032034339045,0.29530496481922675,10576,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-204005,COPII-mediated vesicle transport,2/201,68/11009,0.35337175980089264,0.4959920816926572,0.3008791298037379,10342/966,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5685942,HDR through Homologous Recombination (HRR),2/201,68/11009,0.35337175980089264,0.4959920816926572,0.3008791298037379,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-163560,Triglyceride catabolism,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,2171,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-166208,mTORC1-mediated signalling,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,6009,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-203927,MicroRNA (miRNA) biogenesis,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6783589,Interleukin-6 family signaling,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9620244,Long-term potentiation,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,595,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9820841,M-decay: degradation of maternal mRNAs by maternally stored factors,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,678,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-982772,Growth hormone receptor signaling,1/201,24/11009,0.3577023026038153,0.4959920816926572,0.3008791298037379,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3371453,Regulation of HSF1-mediated heat shock response,2/201,69/11009,0.359990611,0.4984064540495399,0.3023437383742659,3309/10049,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1187000,Fertilization,1/201,25/11009,0.36945485947014534,0.5068876159296722,0.30748858785958516,928,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5357786,TNFR1-induced proapoptotic signaling,1/201,25/11009,0.36945485947014534,0.5068876159296722,0.30748858785958516,10616,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/201,25/11009,0.36945485947014534,0.5068876159296722,0.30748858785958516,1026,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8854691,Interleukin-20 family signaling,1/201,25/11009,0.36945485947014534,0.5068876159296722,0.30748858785958516,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,1/201,25/11009,0.36945485947014534,0.5068876159296722,0.30748858785958516,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664565,Signaling by ERBB2 KD Mutants,1/201,25/11009,0.36945485947014534,0.5068876159296722,0.30748858785958516,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-112315,Transmission across Chemical Synapses,6/201,270/11009,0.37136482460239095,0.5087418875380122,0.3086134276474163,10383/7277/7846/801/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-199992,trans-Golgi Network Vesicle Budding,2/201,72/11009,0.3796930357536663,0.5164955470871929,0.3133169590626567,375/1212,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1227990,Signaling by ERBB2 in Cancer,1/201,26/11009,0.3809934222201906,0.5164955470871929,0.3133169590626567,3320,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-180024,DARPP-32 events,1/201,26/11009,0.3809934222201906,0.5164955470871929,0.3133169590626567,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6803529,FGFR2 alternative splicing,1/201,26/11009,0.3809934222201906,0.5164955470871929,0.3133169590626567,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-912694,Regulation of IFNA/IFNB signaling,1/201,26/11009,0.3809934222201906,0.5164955470871929,0.3133169590626567,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9660826,Purinergic signaling in leishmaniasis infection,1/201,26/11009,0.3809934222201906,0.5164955470871929,0.3133169590626567,7295,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664424,Cell recruitment (pro-inflammatory response),1/201,26/11009,0.3809934222201906,0.5164955470871929,0.3133169590626567,7295,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-70171,Glycolysis,2/201,73/11009,0.3862049905353435,0.5227826840679018,0.3171308673356617,5315/2023,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",1/201,27/11009,0.39232186819430914,0.5255959145956112,0.31883743158206235,8553,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,1/201,27/11009,0.39232186819430914,0.5255959145956112,0.31883743158206235,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-189445,Metabolism of porphyrins,1/201,27/11009,0.39232186819430914,0.5255959145956112,0.31883743158206235,645,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-191273,Cholesterol biosynthesis,1/201,27/11009,0.39232186819430914,0.5255959145956112,0.31883743158206235,3422,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-201556,Signaling by ALK,1/201,27/11009,0.39232186819430914,0.5255959145956112,0.31883743158206235,4192,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,1/201,27/11009,0.39232186819430914,0.5255959145956112,0.31883743158206235,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,1/201,27/11009,0.39232186819430914,0.5255959145956112,0.31883743158206235,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2559580,Oxidative Stress Induced Senescence,3/201,124/11009,0.3954006479942458,0.5289427170671922,0.32086767168556923,7314/7316/7295,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",2/201,75/11009,0.3991387179839945,0.5331603696237814,0.32342618759314257,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,1/201,28/11009,0.40344400482633824,0.5357689335230235,0.32500859679887606,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,1/201,28/11009,0.40344400482633824,0.5357689335230235,0.32500859679887606,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,1/201,28/11009,0.40344400482633824,0.5357689335230235,0.32500859679887606,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,1/201,28/11009,0.40344400482633824,0.5357689335230235,0.32500859679887606,5376,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,2/201,77/11009,0.411945204,0.5462621270653474,0.3313739866073226,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-186763,Downstream signal transduction,1/201,29/11009,0.4143635708977259,0.5462882967985938,0.33138986171270635,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-380972,Energy dependent regulation of mTOR by LKB1-AMPK,1/201,29/11009,0.4143635708977259,0.5462882967985938,0.33138986171270635,6009,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,1/201,29/11009,0.4143635708977259,0.5462882967985938,0.33138986171270635,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72086,mRNA Capping,1/201,29/11009,0.4143635708977259,0.5462882967985938,0.33138986171270635,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5693606,DNA Double Strand Break Response,2/201,78/11009,0.41829828707136607,0.5506788143381712,0.3340532411202725,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-418360,Platelet calcium homeostasis,1/201,30/11009,0.42508423776927007,0.5571967490759785,0.3380071561209644,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-499943,Interconversion of nucleotide di- and triphosphates,1/201,30/11009,0.42508423776927007,0.5571967490759785,0.3380071561209644,7295,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-933541,TRAF6 mediated IRF7 activation,1/201,30/11009,0.42508423776927007,0.5571967490759785,0.3380071561209644,64135,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,1/201,31/11009,0.4356096105908729,0.5647370102183671,0.3425812356168961,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,1/201,31/11009,0.4356096105908729,0.5647370102183671,0.3425812356168961,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1839124,FGFR1 mutant receptor activation,1/201,31/11009,0.4356096105908729,0.5647370102183671,0.3425812356168961,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-201451,Signaling by BMP,1/201,31/11009,0.4356096105908729,0.5647370102183671,0.3425812356168961,3624,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-445095,Interaction between L1 and Ankyrins,1/201,31/11009,0.4356096105908729,0.5647370102183671,0.3425812356168961,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5260271,Diseases of Immune System,1/201,31/11009,0.4356096105908729,0.5647370102183671,0.3425812356168961,4792,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5602358,Diseases associated with the TLR signaling cascade,1/201,31/11009,0.4356096105908729,0.5647370102183671,0.3425812356168961,4792,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9012999,RHO GTPase cycle,9/201,449/11009,0.4357959584890363,0.5647370102183671,0.3425812356168961,55831/9528/10726/389/60/10409/10376/3320/10576,9,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-451326,Activation of kainate receptors upon glutamate binding,1/201,32/11009,0.4459432294896917,0.5754309944265001,0.3490684292263129,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73863,RNA Polymerase I Transcription Termination,1/201,32/11009,0.4459432294896917,0.5754309944265001,0.3490684292263129,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,1/201,32/11009,0.4459432294896917,0.5754309944265001,0.3490684292263129,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-113418,Formation of the Early Elongation Complex,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1660661,Sphingolipid de novo biosynthesis,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,9218,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167287,HIV elongation arrest and recovery,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167290,Pausing and recovery of HIV elongation,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1839126,FGFR2 mutant receptor activation,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2871809,FCERI mediated Ca+2 mobilization,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-352230,Amino acid transport across the plasma membrane,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,6520,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5694530,Cargo concentration in the ER,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,966,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9022692,Regulation of MECP2 expression and activity,1/201,33/11009,0.4560885707370793,0.58030263678977545,0.3520236689752523,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-216083,Integrin cell surface interactions,2/201,85/11009,0.4617546261468187,0.5866924189954698,0.3558998439801509,961/682,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5576892,Phase 0 - rapid depolarisation,1/201,34/11009,0.4660490478946817,0.5913240705181825,0.35870950028545356,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1474228,Degradation of the extracellular matrix,3/201,140/11009,0.47267142547644037,0.5988924459096484,0.3633006344705822,682/7076/4316,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-70263,Gluconeogenesis,1/201,35/11009,0.47582801294007315,0.6020546108172314,0.3652188695811965,2023,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2514859,"Inactivation, recovery and regulation of the phototransduction cascade",1/201,36/11009,0.48542875737228086,0.6091261679974489,0.36950862348912195,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,1/201,36/11009,0.48542875737228086,0.6091261679974489,0.36950862348912195,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5673000,RAF activation,1/201,36/11009,0.48542875737228086,0.6091261679974489,0.36950862348912195,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,1/201,36/11009,0.48542875737228086,0.6091261679974489,0.36950862348912195,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-76046,RNA Polymerase III Transcription Initiation,1/201,36/11009,0.48542875737228086,0.6091261679974489,0.36950862348912195,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8956319,Nucleotide catabolism,1/201,36/11009,0.48542875737228086,0.6091261679974489,0.36950862348912195,7378,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5250924,B-WICH complex positively regulates rRNA expression,2/201,90/11009,0.49161670681112235,0.6158640185984756,0.3735959440339704,5440/60,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111933,Calmodulin induced events,1/201,37/11009,0.4948545132975677,0.6158640185984756,0.3735959440339704,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111997,CaM pathway,1/201,37/11009,0.4948545132975677,0.6158640185984756,0.3735959440339704,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2514856,The phototransduction cascade,1/201,37/11009,0.4948545132975677,0.6158640185984756,0.3735959440339704,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8979227,Triglyceride metabolism,1/201,37/11009,0.4948545132975677,0.6158640185984756,0.3735959440339704,2171,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9694548,Maturation of spike protein,1/201,37/11009,0.4948545132975677,0.6158640185984756,0.3735959440339704,1603,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,2/201,92/11009,0.5032683382685124,0.6222802195741042,0.3774881452150958,5329/4061,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,2/201,92/11009,0.5032683382685124,0.6222802195741042,0.3774881452150958,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111465,Apoptotic cleavage of cellular proteins,1/201,38/11009,0.5041084544958165,0.6222802195741042,0.3774881452150958,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5655302,Signaling by FGFR1 in disease,1/201,38/11009,0.5041084544958165,0.6222802195741042,0.3774881452150958,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8853884,Transcriptional Regulation by VENTX,1/201,38/11009,0.5041084544958165,0.6222802195741042,0.3774881452150958,595,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/201,38/11009,0.5041084544958165,0.6222802195741042,0.3774881452150958,1026,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-70326,Glucose metabolism,2/201,93/11009,0.5090295750443552,0.6275046588165191,0.38065739890077127,5315/2023,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111996,Ca-dependent events,1/201,39/11009,0.5131936974678648,0.6300801326054243,0.3822197349562051,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),1/201,39/11009,0.5131936974678648,0.6300801326054243,0.3822197349562051,5270,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9031628,NGF-stimulated transcription,1/201,39/11009,0.5131936974678648,0.6300801326054243,0.3822197349562051,6446,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9018519,Estrogen-dependent gene expression,3/201,149/11009,0.5141570764903632,0.6304133198959905,0.3824218533079842,5440/595/3320,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5674135,MAP2K and MAPK activation,1/201,40/11009,0.5221133024641236,0.6375941267356791,0.38677788033535326,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8853659,RET signaling,1/201,40/11009,0.5221133024641236,0.6375941267356791,0.38677788033535326,9260,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,1/201,40/11009,0.5221133024641236,0.6375941267356791,0.38677788033535326,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-418594,G alpha (i) signalling events,6/201,318/11009,0.525834363,0.6412785874705038,0.3890129509758097,3576/2919/301/801/6288/6364,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-165159,MTOR signalling,1/201,41/11009,0.5308702744948202,0.6465545722791193,0.39221347327579587,6009,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5693607,Processing of DNA double-strand break ends,2/201,97/11009,0.5316358135085475,0.6466224647613975,0.39225465826995637,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5619102,SLC transporter disorders,2/201,98/11009,0.537176209,0.6524900350897499,0.39581404867077097,6520/682,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/201,42/11009,0.5394675643221853,0.6535305200764773,0.3964452285402397,3422,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9696273,RND1 GTPase cycle,1/201,42/11009,0.5394675643221853,0.6535305200764773,0.3964452285402397,9528,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-15869,Metabolism of nucleotides,2/201,99/11009,0.5426716316921313,0.6550449491538086,0.3973639127687903,7378/7295,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9679191,Potential therapeutics for SARS,2/201,99/11009,0.5426716316921313,0.6550449491538086,0.3973639127687903,10284/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1433557,Signaling by SCF-KIT,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1489509,DAG and IP3 signaling,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167169,HIV Transcription Elongation,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168325,Viral Messenger RNA Synthesis,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5655253,Signaling by FGFR2 in disease,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9696270,RND2 GTPase cycle,1/201,43/11009,0.5479080694349091,0.6550449491538086,0.3973639127687903,10726,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-451927,Interleukin-2 family signaling,1/201,44/11009,0.5561946350051794,0.6614795202215645,0.4012672576305059,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6811438,Intra-Golgi traffic,1/201,44/11009,0.5561946350051794,0.6614795202215645,0.4012672576305059,375,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9749641,Aspirin ADME,1/201,44/11009,0.5561946350051794,0.6614795202215645,0.4012672576305059,682,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975634,Retinoid metabolism and transport,1/201,44/11009,0.5561946350051794,0.6614795202215645,0.4012672576305059,5947,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5633007,Regulation of TP53 Activity,3/201,160/11009,0.5624224429159592,0.6680141401518108,0.4052312942165354,7314/7316/6446,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,1/201,45/11009,0.5643300548286136,0.6694071353500873,0.4060763141242079,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2187338,Visual phototransduction,2/201,104/11009,0.5694675184889498,0.6746227689771565,0.4092402261401664,801/5947,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5250913,Positive epigenetic regulation of rRNA expression,2/201,105/11009,0.574689423,0.676727638,0.4105170834353438,5440/60,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),6/201,335/11009,0.5771453034331592,0.676727638,0.4105170834353438,3576/2919/301/1906/6288/6364,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9658195,Leishmania infection,3/201,164/11009,0.5792440248919034,0.676727638,0.4105170834353438,60/801/7295,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9824443,Parasitic Infection Pathways,3/201,164/11009,0.5792440248919034,0.676727638,0.4105170834353438,60/801/7295,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-427413,NoRC negatively regulates rRNA expression,2/201,106/11009,0.57986532,0.676727638,0.4105170834353438,5440/10284,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167161,HIV Transcription Initiation,1/201,47/11009,0.5801583810568636,0.676727638,0.4105170834353438,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167162,RNA Polymerase II HIV Promoter Escape,1/201,47/11009,0.5801583810568636,0.676727638,0.4105170834353438,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73762,RNA Polymerase I Transcription Initiation,1/201,47/11009,0.5801583810568636,0.676727638,0.4105170834353438,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73776,RNA Polymerase II Promoter Escape,1/201,47/11009,0.5801583810568636,0.676727638,0.4105170834353438,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,1/201,47/11009,0.5801583810568636,0.676727638,0.4105170834353438,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-75953,RNA Polymerase II Transcription Initiation,1/201,47/11009,0.5801583810568636,0.676727638,0.4105170834353438,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,1/201,47/11009,0.5801583810568636,0.676727638,0.4105170834353438,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6806667,Metabolism of fat-soluble vitamins,1/201,48/11009,0.5878566263959962,0.6848304177068446,0.4154323985164867,5947,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,2/201,108/11009,0.5900788388111895,0.6865412798939893,0.41647024316175907,6520/801,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-156580,Phase II - Conjugation of compounds,2/201,109/11009,0.5951163749693356,0.6906382389771525,0.41895554389393375,4259/4257,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5250941,Negative epigenetic regulation of rRNA expression,2/201,109/11009,0.5951163749693356,0.6906382389771525,0.41895554389393375,5440/10284,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1483249,Inositol phosphate metabolism,1/201,50/11009,0.6028342691683678,0.6987048590488334,0.42384892368205845,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-112043,PLC beta mediated events,1/201,51/11009,0.6101187213900265,0.7062492442011615,0.4284255048883353,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,2/201,113/11009,0.6148048076826047,0.7107705327396611,0.4311682127082119,1983/8894,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2980766,Nuclear Envelope Breakdown,1/201,52/11009,0.6172702213900816,0.7109142499195503,0.4312553945436062,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",1/201,52/11009,0.6172702213900816,0.7109142499195503,0.4312553945436062,8894,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-75153,Apoptotic execution phase,1/201,52/11009,0.6172702213900816,0.7109142499195503,0.4312553945436062,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1660499,Synthesis of PIPs at the plasma membrane,1/201,53/11009,0.6242911838342355,0.7180925106982179,0.4356098770773174,375,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,1/201,54/11009,0.6311839797496533,0.725105429,0.43986405969146875,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-71387,Metabolism of carbohydrates,5/201,299/11009,0.6413447863115314,0.7358502523045404,0.4463820930843881,7314/7316/801/5315/2023,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-112040,G-protein mediated events,1/201,56/11009,0.6445943426046388,0.7367947880963939,0.44695506817332803,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-432722,Golgi Associated Vesicle Biogenesis,1/201,56/11009,0.6445943426046388,0.7367947880963939,0.44695506817332803,375,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5578775,Ion homeostasis,1/201,56/11009,0.6445943426046388,0.7367947880963939,0.44695506817332803,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72613,Eukaryotic Translation Initiation,2/201,120/11009,0.6474884356509499,0.7382502689336864,0.4478379931713968,1983/8894,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72737,Cap-dependent Translation Initiation,2/201,120/11009,0.6474884356509499,0.7382502689336864,0.4478379931713968,1983/8894,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-418990,Adherens junctions interactions,1/201,57/11009,0.6511164403985279,0.7405331800287875,0.4492228546017835,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-936837,Ion transport by P-type ATPases,1/201,57/11009,0.6511164403985279,0.7405331800287875,0.4492228546017835,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,3/201,183/11009,0.6534255521489174,0.7422327655955907,0.4502538586142297,6672/5610/4792,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-112382,Formation of RNA Pol II elongation complex,1/201,58/11009,0.6575194348725868,0.7440996337502193,0.4513863397294645,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-186797,Signaling by PDGF,1/201,58/11009,0.6575194348725868,0.7440996337502193,0.4513863397294645,6772,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-75955,RNA Polymerase II Transcription Elongation,1/201,58/11009,0.6575194348725868,0.7440996337502193,0.4513863397294645,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72187,mRNA 3'-end processing,1/201,59/11009,0.66380549,0.746576298,0.45288873610981756,9939,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72649,Translation initiation complex formation,1/201,59/11009,0.66380549,0.746576298,0.45288873610981756,8894,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664407,Parasite infection,1/201,59/11009,0.66380549,0.746576298,0.45288873610981756,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664417,Leishmania phagocytosis,1/201,59/11009,0.66380549,0.746576298,0.45288873610981756,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664422,FCGR3A-mediated phagocytosis,1/201,59/11009,0.66380549,0.746576298,0.45288873610981756,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9007101,Rab regulation of trafficking,2/201,124/11009,0.6651630031701645,0.7471806361134647,0.4532553399498168,81631/11345,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-212165,Epigenetic regulation of gene expression,3/201,187/11009,0.6678018349030977,0.7492210241338941,0.4544930818306019,5440/10284/60,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",1/201,60/11009,0.669976732,0.7507365349171633,0.4554124222445095,8894,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2990846,SUMOylation,3/201,189/11009,0.6748262139083026,0.7528949996702319,0.4567217919312169,6672/5610/4792,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),1/201,61/11009,0.6760352466852356,0.7528949996702319,0.4567217919312169,6446,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,1/201,61/11009,0.6760352466852356,0.7528949996702319,0.4567217919312169,4316,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6790901,rRNA modification in the nucleus and cytosol,1/201,61/11009,0.6760352466852356,0.7528949996702319,0.4567217919312169,4809,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8943724,Regulation of PTEN gene transcription,1/201,61/11009,0.6760352466852356,0.7528949996702319,0.4567217919312169,6009,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4086398,Ca2+ pathway,1/201,62/11009,0.681983083,0.7576665718285769,0.4596163270090737,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,1/201,62/11009,0.681983083,0.7576665718285769,0.4596163270090737,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-196854,Metabolism of vitamins and cofactors,3/201,194/11009,0.6919099288791888,0.7677587639572973,0.46573846100592875,801/3320/5947,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1442490,Collagen degradation,1/201,64/11009,0.6935547339678074,0.7686476431200395,0.4662776736241502,4316,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),2/201,132/11009,0.6983735078493918,0.7730039127959261,0.4689202775641124,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1268020,Mitochondrial protein import,1/201,65/11009,0.6991824633851186,0.7730039127959261,0.4689202775641124,506,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9670095,Inhibition of DNA recombination at telomere,1/201,67/11009,0.710131255,0.7841570582097951,0.47568600792667676,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-168273,Influenza Viral RNA Transcription and Replication,2/201,136/11009,0.7139355456056986,0.7874034891607645,0.4776553605747314,5440/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73856,RNA Polymerase II Transcription Termination,1/201,68/11009,0.7154560232709816,0.7881262844012867,0.4780938232256925,9939,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-211000,Gene Silencing by RNA,2/201,137/11009,0.7177199106878448,0.7896652640538969,0.4790274003446714,5440/3320,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,1/201,69/11009,0.7206834558020604,0.7918700929860698,0.4803648955083328,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5693538,Homology Directed Repair,2/201,138/11009,0.7214623240158484,0.7918700929860698,0.4803648955083328,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-167172,Transcription of the HIV genome,1/201,70/11009,0.7258153228389694,0.7956892408018064,0.48268167013801877,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73894,DNA Repair,5/201,335/11009,0.7369174985060107,0.8068892321381921,0.48947581821312697,9636/7314/7316/5440/60,5,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6807505,RNA polymerase II transcribes snRNA genes,1/201,74/11009,0.7454214375277997,0.8142433208487116,0.4939369616333394,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9013106,RHOC GTPase cycle,1/201,74/11009,0.7454214375277997,0.8142433208487116,0.4939369616333394,389,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,1/201,75/11009,0.750100934,0.8183735935750686,0.49644247111550177,9939,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9659379,Sensory processing of sound,1/201,76/11009,0.7546948346267015,0.8224007109389057,0.4988854044057142,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-500792,GPCR ligand binding,7/201,468/11009,0.7568120257585044,0.8237225274384677,0.4996872458318742,3576/1604/2919/301/1906/6288/6364,7,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,1/201,77/11009,0.7592046981810813,0.8253406683090275,0.5006688437948343,6672,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-416476,G alpha (q) signalling events,3/201,217/11009,0.7618605660582407,0.8271923916152579,0.5017921377295169,301/1906/6288,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1221632,Meiotic synapsis,1/201,78/11009,0.7636320541695192,0.8271923916152579,0.5017921377295169,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3214858,RMTs methylate histone arginines,1/201,78/11009,0.7636320541695192,0.8271923916152579,0.5017921377295169,595,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-112316,Neuronal System,6/201,410/11009,0.7646741883531808,0.8273375125768975,0.5018801711281659,10383/7277/7846/801/10381/10376,6,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,1/201,79/11009,0.7679784046508957,0.8279625167301372,0.5022593116682905,1026,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,1/201,79/11009,0.7679784046508957,0.8279625167301372,0.5022593116682905,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9664433,Leishmania parasite growth and survival,1/201,79/11009,0.7679784046508957,0.8279625167301372,0.5022593116682905,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-416482,G alpha (12/13) signalling events,1/201,80/11009,0.7722452244738756,0.8315784864015373,0.5044528342027929,389,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1474165,Reproduction,2/201,154/11009,0.7758605635881206,0.8341171452477436,0.5059928375470163,928/4000,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-674695,RNA Polymerase II Pre-transcription Events,1/201,81/11009,0.7764339617673837,0.8341171452477436,0.5059928375470163,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8957322,Metabolism of steroids,2/201,155/11009,0.778932753,0.8358159454589801,0.5070233651464146,3638/3422,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",1/201,83/11009,0.7845828505644206,0.8401993829753311,0.5096824496643929,682,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72766,Translation,4/201,292/11009,0.7848624312974828,0.8401993829753311,0.5096824496643929,28998/1983/8894/23480,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1483255,PI Metabolism,1/201,84/11009,0.7885457690191662,0.841177044,0.5102755192099867,375,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/201,84/11009,0.7885457690191662,0.841177044,0.5102755192099867,84246,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,1/201,84/11009,0.7885457690191662,0.841177044,0.5102755192099867,9939,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5368286,Mitochondrial translation initiation,1/201,87/11009,0.8000045005292256,0.8504131855100636,0.5158783550670557,28998,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5389840,Mitochondrial translation elongation,1/201,87/11009,0.8000045005292256,0.8504131855100636,0.5158783550670557,28998,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5419276,Mitochondrial translation termination,1/201,87/11009,0.8000045005292256,0.8504131855100636,0.5158783550670557,28998,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1474244,Extracellular matrix organization,4/201,300/11009,0.8022170728374742,0.8517712743064557,0.5167022000241369,961/682/7076/4316,4,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-418346,Platelet homeostasis,1/201,88/11009,0.8036850622755747,0.8523365445087876,0.5170451047051978,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2980736,Peptide hormone metabolism,1/201,89/11009,0.8072982206386009,0.8541796504085545,0.5181631711415923,3624,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9616222,Transcriptional regulation of granulopoiesis,1/201,89/11009,0.8072982206386009,0.8541796504085545,0.5181631711415923,1026,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1474290,Collagen formation,1/201,90/11009,0.8108452039400332,0.8559443578092355,0.5192336794151581,4316,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73772,RNA Polymerase I Promoter Escape,1/201,90/11009,0.8108452039400332,0.8559443578092355,0.5192336794151581,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5693532,DNA Double-Strand Break Repair,2/201,168/11009,0.8156409923279825,0.8600103518643426,0.5217001961162169,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-111885,Opioid Signalling,1/201,92/11009,0.8177454476778955,0.860237994,0.521838289,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1912408,Pre-NOTCH Transcription and Translation,1/201,92/11009,0.8177454476778955,0.860237994,0.521838289,595,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-428157,Sphingolipid metabolism,1/201,93/11009,0.8211010549891296,0.8617777201556417,0.5227723185414661,9218,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5368287,Mitochondrial translation,1/201,93/11009,0.8211010549891296,0.8617777201556417,0.5227723185414661,28998,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3214815,HDACs deacetylate histones,1/201,94/11009,0.824395182,0.8632459891874381,0.5236630011247386,10284,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69473,G2/M DNA damage checkpoint,1/201,94/11009,0.824395182,0.8632459891874381,0.5236630011247386,2810,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-373080,Class B/2 (Secretin family receptors),1/201,95/11009,0.8276289489226616,0.8646444638400742,0.5245113449835795,1604,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6803157,Antimicrobial peptides,1/201,95/11009,0.8276289489226616,0.8646444638400742,0.5245113449835795,3934,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-141424,Amplification of signal from the kinetochores,1/201,96/11009,0.830803457,0.8659747704075756,0.5253183366618259,10726,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,1/201,96/11009,0.830803457,0.8659747704075756,0.5253183366618259,10726,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-425407,SLC-mediated transmembrane transport,3/201,247/11009,0.8332396998144627,0.8675215617496863,0.5262566525143975,6520/682/801,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/201,104/11009,0.8541918373065964,0.8883205066053759,0.5388737257702032,1026,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,2/201,185/11009,0.8554150125707374,0.8885781943579724,0.539030045,8780/4809,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5578749,Transcriptional regulation by small RNAs,1/201,105/11009,0.8568793605254295,0.8890855323902803,0.5393378063491793,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/201,106/11009,0.8595175894812612,0.890808332,0.5403828926144089,8870,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1912422,Pre-NOTCH Expression and Processing,1/201,108/11009,0.8646497471109426,0.8951089995659871,0.5429917670254124,595,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73854,RNA Polymerase I Promoter Clearance,1/201,109/11009,0.8671454264826242,0.8963570363667918,0.5437488521492467,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9748784,Drug ADME,1/201,110/11009,0.8695953135722565,0.8963570363667918,0.5437488521492467,682,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73864,RNA Polymerase I Transcription,1/201,111/11009,0.8720002444807781,0.8963570363667918,0.5437488521492467,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,1/201,112/11009,0.8743610401184514,0.8963570363667918,0.5437488521492467,8894,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-157579,Telomere Maintenance,1/201,112/11009,0.8743610401184514,0.8963570363667918,0.5437488521492467,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-69618,Mitotic Spindle Checkpoint,1/201,112/11009,0.8743610401184514,0.8963570363667918,0.5437488521492467,10726,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3247509,Chromatin modifying enzymes,3/201,270/11009,0.8748018769099644,0.8963570363667918,0.5437488521492467,10284/60/595,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-4839726,Chromatin organization,3/201,270/11009,0.8748018769099644,0.8963570363667918,0.5437488521492467,10284/60/595,3,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8868773,rRNA processing in the nucleus and cytosol,2/201,195/11009,0.8750057201783956,0.8963570363667918,0.5437488521492467,8780/4809,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,1/201,113/11009,0.8766785064794858,0.8963570363667918,0.5437488521492467,23480,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-199418,Negative regulation of the PI3K/AKT network,1/201,113/11009,0.8766785064794858,0.8963570363667918,0.5437488521492467,8870,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-187037,Signaling by NTRK1 (TRKA),1/201,115/11009,0.8811866023814532,0.8983501785783805,0.5449579337381129,6446,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-927802,Nonsense-Mediated Decay (NMD),1/201,116/11009,0.883378772,0.8983501785783805,0.5449579337381129,9939,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9610379,HCMV Late Events,1/201,116/11009,0.883378772,0.8983501785783805,0.5449579337381129,25978,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),1/201,116/11009,0.883378772,0.8983501785783805,0.5449579337381129,9939,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1500620,Meiosis,1/201,117/11009,0.8855306919466364,0.8983501785783805,0.5449579337381129,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1989781,PPARA activates gene expression,1/201,117/11009,0.8855306919466364,0.8983501785783805,0.5449579337381129,84246,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-9816359,Maternal to zygotic transition (MZT),1/201,117/11009,0.8855306919466364,0.8983501785783805,0.5449579337381129,678,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/201,119/11009,0.8897167130408472,0.9015927981982333,0.5469249743533103,84246,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-72312,rRNA processing,2/201,205/11009,0.8921349789210341,0.9026680764042592,0.5475772605144561,8780/4809,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,1/201,121/11009,0.8937503895901666,0.9026680764042592,0.5475772605144561,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5619507,Activation of HOX genes during differentiation,1/201,121/11009,0.8937503895901666,0.9026680764042592,0.5475772605144561,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5576891,Cardiac conduction,1/201,132/11009,0.9134492715017324,0.9215418453356348,0.5590264819472046,801,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-211859,Biological oxidations,2/201,222/11009,0.9163570140130294,0.9226956938929242,0.5597264305202901,4259/4257,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-166520,Signaling by NTRKs,1/201,134/11009,0.9166186640758468,0.9226956938929242,0.5597264305202901,6446,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-73886,Chromosome Maintenance,1/201,140/11009,0.9254504266866468,0.92989128,0.5640914227568109,5440,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-3214847,HATs acetylate histones,1/201,141/11009,0.9268290690857621,0.92989128,0.5640914227568109,60,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-68875,Mitotic Prophase,1/201,141/11009,0.9268290690857621,0.92989128,0.5640914227568109,4000,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-8980692,RHOA GTPase cycle,1/201,147/11009,0.9345841070934444,0.9366403977581165,0.5681855783962229,55831,1,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-5668914,Diseases of metabolism,2/201,250/11009,0.9454842388456659,0.946523233,0.5741807118495946,7314/7316,2,PTX_72.vs.DMSO_72,reactome
NA,R-HSA-1483257,Phospholipid metabolism,1/201,212/11009,0.9806429828741564,0.9806429828741564,0.5948784632375435,375,1,PTX_72.vs.DMSO_72,reactome
BP,GO:0042060,wound healing,14/131,423/18870,1.473433521858547e-6,0.002920279,0.002490622,CHMP2B/RHOC/HSPB1/EDN1/ACTB/ANXA2/CD9/CD59/TIMP1/CDKN1A/SERPINE2/S100A10/CCN1/CLDN4,14,PTX_72_unique,MSigDB
BP,GO:0097193,intrinsic apoptotic signaling pathway,12/131,319/18870,2.3334228301666173e-6,0.002920279,0.002490622,UBB/PPP1R15A/SFN/SELENOK/VDAC2/HSPB1/RPS27L/CYCS/CDKN1A/ENO1/PERP/IER3,12,PTX_72_unique,MSigDB
BP,GO:0010755,regulation of plasminogen activation,4/131,18/18870,6.2949644724234866e-6,0.005252099,0.004479364,ANXA2/SERPINE2/S100A10/ENO1,4,PTX_72_unique,MSigDB
BP,GO:0061077,chaperone-mediated protein folding,6/131,75/18870,1.3571602012052225e-5,0.007489839,0.006387869,PFDN2/CCT5/HSPA5/CCT4/HSPB1/CCT2,6,PTX_72_unique,MSigDB
BP,GO:0031647,regulation of protein stability,11/131,325/18870,1.6882128637011804e-5,0.007489839,0.006387869,PFDN2/DAD1/CCT5/RTN4/CCT4/PIM1/HSP90AA1/LMNA/CRYAB/EFNA1/CCT2,11,PTX_72_unique,MSigDB
BP,GO:0070972,protein localization to endoplasmic reticulum,6/131,79/18870,1.831492405535215e-5,0.007489839,0.006387869,PPP1R15A/HSPA5/RTN4/SEC61G/GABARAPL2/INSIG1,6,PTX_72_unique,MSigDB
BP,GO:0050821,protein stabilization,9/131,217/18870,2.0946414507645468e-5,0.007489839,0.006387869,PFDN2/CCT5/RTN4/CCT4/PIM1/HSP90AA1/CRYAB/EFNA1/CCT2,9,PTX_72_unique,MSigDB
BP,GO:0006457,protein folding,9/131,223/18870,2.5974676934859844e-5,0.007552563,0.006441364,PFDN2/CCT5/HSPA5/NUDC/CCT4/HSPB1/HSP90AA1/CRYAB/CCT2,9,PTX_72_unique,MSigDB
BP,GO:0035036,sperm-egg recognition,5/131,51/18870,2.71566399731412e-5,0.007552563,0.006441364,CCT5/VDAC2/CCT4/CD9/CCT2,5,PTX_72_unique,MSigDB
BP,GO:0031639,plasminogen activation,4/131,27/18870,3.439638567953639e-5,0.007826741,0.006675203,ANXA2/SERPINE2/S100A10/ENO1,4,PTX_72_unique,MSigDB
BP,GO:0042026,protein refolding,4/131,27/18870,3.439638567953639e-5,0.007826741,0.006675203,HSPA5/HSPB1/HSP90AA1/CRYAB,4,PTX_72_unique,MSigDB
BP,GO:1904851,positive regulation of establishment of protein localization to telomere,3/131,10/18870,3.786559955342444e-5,0.007898133,0.006736091,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:0070203,regulation of establishment of protein localization to telomere,3/131,11/18870,5.180083497697683e-5,0.008190435,0.006985387,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:1904869,regulation of protein localization to Cajal body,3/131,11/18870,5.180083497697683e-5,0.008190435,0.006985387,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:1904871,positive regulation of protein localization to Cajal body,3/131,11/18870,5.180083497697683e-5,0.008190435,0.006985387,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:0031638,zymogen activation,5/131,59/18870,5.5364293719538824e-5,0.008190435,0.006985387,ANXA2/SERPINE2/S100A10/ENO1/PERP,5,PTX_72_unique,MSigDB
BP,GO:0052547,regulation of peptidase activity,10/131,312/18870,6.53199412406333e-5,0.008190435,0.006985387,SFN/MTCH1/RPS27L/CYCS/SERPINB5/TIMP1/SERPINE2/EFNA1/CLDN4/PERP,10,PTX_72_unique,MSigDB
BP,GO:0070202,regulation of establishment of protein localization to chromosome,3/131,12/18870,6.871718992630351e-5,0.008190435,0.006985387,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:1903405,protein localization to nuclear body,3/131,12/18870,6.871718992630351e-5,0.008190435,0.006985387,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:1904816,"positive regulation of protein localization to chromosome, telomeric region",3/131,12/18870,6.871718992630351e-5,0.008190435,0.006985387,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:1904867,protein localization to Cajal body,3/131,12/18870,6.871718992630351e-5,0.008190435,0.006985387,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
BP,GO:0006885,regulation of pH,6/131,103/18870,8.224993631572832e-5,0.0093578,0.007980999,ATP6V0B/CA2/RNASEK/ATP6V0C/EDN1/ATP5F1B,6,PTX_72_unique,MSigDB
BP,GO:0061795,Golgi lumen acidification,3/131,13/18870,8.887903072814198e-5,0.009672357,0.008249276,ATP6V0B/RNASEK/ATP6V0C,3,PTX_72_unique,MSigDB
CC,GO:0016469,proton-transporting two-sector ATPase complex,6/130,50/19886,8.724291979124512e-7,3.001156440818832e-4,2.1948481926429035e-4,ATP6V1E1/ATP6V0B/RNASEK/ATP6V0C/ATP5F1B/ATP5F1C,6,PTX_72_unique,MSigDB
CC,GO:0000502,proteasome complex,6/130,60/19886,2.6056189887809203e-6,4.481664660703183e-4,3.2775944122033685e-4,ADRM1/PSMD8/PSMB6/PSMC4/HSPB1/PSMB1,6,PTX_72_unique,MSigDB
CC,GO:0034774,secretory granule lumen,11/130,322/19886,8.873694853351232e-6,6.855446914453067e-4,5.013622437436608e-4,CXCL1/TUBB4B/CAP1/FABP5/ANXA2/COTL1/TIMP1/PSMB1/HSP90AA1/PKM/CCT2,11,PTX_72_unique,MSigDB
CC,GO:0060205,cytoplasmic vesicle lumen,11/130,325/19886,9.681260356437616e-6,6.855446914453067e-4,5.013622437436608e-4,CXCL1/TUBB4B/CAP1/FABP5/ANXA2/COTL1/TIMP1/PSMB1/HSP90AA1/PKM/CCT2,11,PTX_72_unique,MSigDB
CC,GO:0031983,vesicle lumen,11/130,326/19886,9.964312375658528e-6,6.855446914453067e-4,5.013622437436608e-4,CXCL1/TUBB4B/CAP1/FABP5/ANXA2/COTL1/TIMP1/PSMB1/HSP90AA1/PKM/CCT2,11,PTX_72_unique,MSigDB
CC,GO:0005874,microtubule,13/130,467/19886,1.206617677017013e-5,6.917941348230875e-4,5.059326751001161e-4,CHMP2B/MAP1LC3B/DYNLRB1/TUBB4B/TUBA4A/TUBA1A/CCT5/NUDC/CCT4/CALM1/TUBB3/TUBA1B/CCT2,13,PTX_72_unique,MSigDB
CC,GO:0005774,vacuolar membrane,13/130,484/19886,1.759211786501017e-5,7.579113259674963e-4,5.5428643484159e-4,CHMP2B/IFITM1/MAP1LC3B/ATP6V1E1/ATP6V0B/CD63/RNASEK/TMEM59/ATP6V0C/RHEB/ANXA2/GABARAPL2/VMP1,13,PTX_72_unique,MSigDB
CC,GO:1905369,endopeptidase complex,6/130,84/19886,1.861308587120168e-5,7.579113259674963e-4,5.5428643484159e-4,ADRM1/PSMD8/PSMB6/PSMC4/HSPB1/PSMB1,6,PTX_72_unique,MSigDB
CC,GO:0016471,vacuolar proton-transporting V-type ATPase complex,4/130,25/19886,1.9829075388684495e-5,7.579113259674963e-4,5.5428643484159e-4,ATP6V1E1/ATP6V0B/RNASEK/ATP6V0C,4,PTX_72_unique,MSigDB
CC,GO:0033176,proton-transporting V-type ATPase complex,4/130,27/19886,2.7232698502583322e-5,9.368048284888662e-4,6.851173623281489e-4,ATP6V1E1/ATP6V0B/RNASEK/ATP6V0C,4,PTX_72_unique,MSigDB
CC,GO:0000220,"vacuolar proton-transporting V-type ATPase, V0 domain",3/130,10/19886,3.167826324431647e-5,9.906656869131697e-4,7.245076474058983e-4,ATP6V0B/RNASEK/ATP6V0C,3,PTX_72_unique,MSigDB
CC,GO:0005832,chaperonin-containing T-complex,3/130,11/19886,4.334935997190799e-5,0.001242682,9.088155292356149e-4,CCT5/CCT4/CCT2,3,PTX_72_unique,MSigDB
CC,GO:1904949,ATPase complex,7/130,146/19886,4.9526355092323844e-5,0.001310544,9.584452523939595e-4,ATP6V1E1/ATP6V0B/RNASEK/ATP6V0C/ACTB/ATP5F1B/ATP5F1C,7,PTX_72_unique,MSigDB
CC,GO:0033179,"proton-transporting V-type ATPase, V0 domain",3/130,12/19886,5.75228833817823e-5,0.001413419,0.001033682,ATP6V0B/RNASEK/ATP6V0C,3,PTX_72_unique,MSigDB
CC,GO:0005766,primary lysosome,7/130,155/19886,7.233586916271346e-5,0.001555221,0.001137386,TUBB4B/CD63/CAP1/ATP6V0C/FABP5/ANXA2/CCT2,7,PTX_72_unique,MSigDB
CC,GO:0042582,azurophil granule,7/130,155/19886,7.233586916271346e-5,0.001555221,0.001137386,TUBB4B/CD63/CAP1/ATP6V0C/FABP5/ANXA2/CCT2,7,PTX_72_unique,MSigDB
CC,GO:0042470,melanosome,6/130,112/19886,9.437778867127618e-5,0.001803664,0.001319081,CD63/HSPA5/BSG/CCT4/ANXA2/HSP90AA1,6,PTX_72_unique,MSigDB
CC,GO:0048770,pigment granule,6/130,112/19886,9.437778867127618e-5,0.001803664,0.001319081,CD63/HSPA5/BSG/CCT4/ANXA2/HSP90AA1,6,PTX_72_unique,MSigDB
CC,GO:0005925,focal adhesion,11/130,421/19886,1.0230082514411312e-4,0.001852183,0.001354565,HSPA5/CAP1/BSG/ATP6V0C/HSPB1/ARF1/CFL1/ACTB/CD9/CD59/PDLIM7,11,PTX_72_unique,MSigDB
CC,GO:0030055,cell-substrate junction,11/130,431/19886,1.2573785421138758e-4,0.002162691,0.00158165,HSPA5/CAP1/BSG/ATP6V0C/HSPB1/ARF1/CFL1/ACTB/CD9/CD59/PDLIM7,11,PTX_72_unique,MSigDB
CC,GO:1905368,peptidase complex,6/130,120/19886,1.3809677571279864e-4,0.002262157,0.001654392,ADRM1/PSMD8/PSMB6/PSMC4/HSPB1/PSMB1,6,PTX_72_unique,MSigDB
CC,GO:0101031,protein folding chaperone complex,4/130,42/19886,1.6099869477694198e-4,0.002517434,0.001841086,PFDN2/CCT5/CCT4/CCT2,4,PTX_72_unique,MSigDB
CC,GO:0016363,nuclear matrix,6/130,128/19886,1.96514592030429e-4,0.002939175,0.002149519,CFL1/ACTB/ANXA2/BASP1/S100A10/LMNA,6,PTX_72_unique,MSigDB
CC,GO:0030135,coated vesicle,9/130,311/19886,2.0985156894166211e-4,0.003007872,0.00219976,ATP6V1E1/ATP6V0B/TMED9/RNASEK/ATP6V0C/COPE/EDN1/CD9/CD59,9,PTX_72_unique,MSigDB
CC,GO:0043209,myelin sheath,4/130,46/19886,2.30031765225414e-4,0.003121675,0.002282987,CA2/ANXA2/CALM1/HSP90AA1,4,PTX_72_unique,MSigDB
CC,GO:0005838,proteasome regulatory particle,3/130,19/19886,2.450151613253102e-4,0.003121675,0.002282987,ADRM1/PSMD8/PSMC4,3,PTX_72_unique,MSigDB
CC,GO:0033178,"proton-transporting two-sector ATPase complex, catalytic domain",3/130,19/19886,2.450151613253102e-4,0.003121675,0.002282987,ATP6V1E1/ATP5F1B/ATP5F1C,3,PTX_72_unique,MSigDB
CC,GO:0035578,azurophil granule lumen,5/130,91/19886,3.2781575547061507e-4,0.004027451,0.002945412,TUBB4B/CAP1/FABP5/ANXA2/CCT2,5,PTX_72_unique,MSigDB
CC,GO:0000421,autophagosome membrane,4/130,52/19886,3.70250465863284e-4,0.00437548,0.003199938,CHMP2B/MAP1LC3B/GABARAPL2/VMP1,4,PTX_72_unique,MSigDB
CC,GO:0030662,coated vesicle membrane,7/130,203/19886,3.8158259898612724e-4,0.00437548,0.003199938,ATP6V1E1/ATP6V0B/RNASEK/ATP6V0C/COPE/CD9/CD59,7,PTX_72_unique,MSigDB
CC,GO:0022624,proteasome accessory complex,3/130,23/19886,4.3932642206085813e-4,0.004875106,0.003565332,ADRM1/PSMD8/PSMC4,3,PTX_72_unique,MSigDB
CC,GO:0034399,nuclear periphery,6/130,150/19886,4.6095482958376075e-4,0.004955264,0.003623954,CFL1/ACTB/ANXA2/BASP1/S100A10/LMNA,6,PTX_72_unique,MSigDB
CC,GO:0030136,clathrin-coated vesicle,7/130,212/19886,4.947875341510427e-4,0.005157785,0.003772064,ATP6V1E1/ATP6V0B/TMED9/RNASEK/ATP6V0C/EDN1/CD9,7,PTX_72_unique,MSigDB
CC,GO:0030017,sarcomere,7/130,216/19886,5.530052282607221e-4,0.005595112,0.004091896,MYL12B/HSPB1/ARF1/CALM1/PDLIM7/CRYAB/ENO1,7,PTX_72_unique,MSigDB
CC,GO:0033177,"proton-transporting two-sector ATPase complex, proton-transporting domain",3/130,26/19886,6.358038062679346e-4,0.005873608,0.00429557,ATP6V0B/RNASEK/ATP6V0C,3,PTX_72_unique,MSigDB
CC,GO:0001533,cornified envelope,4/130,60/19886,6.405668536791411e-4,0.005873608,0.00429557,HSPB1/ANXA2/SERPINB5/KRT14,4,PTX_72_unique,MSigDB
CC,GO:0005765,lysosomal membrane,10/130,441/19886,6.488287567108519e-4,0.005873608,0.00429557,CHMP2B/IFITM1/ATP6V1E1/ATP6V0B/CD63/RNASEK/TMEM59/ATP6V0C/RHEB/ANXA2,10,PTX_72_unique,MSigDB
CC,GO:0098852,lytic vacuole membrane,10/130,441/19886,6.488287567108519e-4,0.005873608,0.00429557,CHMP2B/IFITM1/ATP6V1E1/ATP6V0B/CD63/RNASEK/TMEM59/ATP6V0C/RHEB/ANXA2,10,PTX_72_unique,MSigDB
CC,GO:0098862,cluster of actin-based cell projections,6/130,165/19886,7.612918936025294e-4,0.006714985,0.004910898,MYL12B/RHOC/ACTB/HSP90AA1/MYL6/CALB1,6,PTX_72_unique,MSigDB
CC,GO:0030016,myofibril,7/130,236/19886,9.310714576396424e-4,0.008007215,0.005855949,MYL12B/HSPB1/ARF1/CALM1/PDLIM7/CRYAB/ENO1,7,PTX_72_unique,MSigDB
CC,GO:0005775,vacuolar lumen,6/130,176/19886,0.001064073,0.008893568,0.00650417,TUBB4B/CAP1/FABP5/ANXA2/HSP90AA1/CCT2,6,PTX_72_unique,MSigDB
CC,GO:0030667,secretory granule membrane,8/130,314/19886,0.001085843,0.008893568,0.00650417,CD55/CYSTM1/CD63/BSG/ATP6V0C/FABP5/CD9/CD59,8,PTX_72_unique,MSigDB
CC,GO:0043292,contractile fiber,7/130,245/19886,0.001156796,0.009254368,0.006768036,MYL12B/HSPB1/ARF1/CALM1/PDLIM7/CRYAB/ENO1,7,PTX_72_unique,MSigDB
MF,GO:0051082,unfolded protein binding,10/131,122/18496,1.581674100306632e-8,5.20370779000882e-6,4.278844671355836e-6,PFDN2/TUBB4B/CCT5/HSPA5/NUDC/CCT4/HSPB1/HSP90AA1/CRYAB/CCT2,10,PTX_72_unique,MSigDB
MF,GO:0045296,cadherin binding,14/131,334/18496,1.0911396643437306e-7,1.794924747845437e-5,1.475909967033362e-5,CHMP2B/PCMT1/EPCAM/SFN/PSMB6/HSPA5/TAGLN2/BSG/NUDC/RTN4/ANXA2/BZW1/PKM/ENO1,14,PTX_72_unique,MSigDB
MF,GO:0044183,protein folding chaperone,7/131,66/18496,4.1866544351453606e-7,4.591364363876079e-5,3.7753339994117816e-5,PFDN2/CCT5/HSPA5/CCT4/HSPB1/HSP90AA1/CCT2,7,PTX_72_unique,MSigDB
MF,GO:0005200,structural constituent of cytoskeleton,8/131,112/18496,1.3097794041618021e-6,1.0772935599230822e-4,8.858244917620609e-5,TUBB4B/TUBA4A/TUBA1A/ACTB/TUBB3/TUBA1B/LMNA/KRT14,8,PTX_72_unique,MSigDB
MF,GO:0140662,ATP-dependent protein folding chaperone,5/131,40/18496,8.902480906352408e-6,5.857832436379885e-4,4.816710721963303e-4,CCT5/HSPA5/CCT4/HSP90AA1/CCT2,5,PTX_72_unique,MSigDB
MF,GO:0031625,ubiquitin protein ligase binding,11/131,308/18496,1.230747935154785e-5,6.748601177765405e-4,5.549161742715435e-4,MAP1LC3B/UBB/HSPA5/RTN4/ATP6V0C/GABARAPL2/TUBA1B/CDKN1A/HSP90AA1/NFKBIA/CCT2,11,PTX_72_unique,MSigDB
MF,GO:0044389,ubiquitin-like protein ligase binding,11/131,327/18496,2.1452419997307543e-5,7.527326934402701e-4,6.189483353516219e-4,MAP1LC3B/UBB/HSPA5/RTN4/ATP6V0C/GABARAPL2/TUBA1B/CDKN1A/HSP90AA1/NFKBIA/CCT2,11,PTX_72_unique,MSigDB
MF,GO:0042625,ATPase-coupled ion transmembrane transporter activity,4/131,24/18496,2.2879413174476297e-5,7.527326934402701e-4,6.189483353516219e-4,ATP6V1E1/ATP6V0B/ATP6V0C/ATP5F1B,4,PTX_72_unique,MSigDB
MF,GO:0044769,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism",4/131,24/18496,2.2879413174476297e-5,7.527326934402701e-4,6.189483353516219e-4,ATP6V1E1/ATP6V0B/ATP6V0C/ATP5F1B,4,PTX_72_unique,MSigDB
MF,GO:0046961,"proton-transporting ATPase activity, rotational mechanism",4/131,24/18496,2.2879413174476297e-5,7.527326934402701e-4,6.189483353516219e-4,ATP6V1E1/ATP6V0B/ATP6V0C/ATP5F1B,4,PTX_72_unique,MSigDB
MF,GO:0046933,"proton-transporting ATP synthase activity, rotational mechanism",3/131,18/18496,2.6211935139279345e-4,0.007839752,0.00644638,ATP6V0C/ATP5F1B/ATP5F1C,3,PTX_72_unique,MSigDB
BP,GO:0048525,negative regulation of viral process,11/115,93/18870,1.0607531106502904e-11,2.439732154495668e-8,1.970767621366066e-8,ISG15/IFIH1/IFITM3/IFIT1/PLSCR1/EIF2AK2/LY6E/STAT1/BST2/ISG20/SLPI,11,PTX_72_shared,MSigDB
BP,GO:0045071,negative regulation of viral genome replication,9/115,55/18870,4.244077525773953e-11,4.880689154640046e-8,3.9425246489426466e-8,ISG15/IFIH1/IFITM3/IFIT1/PLSCR1/EIF2AK2/BST2/ISG20/SLPI,9,PTX_72_shared,MSigDB
BP,GO:0019079,viral genome replication,11/115,131/18870,4.5522595817549163e-10,3.490065679345436e-7,2.8192063725605007e-7,ISG15/IFIH1/IFITM3/IFIT1/IFI27/PLSCR1/EIF2AK2/VAPA/BST2/ISG20/SLPI,11,PTX_72_shared,MSigDB
BP,GO:0051607,defense response to virus,15/115,334/18870,1.8593620820121754e-9,8.909067081927679e-7,7.196569061602908e-7,IFI6/ISG15/IFI44L/IFIH1/IFITM3/IFIT1/IFI27/PLSCR1/EIF2AK2/PMAIP1/STAT1/RIOK3/BST2/ISG20/DDIT4,15,PTX_72_shared,MSigDB
BP,GO:0140546,defense response to symbiont,15/115,335/18870,1.936753713462539e-9,8.909067081927679e-7,7.196569061602908e-7,IFI6/ISG15/IFI44L/IFIH1/IFITM3/IFIT1/IFI27/PLSCR1/EIF2AK2/PMAIP1/STAT1/RIOK3/BST2/ISG20/DDIT4,15,PTX_72_shared,MSigDB
BP,GO:0045069,regulation of viral genome replication,9/115,85/18870,2.3604821992868673e-9,9.048515097266324e-7,7.309212424107581e-7,ISG15/IFIH1/IFITM3/IFIT1/PLSCR1/EIF2AK2/BST2/ISG20/SLPI,9,PTX_72_shared,MSigDB
BP,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,6/115,23/18870,4.1666031177227245e-9,1.3690267386803237e-6,1.105872857560994e-6,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0050792,regulation of viral process,11/115,168/18870,6.415903475281149e-9,1.8445722491433304e-6,1.4900091623514775e-6,ISG15/IFIH1/IFITM3/IFIT1/PLSCR1/EIF2AK2/LY6E/STAT1/BST2/ISG20/SLPI,11,PTX_72_shared,MSigDB
BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,6/115,25/18870,7.237675428774687e-9,1.8496281651313088e-6,1.4940932317879909e-6,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0019058,viral life cycle,14/115,321/18870,9.728044879740311e-9,2.2374503223402715e-6,1.8073683381833316e-6,ISG15/SLC3A2/IFIH1/IFITM3/IFIT1/IFI27/PLSCR1/EIF2AK2/VAPA/CHMP5/LY6E/BST2/ISG20/SLPI,14,PTX_72_shared,MSigDB
BP,GO:1903900,regulation of viral life cycle,10/115,143/18870,1.7222651455060086e-8,3.6010998496943814e-6,2.9088975902565605e-6,ISG15/IFIH1/IFITM3/IFIT1/PLSCR1/EIF2AK2/LY6E/BST2/ISG20/SLPI,10,PTX_72_shared,MSigDB
BP,GO:0019883,antigen processing and presentation of endogenous antigen,6/115,32/18870,3.5770599201961193e-8,6.856031513709229e-6,5.538167332584343e-6,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0016032,viral process,15/115,432/18870,5.79265946682972e-8,1.0018132307238068e-5,8.092450124611072e-6,ISG15/SLC3A2/IFIH1/IFITM3/IFIT1/IFI27/PLSCR1/EIF2AK2/VAPA/CHMP5/LY6E/STAT1/BST2/ISG20/SLPI,15,PTX_72_shared,MSigDB
BP,GO:0002428,antigen processing and presentation of peptide antigen via MHC class Ib,5/115,18/18870,6.194232387987001e-8,1.0018132307238068e-5,8.092450124611072e-6,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0009615,response to virus,15/115,436/18870,6.53356454819874e-8,1.0018132307238068e-5,8.092450124611072e-6,IFI6/ISG15/IFI44L/IFIH1/IFITM3/IFIT1/IFI27/PLSCR1/EIF2AK2/PMAIP1/STAT1/RIOK3/BST2/ISG20/DDIT4,15,PTX_72_shared,MSigDB
BP,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,6/115,36/18870,7.537674899547788e-8,1.0835407668099945e-5,8.752629077435426e-6,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0045104,intermediate filament cytoskeleton organization,8/115,94/18870,1.0710740432772651e-7,1.4491001761986526e-5,1.1705546045723673e-5,KRT17/DNAJB6/KRT16/KRT18/KRT6B/KRT6A/KRT81/KRT7,8,PTX_72_shared,MSigDB
BP,GO:0045103,intermediate filament-based process,8/115,95/18870,1.1636754658519984e-7,1.4869186508108868e-5,1.201103624110396e-5,KRT17/DNAJB6/KRT16/KRT18/KRT6B/KRT6A/KRT81/KRT7,8,PTX_72_shared,MSigDB
BP,GO:2001233,regulation of apoptotic signaling pathway,14/115,398/18870,1.4149329655977615e-7,1.7128135899341323e-5,1.3835771104044594e-5,IFI6/PLAUR/NUPR1/SP100/DDIT3/DNAJA1/TNFRSF12A/SOD2/PMAIP1/XBP1/HERPUD1/RBCK1/LGALS3/INHBA,14,PTX_72_shared,MSigDB
BP,GO:0045109,intermediate filament organization,7/115,73/18870,3.0362591174022285e-7,3.491697985012563e-5,2.8205249169552282e-5,KRT17/DNAJB6/KRT16/KRT6B/KRT6A/KRT81/KRT7,7,PTX_72_shared,MSigDB
BP,GO:0002475,antigen processing and presentation via MHC class Ib,5/115,25/18870,3.7124668075861803e-07,4.06603507497534e-5,3.2844631154835135e-5,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0071357,cellular response to type I interferon,7/115,83/18870,7.358968358308995e-7,7.693466920050312e-5,6.214631173404487e-5,ISG15/IFIH1/IFITM3/IFIT1/IFI27/SP100/STAT1,7,PTX_72_shared,MSigDB
BP,GO:0034340,response to type I interferon,7/115,89/18870,1.1850982423472112e-6,1.1850982423472111e-4,9.572990378685711e-5,ISG15/IFIH1/IFITM3/IFIT1/IFI27/SP100/STAT1,7,PTX_72_shared,MSigDB
BP,GO:0043331,response to dsRNA,6/115,57/18870,1.2655728009400965e-6,1.2128406009009257e-4,9.797087691488028e-5,SLC3A2/IFIH1/RIPK2/IFIT1/PMAIP1/RIOK3,6,PTX_72_shared,MSigDB
BP,GO:0097191,extrinsic apoptotic signaling pathway,10/115,229/18870,1.3955374828174849e-6,1.283894484192086e-4,1.037104697756994e-4,IFI6/IFI27/SP100/TNFRSF12A/PMAIP1/RBCK1/KRT8/LGALS3/INHBA/KRT18,10,PTX_72_shared,MSigDB
BP,GO:0072593,reactive oxygen species metabolic process,10/115,234/18870,1.6958899326391444e-6,1.5002103250269356e-4,1.211840376966838e-4,IFI6/GADD45A/EIF6/ARF4/PRDX1/SOD2/PMAIP1/PRDX5/NQO1/DDIT4,10,PTX_72_shared,MSigDB
BP,GO:0001819,positive regulation of cytokine production,14/115,499/18870,2.1095529928322944e-6,1.7970266235238063e-4,1.4516027416565302e-4,ISG15/B2M/IFIH1/RIPK2/HLA-E/HLA-A/ANXA1/EIF2AK2/DDIT3/XBP1/STAT1/RIOK3/SAA1/MDK,14,PTX_72_shared,MSigDB
BP,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",4/115,16/18870,2.2514064503431026e-6,1.8493695842104055e-4,1.4938843552088634e-4,HLA-C/HLA-B/HLA-E/HLA-A,4,PTX_72_shared,MSigDB
BP,GO:0002476,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,4/115,17/18870,2.9303148010344826e-6,2.2465746807931035e-4,1.8147388153774954e-4,HLA-C/HLA-B/HLA-E/HLA-A,4,PTX_72_shared,MSigDB
BP,GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,4/115,17/18870,2.9303148010344826e-6,2.2465746807931035e-4,1.8147388153774954e-4,HLA-C/HLA-B/HLA-E/HLA-A,4,PTX_72_shared,MSigDB
BP,GO:0097193,intrinsic apoptotic signaling pathway,11/115,319/18870,4.045636250343799e-6,3.001601088964754e-4,2.424634289255282e-4,IFI6/PLAUR/NUPR1/DDIT3/DNAJA1/SOD2/PMAIP1/XBP1/HERPUD1/CD24/DDIT4,11,PTX_72_shared,MSigDB
BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,5/115,40/18870,4.274697682955048e-6,3.072438959623941e-4,2.4818557271104146e-4,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0048002,antigen processing and presentation of peptide antigen,6/115,71/18870,4.660572760869275e-6,3.248277984848283e-4,2.623895031239002e-4,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0030968,endoplasmic reticulum unfolded protein response,6/115,75/18870,6.424227991111168e-6,4.345801288104613e-4,3.5104527567526975e-4,EIF2AK2/DDIT3/XBP1/HERPUD1/SERP1/CCND1,6,PTX_72_shared,MSigDB
BP,GO:1903706,regulation of hemopoiesis,12/115,417/18870,9.176881210275299e-6,6.03052193818091e-4,4.871336943198768e-4,ISG15/B2M/HLA-B/RIPK2/EIF6/ANXA1/XBP1/STAT1/TSC22D1/INHBA/ZFP36L2/MDK,12,PTX_72_shared,MSigDB
BP,GO:0060337,type I interferon-mediated signaling pathway,6/115,82/18870,1.07917173043219e-5,6.894708277761213e-4,5.569409661440981e-4,ISG15/IFIH1/IFITM3/IFI27/SP100/STAT1,6,PTX_72_shared,MSigDB
BP,GO:0002698,negative regulation of immune effector process,7/115,125/18870,1.1454238549640996e-5,7.006095205265167e-4,5.659385829424723e-4,HLA-B/HLA-E/HLA-A/CD47/ANXA1/LGALS3/BST2,7,PTX_72_shared,MSigDB
BP,GO:0031424,keratinization,6/115,83/18870,1.1575287730438102e-5,7.006095205265167e-4,5.659385829424723e-4,KRT17/KRT16/KRT6B/KRT6A/KRT81/KRT7,6,PTX_72_shared,MSigDB
BP,GO:0001914,regulation of T cell mediated cytotoxicity,5/115,50/18870,1.3112435462780348e-5,7.732974760101231e-4,6.246544829097791e-4,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0034620,cellular response to unfolded protein,6/115,89/18870,1.7300473333355784e-5,9.947772166679575e-4,8.035614587729726e-4,EIF2AK2/DDIT3/XBP1/HERPUD1/SERP1/CCND1,6,PTX_72_shared,MSigDB
BP,GO:0006986,response to unfolded protein,7/115,137/18870,2.0806574044747023e-5,0.001167198,9.428396197427085e-4,EIF2AK2/DDIT3/DNAJA1/XBP1/HERPUD1/SERP1/CCND1,7,PTX_72_shared,MSigDB
BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,8/115,190/18870,2.151400632995643e-5,0.001178148,9.516847411622332e-4,PLAUR/NUPR1/DDIT3/DNAJA1/SOD2/PMAIP1/XBP1/HERPUD1,8,PTX_72_shared,MSigDB
BP,GO:0050870,positive regulation of T cell activation,9/115,251/18870,2.331026948627647e-5,0.001246828,0.001007163,B2M/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/CD24/MDK,9,PTX_72_shared,MSigDB
BP,GO:0002697,regulation of immune effector process,11/115,389/18870,2.5942003494526994e-5,0.001356059,0.001095398,HLA-C/B2M/HLA-B/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/LGALS3/BST2,11,PTX_72_shared,MSigDB
BP,GO:0022409,positive regulation of cell-cell adhesion,10/115,322/18870,2.7874857853907665e-5,0.001424715,0.001150857,B2M/PLAUR/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/CD24/MDK,10,PTX_72_shared,MSigDB
BP,GO:0001913,T cell mediated cytotoxicity,5/115,60/18870,3.220055756361865e-5,0.001610028,0.001300549,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0042742,defense response to bacterium,10/115,330/18870,3.432942880892861e-5,0.001679951,0.001357031,ISG15/RIPK2/HLA-E/HLA-A/ANXA3/RBCK1/LCN2/WFDC2/KRT6A/SLPI,10,PTX_72_shared,MSigDB
BP,GO:0031960,response to corticosteroid,7/115,149/18870,3.572350673980724e-5,0.001711751,0.001382719,ANXA1/ANXA3/INHBA/IGFBP7/ZFP36L2/FBXO32/DDIT4,7,PTX_72_shared,MSigDB
BP,GO:0051701,biological process involved in interaction with host,8/115,211/18870,4.54545972109826e-5,0.00210825,0.001703003,SLC3A2/IFITM3/IFIT1/PLSCR1/VAPA/CHMP5/LY6E/KRT6A,8,PTX_72_shared,MSigDB
BP,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,4/115,33/18870,4.672977272586714e-5,0.00210825,0.001703003,DDIT3/PMAIP1/XBP1/HERPUD1,4,PTX_72_shared,MSigDB
BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,9/115,275/18870,4.7567709486029436e-5,0.00210825,0.001703003,B2M/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/CD24/MDK,9,PTX_72_shared,MSigDB
BP,GO:0022407,regulation of cell-cell adhesion,12/115,493/18870,4.7664777305283686e-5,0.00210825,0.001703003,B2M/PLAUR/RIPK2/HLA-E/SPINT2/HLA-A/CD47/ANXA1/XBP1/LGALS3/CD24/MDK,12,PTX_72_shared,MSigDB
BP,GO:0140888,interferon-mediated signaling pathway,6/115,107/18870,4.922996084348398e-5,0.002136395,0.001725737,ISG15/IFIH1/IFITM3/IFI27/SP100/STAT1,6,PTX_72_shared,MSigDB
BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,7/115,158/18870,5.191829040811929e-5,0.002203995,0.001780344,IFI6/SP100/TNFRSF12A/PMAIP1/RBCK1/LGALS3/INHBA,7,PTX_72_shared,MSigDB
BP,GO:0035456,response to interferon-beta,4/115,34/18870,5.271226080811496e-5,0.002203995,0.001780344,IFITM3/PLSCR1/STAT1/BST2,4,PTX_72_shared,MSigDB
BP,GO:0035966,response to topologically incorrect protein,7/115,159/18870,5.4038811199044345e-5,0.002203995,0.001780344,EIF2AK2/DDIT3/DNAJA1/XBP1/HERPUD1/SERP1/CCND1,7,PTX_72_shared,MSigDB
BP,GO:0035967,cellular response to topologically incorrect protein,6/115,109/18870,5.4620742556755006e-05,0.002203995,0.001780344,EIF2AK2/DDIT3/XBP1/HERPUD1/SERP1/CCND1,6,PTX_72_shared,MSigDB
BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,5/115,69/18870,6.343545795248468e-5,0.002472908,0.001997566,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0002711,positive regulation of T cell mediated immunity,5/115,69/18870,6.343545795248468e-5,0.002472908,0.001997566,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:1905898,positive regulation of response to endoplasmic reticulum stress,4/115,36/18870,6.632727070154244e-5,0.002542545,0.002053818,DDIT3/PMAIP1/XBP1/HERPUD1,4,PTX_72_shared,MSigDB
BP,GO:0019882,antigen processing and presentation,6/115,116/18870,7.731848833373998e-5,0.002887486,0.002332455,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0032481,positive regulation of type I interferon production,5/115,72/18870,7.783658408421606e-5,0.002887486,0.002332455,ISG15/IFIH1/RIPK2/STAT1/RIOK3,5,PTX_72_shared,MSigDB
BP,GO:0032609,type II interferon production,6/115,119/18870,8.909553907879362e-5,0.003201871,0.002586408,ISG15/RIPK2/HLA-A/CD47/DDIT3/INHBA,6,PTX_72_shared,MSigDB
BP,GO:0032649,regulation of type II interferon production,6/115,119/18870,8.909553907879362e-5,0.003201871,0.002586408,ISG15/RIPK2/HLA-A/CD47/DDIT3/INHBA,6,PTX_72_shared,MSigDB
BP,GO:0031343,positive regulation of cell killing,5/115,76/18870,1.0080803296527352e-4,0.003519409,0.002842909,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0032728,positive regulation of interferon-beta production,4/115,40/18870,1.0099173284174472e-4,0.003519409,0.002842909,ISG15/IFIH1/RIPK2/RIOK3,4,PTX_72_shared,MSigDB
BP,GO:0030216,keratinocyte differentiation,7/115,177/18870,1.0610080645029298e-4,0.003642266,0.002942151,ANXA1/KRT17/KRT16/KRT6B/KRT6A/KRT81/KRT7,7,PTX_72_shared,MSigDB
BP,GO:0045454,cell redox homeostasis,4/115,41/18870,1.1138599261202136e-4,0.003728704,0.003011973,PRDX1/DDIT3/PRDX5/NQO1,4,PTX_72_shared,MSigDB
BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6/115,124/18870,1.1186110513831192e-4,0.003728704,0.003011973,HLA-C/B2M/HLA-B/RIPK2/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0050863,regulation of T cell activation,10/115,381/18870,1.1363277107661594e-4,0.003733648,0.003015968,B2M/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/LGALS3/CD24/MDK,10,PTX_72_shared,MSigDB
BP,GO:1903037,regulation of leukocyte cell-cell adhesion,10/115,382/18870,1.1609719463312766e-4,0.003760895,0.003037977,B2M/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/LGALS3/CD24/MDK,10,PTX_72_shared,MSigDB
BP,GO:0051384,response to glucocorticoid,6/115,127/18870,1.2759414384674192e-4,0.004075924,0.003292451,ANXA1/ANXA3/IGFBP7/ZFP36L2/FBXO32/DDIT4,6,PTX_72_shared,MSigDB
BP,GO:0062197,cellular response to chemical stress,9/115,317/18870,1.4070976818823385e-4,0.004389183,0.003545496,SQSTM1/PRDX1/ANXA1/DDIT3/DNAJA1/SOD2/PRDX5/NQO1/MGST1,9,PTX_72_shared,MSigDB
BP,GO:0032872,regulation of stress-activated MAPK cascade,7/115,186/18870,1.44397391728172e-4,0.004389183,0.003545496,GADD45A/RIPK2/SDCBP/PRDX1/EIF2AK2/DNAJA1/IGFBP6,7,PTX_72_shared,MSigDB
BP,GO:1905897,regulation of response to endoplasmic reticulum stress,5/115,82/18870,1.4462554608496607e-4,0.004389183,0.003545496,NUPR1/DDIT3/PMAIP1/XBP1/HERPUD1,5,PTX_72_shared,MSigDB
BP,GO:0002821,positive regulation of adaptive immune response,6/115,130/18870,1.4503388808287756e-4,0.004389183,0.003545496,HLA-C/B2M/HLA-B/RIPK2/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0044000,movement in host,7/115,188/18870,1.5426857467960278e-4,0.004608022,0.00372227,SLC3A2/IFITM3/PLSCR1/VAPA/CHMP5/LY6E/KRT6A,7,PTX_72_shared,MSigDB
BP,GO:0044403,biological process involved in symbiotic interaction,9/115,322/18870,1.5823460817890528e-4,0.004640916,0.00374884,SLC3A2/IFITM3/IFIT1/IFI27/PLSCR1/VAPA/CHMP5/LY6E/KRT6A,9,PTX_72_shared,MSigDB
BP,GO:0070302,regulation of stress-activated protein kinase signaling cascade,7/115,189/18870,1.59405358977827e-4,0.004640916,0.00374884,GADD45A/RIPK2/SDCBP/PRDX1/EIF2AK2/DNAJA1/IGFBP6,7,PTX_72_shared,MSigDB
BP,GO:0035455,response to interferon-alpha,3/115,18/18870,1.6830954957314364e-4,0.0048389,0.003908768,IFITM3/EIF2AK2/BST2,3,PTX_72_shared,MSigDB
BP,GO:0045646,regulation of erythrocyte differentiation,4/115,46/18870,1.75326721058635e-4,0.004929464,0.003981924,ISG15/B2M/STAT1/INHBA,4,PTX_72_shared,MSigDB
BP,GO:0045785,positive regulation of cell adhesion,11/115,482/18870,1.7574612171753387e-4,0.004929464,0.003981924,B2M/PLAUR/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/SAA1/CD24/MDK,11,PTX_72_shared,MSigDB
BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7/115,193/18870,1.81357729158184e-4,0.005025576,0.004059561,HLA-C/B2M/HLA-B/RIPK2/HLA-E/HLA-A/ANXA1,7,PTX_72_shared,MSigDB
BP,GO:0051251,positive regulation of lymphocyte activation,9/115,330/18870,1.9005063596366385e-4,0.005203767,0.004203501,B2M/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/CD24/MDK,9,PTX_72_shared,MSigDB
BP,GO:0001909,leukocyte mediated cytotoxicity,6/115,140/18870,2.17207800866641e-4,0.005877388,0.004747638,HLA-C/B2M/HLA-B/HLA-E/PRDX1/HLA-A,6,PTX_72_shared,MSigDB
BP,GO:0043122,regulation of canonical NF-kappaB signal transduction,8/115,265/18870,2.2048219428300034e-4,0.005896617,0.004763171,RIPK2/SQSTM1/VAPA/TFG/RBCK1/STAT1/RIOK3/BST2,8,PTX_72_shared,MSigDB
BP,GO:0043330,response to exogenous dsRNA,4/115,49/18870,2.2446287194779468e-4,0.005911519,0.004775208,SLC3A2/IFIH1/RIPK2/IFIT1,4,PTX_72_shared,MSigDB
BP,GO:0034976,response to endoplasmic reticulum stress,8/115,266/18870,2.2617984445085326e-4,0.005911519,0.004775208,NUPR1/EIF2AK2/DDIT3/PMAIP1/XBP1/HERPUD1/SERP1/CCND1,8,PTX_72_shared,MSigDB
BP,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,3/115,20/18870,2.3305757607014935e-4,0.006022836,0.004865129,HLA-B/HLA-E/HLA-A,3,PTX_72_shared,MSigDB
BP,GO:0071385,cellular response to glucocorticoid stimulus,4/115,50/18870,2.428411707725784e-4,0.006196382,0.005005315,ANXA1/ZFP36L2/FBXO32/DDIT4,4,PTX_72_shared,MSigDB
BP,GO:0007159,leukocyte cell-cell adhesion,10/115,419/18870,2.451611896226157e-4,0.006196382,0.005005315,B2M/RIPK2/HLA-E/HLA-A/CD47/ANXA1/XBP1/LGALS3/CD24/MDK,10,PTX_72_shared,MSigDB
BP,GO:0002699,positive regulation of immune effector process,8/115,270/18870,2.5019328126507103e-4,0.006254832,0.00505253,HLA-C/B2M/HLA-B/RIPK2/HLA-E/HLA-A/ANXA1/XBP1,8,PTX_72_shared,MSigDB
BP,GO:0000302,response to reactive oxygen species,7/115,205/18870,2.622854384410235e-4,0.006402685,0.005171963,SQSTM1/PRDX1/ANXA1/SOD2/PRDX5/STAT1/NQO1,7,PTX_72_shared,MSigDB
BP,GO:2001235,positive regulation of apoptotic signaling pathway,6/115,145/18870,2.62589466769112e-4,0.006402685,0.005171963,NUPR1/DDIT3/TNFRSF12A/PMAIP1/RBCK1/INHBA,6,PTX_72_shared,MSigDB
BP,GO:0042060,wound healing,10/115,423/18870,2.6445873487150156e-4,0.006402685,0.005171963,MYL12A/PLAUR/CLIC1/PLSCR1/ANXA1/TNFRSF12A/CHMP5/XBP1/SAA1/KRT6A,10,PTX_72_shared,MSigDB
BP,GO:0002716,negative regulation of natural killer cell mediated immunity,3/115,21/18870,2.7069526788773386e-4,0.006485407,0.005238785,HLA-B/HLA-E/HLA-A,3,PTX_72_shared,MSigDB
BP,GO:0002819,regulation of adaptive immune response,7/115,208/18870,2.864884058162515e-4,0.006793024,0.005487271,HLA-C/B2M/HLA-B/RIPK2/HLA-E/HLA-A/ANXA1,7,PTX_72_shared,MSigDB
BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,5/115,96/18870,3.0280483507291815e-4,0.007073398,0.005713752,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,4/115,53/18870,3.0446364636164253e-4,0.007073398,0.005713752,TNFRSF12A/PMAIP1/RBCK1/INHBA,4,PTX_72_shared,MSigDB
BP,GO:0002709,regulation of T cell mediated immunity,5/115,99/18870,3.492292008089405e-4,0.007952744,0.00642407,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
BP,GO:0098869,cellular oxidant detoxification,5/115,99/18870,3.492292008089405e-4,0.007952744,0.00642407,PRDX1/SOD2/PRDX5/NQO1/MGST1,5,PTX_72_shared,MSigDB
BP,GO:0019430,removal of superoxide radicals,3/115,23/18870,3.572649476045374e-4,0.007977761,0.006444278,PRDX1/SOD2/NQO1,3,PTX_72_shared,MSigDB
BP,GO:0071359,cellular response to dsRNA,3/115,23/18870,3.572649476045374e-4,0.007977761,0.006444278,IFIH1/IFIT1/RIOK3,3,PTX_72_shared,MSigDB
BP,GO:0034614,cellular response to reactive oxygen species,6/115,154/18870,3.6279621058290883e-4,0.008023378,0.006481127,SQSTM1/PRDX1/ANXA1/SOD2/PRDX5/NQO1,6,PTX_72_shared,MSigDB
BP,GO:0001836,release of cytochrome c from mitochondria,4/115,56/18870,3.7656361369306165e-4,0.008248536,0.006663005,IFI6/PLAUR/SOD2/PMAIP1,4,PTX_72_shared,MSigDB
BP,GO:0032727,positive regulation of interferon-alpha production,3/115,24/18870,4.0649436724362166e-4,0.008737729,0.007058166,IFIH1/RIPK2/STAT1,3,PTX_72_shared,MSigDB
BP,GO:0060706,cell differentiation involved in embryonic placenta development,3/115,24/18870,4.0649436724362166e-4,0.008737729,0.007058166,SPINT2/DNAJB6/KRT8,3,PTX_72_shared,MSigDB
BP,GO:0001906,cell killing,7/115,223/18870,4.358918890575315e-4,0.009282883,0.00749853,HLA-C/B2M/HLA-B/HLA-E/PRDX1/HLA-A/KRT6A,7,PTX_72_shared,MSigDB
BP,GO:0042102,positive regulation of T cell proliferation,5/115,105/18870,4.580334301178522e-4,0.009283012,0.007498634,RIPK2/HLA-E/HLA-A/ANXA1/CD24,5,PTX_72_shared,MSigDB
BP,GO:0046641,positive regulation of alpha-beta T cell proliferation,3/115,25/18870,4.598800259810592e-4,0.009283012,0.007498634,RIPK2/HLA-E/HLA-A,3,PTX_72_shared,MSigDB
BP,GO:0071450,cellular response to oxygen radical,3/115,25/18870,4.598800259810592e-4,0.009283012,0.007498634,PRDX1/SOD2/NQO1,3,PTX_72_shared,MSigDB
BP,GO:0071451,cellular response to superoxide,3/115,25/18870,4.598800259810592e-4,0.009283012,0.007498634,PRDX1/SOD2/NQO1,3,PTX_72_shared,MSigDB
BP,GO:0032608,interferon-beta production,4/115,59/18870,4.601144889785051e-4,0.009283012,0.007498634,ISG15/IFIH1/RIPK2/RIOK3,4,PTX_72_shared,MSigDB
BP,GO:0032648,regulation of interferon-beta production,4/115,59/18870,4.601144889785051e-4,0.009283012,0.007498634,ISG15/IFIH1/RIPK2/RIOK3,4,PTX_72_shared,MSigDB
BP,GO:0071384,cellular response to corticosteroid stimulus,4/115,60/18870,4.906797697938549e-4,0.009813595,0.007927229,ANXA1/ZFP36L2/FBXO32/DDIT4,4,PTX_72_shared,MSigDB
CC,GO:0030670,phagocytic vesicle membrane,8/116,80/19886,2.1461196960315268e-8,5.773061982324807e-6,4.676281863984485e-6,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A/ATP6V0E1/ANXA3,8,PTX_72_shared,MSigDB
CC,GO:0045095,keratin filament,8/116,97/19886,9.855526212321943e-8,1.3255682755573013e-5,1.0737336452371803e-5,KRT17/KRT8/KRT16/KRT18/KRT6B/KRT6A/KRT81/KRT7,8,PTX_72_shared,MSigDB
CC,GO:0042611,MHC protein complex,5/116,25/19886,2.9971359668914616e-7,2.687431916979344e-5,2.176867175952746e-5,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
CC,GO:0045335,phagocytic vesicle,8/116,142/19886,1.840513025761455e-6,1.2377450098245785e-4,1.0025952535068981e-4,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A/ATP6V0E1/ANXA3,8,PTX_72_shared,MSigDB
CC,GO:0030666,endocytic vesicle membrane,9/116,202/19886,2.8764196204448885e-6,1.54751375579935e-4,1.2535133924886148e-4,HLA-C/B2M/HLA-B/TAP1/UBC/HLA-E/HLA-A/ATP6V0E1/ANXA3,9,PTX_72_shared,MSigDB
CC,GO:0005882,intermediate filament,9/116,214/19886,4.609000253580763e-6,2.0663684470220424e-4,1.6737948289319616e-4,EIF6/KRT17/KRT8/KRT16/KRT18/KRT6B/KRT6A/KRT81/KRT7,9,PTX_72_shared,MSigDB
CC,GO:0030139,endocytic vesicle,11/116,348/19886,6.152783097820337e-6,2.3644266475909582e-4,1.9152272199230222e-4,HLA-C/B2M/HLA-B/TAP1/UBC/HLA-E/HLA-A/ATP6V0E1/ANXA3/CLTB/SAA1,11,PTX_72_shared,MSigDB
CC,GO:0045111,intermediate filament cytoskeleton,9/116,250/19886,1.6082238736287324e-5,5.407652775076613e-4,4.380293971594048e-4,EIF6/KRT17/KRT8/KRT16/KRT18/KRT6B/KRT6A/KRT81/KRT7,9,PTX_72_shared,MSigDB
CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,4/116,29/19886,2.3324354372960015e-5,6.971390362584715e-4,5.646948953453479e-4,HLA-C/HLA-B/HLA-E/HLA-A,4,PTX_72_shared,MSigDB
CC,GO:0012507,ER to Golgi transport vesicle membrane,5/116,64/19886,3.588220938425149e-5,9.652314324363649e-4,7.818544571094798e-4,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
CC,GO:0098576,lumenal side of membrane,4/116,38/19886,6.9613709134019625e-05,0.001702372,0.001378951,HLA-C/HLA-B/HLA-E/HLA-A,4,PTX_72_shared,MSigDB
CC,GO:0031901,early endosome membrane,7/116,195/19886,1.482184843927108e-4,0.003322564,0.002691336,HLA-C/B2M/HLA-B/IFITM3/HLA-E/HLA-A/ANXA1,7,PTX_72_shared,MSigDB
CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,5/116,94/19886,2.248218009913269e-4,0.004652082,0.003768268,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
CC,GO:0042581,specific granule,6/116,160/19886,3.535501861707302e-4,0.006793214,0.005502623,B2M/PLAUR/CD47/ANXA3/LCN2/SLPI,6,PTX_72_shared,MSigDB
CC,GO:0055038,recycling endosome membrane,5/116,107/19886,4.10035162853458e-4,0.007353297,0.0059563,HLA-C/B2M/HLA-B/HLA-E/HLA-A,5,PTX_72_shared,MSigDB
CC,GO:0030667,secretory granule membrane,8/116,314/19886,5.133220126739092e-4,0.008630226,0.006990635,HLA-C/HLA-B/PLAUR/CD47/VAPA/LGALS3/BST2/MGST1,8,PTX_72_shared,MSigDB
MF,GO:0042605,peptide antigen binding,6/113,47/18496,3.983046466349452e-7,1.2586426833664267e-4,1.1068676495960582e-4,HLA-C/B2M/HLA-B/TAP1/HLA-E/HLA-A,6,PTX_72_shared,MSigDB
MF,GO:0045296,cadherin binding,12/113,334/18496,9.539162845803498e-7,1.5071877296369526e-4,1.3254415743642754e-4,SLC3A2/CLIC1/PRDX1/CNN3/ANXA1/EIF5/VAPA/CHMP5/S100A11/STAT1/S100P/KRT18,12,PTX_72_shared,MSigDB
MF,GO:0098641,cadherin binding involved in cell-cell adhesion,4/113,18/18496,3.783144642236756e-6,3.984912356489383e-4,3.504386615966679e-4,CNN3/ANXA1/S100A11/KRT18,4,PTX_72_shared,MSigDB
MF,GO:0098632,cell-cell adhesion mediator activity,5/113,52/18496,1.6095799417785252e-5,0.001271568,0.001118234,CD47/CNN3/ANXA1/S100A11/KRT18,5,PTX_72_shared,MSigDB
MF,GO:0098631,cell adhesion mediator activity,5/113,65/18496,4.8026802931350704e-5,0.003035294,0.002669279,CD47/CNN3/ANXA1/S100A11/KRT18,5,PTX_72_shared,MSigDB
MF,GO:0030280,structural constituent of skin epidermis,4/113,36/18496,6.690566618792198e-5,0.003523698,0.003098789,KRT6B/KRT6A/KRT81/KRT7,4,PTX_72_shared,MSigDB
MF,GO:0016209,antioxidant activity,5/113,83/18496,1.5471792587537503e-4,0.006984409,0.006142185,PRDX1/SOD2/PRDX5/NQO1/MGST1,5,PTX_72_shared,MSigDB
MF,GO:0005520,insulin-like growth factor binding,3/113,19/18496,2.0034186168903058e-4,0.007913504,0.006959244,IGFBP7/IGFBP6/IGFBP3,3,PTX_72_shared,MSigDB
MF,GO:0003743,translation initiation factor activity,4/113,51/18496,2.6452965403246344e-4,0.00928793,0.008167933,EIF6/EIF5/EIF2S2/EIF1,4,PTX_72_shared,MSigDB
